Datasets:
ChatDOC
/
OCRFlux-pubtabnet-single

Dataset card Data Studio Files Community
image_name
stringlengths
68
68
type
stringclasses
2 values
gt_table
stringlengths
116
12.6k
9411efb69a3d53f63188a57a3a98dccd5a72e574a1ec3e4b67efa0319a278656.png
complex
<table><tr><td rowspan="2">Genotype</td><td>Case</td><td>Control</td><td colspan="2">Dominant</td><td colspan="2">Recessive</td><td colspan="2">Additive</td></tr><tr><td><i>n</i> (%)</td><td><i>n</i> (%)</td><td>OR (95%CI)</td><td><i>p</i></td><td>OR (95%CI)</td><td><i>p</i></td><td>OR (95%CI)</td><td><i>p</i></td></tr><tr><td>GG</td><td>89 (18.39)</td><td>46 (21.90)</td><td>0.96 (0.65,1.42)</td><td>0.83</td><td>0.68 (0.44,1.06)</td><td>0.09</td><td>0.87 (0.67,1.12)</td><td>0.27</td></tr><tr><td>GA</td><td>243 (50.21)</td><td>101 (48.10)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>AA</td><td>152 (31.40)</td><td>63 (30.00)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr></table>
66259e58bdf67b7b0e679fa324b971b51f1447ce02345a350c1ebf20dfb69abb.png
complex
<table><tr><td rowspan="2"></td><td colspan="2">Overall frequency</td><td colspan="5">Uptake of facility-based delivery</td></tr><tr><td><i>N</i></td><td>%</td><td>%</td><td>PR<sub>u</sub></td><td>95 % CI</td><td>PR<sub>a</sub></td><td>95 % CI<sup>a</sup></td></tr><tr><td>Self-reported HIV status</td><td></td><td></td><td></td><td colspan="2">(<i>p</i> &lt; 0.001)</td><td colspan="2">(<i>p</i> &lt; 0.001)</td></tr><tr><td>Not tested / unknown status before delivery</td><td>686</td><td>(7.8)</td><td>44.4</td><td>0.56</td><td>(0.49&#8211;0.64)</td><td>0.60</td><td>(0.54&#8211;0.68)</td></tr><tr><td>Self-reported HIV-negative before delivery</td><td>7067</td><td>(80.3)</td><td>79.3</td><td>1.00</td><td></td><td>1.00</td><td></td></tr><tr><td>Self-reportedHIV-positive before pregnancy</td><td>584</td><td>(6.6)</td><td>82.2</td><td>1.04</td><td>(0.99&#8211;1.09)</td><td>1.04</td><td>(1.00&#8211;1.09)</td></tr><tr><td>Self-reported HIV-positive during pregnancy</td><td>459</td><td>(5.2)</td><td>80.4</td><td>1.01</td><td>(0.97&#8211;1.06)</td><td>1.05</td><td>(1.01&#8211;1.09)</td></tr></table>
81de23a8da6210b7f9991ef4dc850cea41438a8396f779094160bb1c3146e271.png
complex
<table><tr><td></td><td>Aneurysms</td><td>Pseudo-aneurysms</td></tr><tr><td>Location</td><td>3% posterior</td><td>Posterior or inferior</td></tr><tr><td>Echocardiography</td><td></td><td></td></tr><tr><td> Anatomy</td><td>Thinned myocardium</td><td>Ruptures</td></tr><tr><td> Contractility</td><td>Non contractile</td><td>Dyskinesia</td></tr><tr><td>Consequences/Complications</td><td colspan="2">Congestive heart failureEmbolic eventsVentricular arrhythmias</td></tr><tr><td>Therapy</td><td>Medical or Surgical therapy</td><td>Surgery</td></tr><tr><td>Surgical risk</td><td>Dubious</td><td>Lower than medical therapy</td></tr></table>
7fb4ae1124b96cbab55538ed38bfd6efdfd59f947b25a7ff119411522c7d82b1.png
complex
<table><tr><td rowspan="3">Impression technique</td><td rowspan="3"><i>n</i></td><td colspan="6">Internal discrepancy to master model (<i>&#956;</i>m)</td></tr><tr><td colspan="2">Premolar 34</td><td colspan="2">Molar 36</td><td colspan="2">FDP 34&#8211;36</td></tr><tr><td>Mean</td><td>(SD)</td><td>Mean</td><td>(SD)</td><td>Mean</td><td>(SD)</td></tr><tr><td>Conventional</td><td>10</td><td>100</td><td>6.7</td><td>127</td><td>15.7</td><td>117</td><td>11.6</td></tr><tr><td>Digital</td><td>10</td><td>91</td><td>8.8</td><td>95</td><td>8.5</td><td>93</td><td>8.2</td></tr><tr><td>Significance (2-tailed) (<i>P</i> &lt; 0.01)</td><td> </td><td>0.016</td><td> </td><td>&lt;0.001</td><td> </td><td>&lt;0.001</td><td> </td></tr></table>
4e049457ee30e2ce79cdd1625e9df1accb42374f6f90ac8586f57418393141d0.png
complex
<table><tr><td></td><td>Numb PTB/Pon A2B2 complex</td><td>Numb PTB/Pon B1A2 complex</td></tr><tr><td colspan="3"><i>Data collection</i></td></tr><tr><td>Space group</td><td><i>P</i>3221</td><td><i>P</i>3112</td></tr><tr><td colspan="3"> Cell dimensions</td></tr><tr><td><i>a</i>, <i>b</i>, <i>c</i> (A&#778;)</td><td>43.392, 43.392, 181.304</td><td>65.593, 65.593, 143.879</td></tr><tr><td><i>&#945;</i>, <i>&#946;</i>, <i>&#947;</i> (&#176;)</td><td>90, 90, 120</td><td>90, 90,120</td></tr><tr><td> Resolution (A&#778;)</td><td>50.00&#8211;2.00 (2.03&#8211;2.00)<sup>a</sup></td><td>50.00&#8211;1.70 (1.73&#8211;1.70)<sup>a</sup></td></tr><tr><td><i> R</i><sub>merge</sub> (%)</td><td>5.2 (76.2)</td><td>5.6 (79.5)</td></tr><tr><td><i> I</i>/<i>&#963;I</i></td><td>24.6 (2.0)</td><td>52.1 (3.1)</td></tr><tr><td> Completeness (%)</td><td>98.6 (96.7)</td><td>99.3 (97.7)</td></tr><tr><td> Redundancy</td><td>4.8 (4.3)</td><td>9.8 (9.4)</td></tr><tr><td colspan="3"><i>Refinement</i></td></tr><tr><td>Resolution (A&#778;)</td><td>36.80&#8211;2.00</td><td>30.39&#8211;1.70</td></tr><tr><td>No. of reflections</td><td>13,901</td><td>39,079</td></tr><tr><td> <i> R</i><sub>work</sub>/<i>R</i><sub>free</sub></td><td>19.1/22.7</td><td>19.4/21.8</td></tr><tr><td colspan="3"> No. of atoms</td></tr><tr><td>Protein</td><td>1222</td><td>2164</td></tr><tr><td>FMT</td><td>3</td><td></td></tr><tr><td>Glycerol</td><td></td><td>12</td></tr><tr><td>Water</td><td>53</td><td>155</td></tr><tr><td colspan="3"><i> B</i>-factors</td></tr><tr><td>Protein</td><td>30.84</td><td>29.00</td></tr><tr><td>FMT</td><td>41.56</td><td></td></tr><tr><td>Glycerol</td><td></td><td>38.18</td></tr><tr><td>Water</td><td>31.58</td><td>32.91</td></tr><tr><td colspan="3"> R.m.s. deviations</td></tr><tr><td>Bond lengths (A&#778;)</td><td>0.010</td><td>0.011</td></tr><tr><td>Bond angles (&#176;)</td><td>0.951</td><td>1.138</td></tr></table>
3d91373152c5aef82c4a1d75f234ef5681eec53bf841cbf8648064534985fbb1.png
simple
<table><tr><td>Variable</td><td>Min</td><td>Max</td><td>Mean</td><td>SD</td><td>CV</td></tr><tr><td>RVd (cm)</td><td>4.3</td><td>8.0</td><td>5.3</td><td>1.2</td><td>22%</td></tr><tr><td>RVs (cm)</td><td>4.2</td><td>4.6</td><td>4.1</td><td>0.4</td><td>10%</td></tr><tr><td>LVd (cm)</td><td>9.9</td><td>15.5</td><td>11.8</td><td>1.6</td><td>14%</td></tr><tr><td>LVs (cm)</td><td>7.8</td><td>9.4</td><td>8.2</td><td>0.6</td><td>10%</td></tr><tr><td>RAd (cm)</td><td>5.0</td><td>6.5</td><td>5.9</td><td>0.5</td><td>10%</td></tr><tr><td>RAs (cm)</td><td>3.0</td><td>4.5</td><td>3.9</td><td>0.4</td><td>10%</td></tr><tr><td>LAd (cm)</td><td>6.8</td><td>8.8</td><td>7.6</td><td>0.6</td><td>10%</td></tr><tr><td>LAs (cm)</td><td>4.7</td><td>6.4</td><td>5.6</td><td>0.5</td><td>10%</td></tr><tr><td>RVWd (cm)</td><td>1.5</td><td>2.4</td><td>1.8</td><td>0.2</td><td>10%</td></tr><tr><td>RVWs (cm)</td><td>1.2</td><td>2.0</td><td>1.5</td><td>0.2</td><td>13%</td></tr><tr><td>IVSd (cm)</td><td>1.7</td><td>3.0</td><td>2.1</td><td>0.3</td><td>14%</td></tr><tr><td>IVSs (cm)</td><td>1.2</td><td>3.9</td><td>2.8</td><td>0.7</td><td>30%</td></tr><tr><td>LVWd (cm)</td><td>1.8</td><td>3.4</td><td>2.8</td><td>0.4</td><td>14%</td></tr><tr><td>LVWs (cm)</td><td>1.1</td><td>2.4</td><td>1.9</td><td>0.4</td><td>21%</td></tr><tr><td>AOd(cm)</td><td>6.0</td><td>8.2</td><td>7.0</td><td>0.8</td><td>11%</td></tr><tr><td>PAd (cm)</td><td>6.0</td><td>9.7</td><td>8.1</td><td>1.2</td><td>15%</td></tr><tr><td>TVDs (cm)</td><td>2.6</td><td>6.8</td><td>4.1</td><td>1.1</td><td>27%</td></tr><tr><td>MVDs (cm)</td><td>4.3</td><td>7.8</td><td>6.2</td><td>1.0</td><td>16%</td></tr></table>
7784572b2adaba9c441f49e72c73d2f288cee22206129adc281ef3f2593dc637.png
simple
<table><tr><td>District</td><td>No. of IDUs</td><td>Male</td><td>Female</td><td>Married</td><td>Education</td><td>Economic status</td></tr><tr><td>Peshawar</td><td>100</td><td>98</td><td>2</td><td>62</td><td></td><td></td></tr><tr><td>Kohat</td><td>60</td><td>60</td><td>-</td><td>30</td><td>Basic: 98%</td><td>&lt; 1$/day: 95%</td></tr><tr><td>Mardan</td><td>40</td><td>40</td><td>-</td><td>28</td><td>High: 2%</td><td>Well off: 5%</td></tr><tr><td>Total</td><td>200</td><td>198</td><td>2</td><td>120</td><td></td><td></td></tr></table>
faa65ee37108fe88a9bf93106badd1fb5956eb79f4bbbc11bc57ee6debbd02e1.png
complex
<table><tr><td rowspan="3"><i>T</i><sub>b</sub> (&#176;C)</td><td colspan="8">Season</td></tr><tr><td colspan="2">Dec&#8211;Feb &#8220;Summer&#8221;</td><td colspan="2">Mar&#8211;May &#8220;Autumn&#8221;</td><td colspan="2">Jun&#8211;Aug &#8220;Winter&#8221;</td><td colspan="2">Sep&#8211;Nov &#8220;Spring&#8221;</td></tr><tr><td>M (<i>n</i> = 12)</td><td>F (<i>n</i> = 6)</td><td>M (<i>n</i> = 12)</td><td>F (<i>n</i> = 6)</td><td>M (<i>n</i> = 10)</td><td>F (<i>n</i> = 5)</td><td>M (<i>n</i> = 8)</td><td>F (<i>n</i> = 5)</td></tr><tr><td>Mean</td><td>37.7 &#177; 0.1</td><td>37.8 &#177; 0.1</td><td>37.5 &#177; 0.2</td><td>37.7 &#177; 0.1</td><td>37.3 &#177; 0.3</td><td>37.5 &#177; 0.5</td><td>37.5 &#177; 0.2</td><td>37.7 &#177; 0.1</td></tr><tr><td>Minimum</td><td>36.7 &#177; 0.2</td><td>36.7 &#177; 0.3</td><td>36.3 &#177; 0.2</td><td>36.8 &#177; 0.2</td><td>35.9 &#177; 0.4</td><td>36.3 &#177; 0.5</td><td>36.0 &#177; 0.3</td><td>36.4 &#177; 0.3</td></tr><tr><td>Maximum</td><td>38.8 &#177; 0.1</td><td>39.0 &#177; 0.1</td><td>38.7 &#177; 0.2</td><td>38.8 &#177; 0.1</td><td>38.6 &#177; 0.4</td><td>38.6 &#177; 0.6</td><td>38.8 &#177; 0.2</td><td>39.0 &#177; 0.1</td></tr><tr><td>Amplitude</td><td>2.1 &#177; 0.2</td><td>2.3 &#177; 0.3</td><td>2.5 &#177; 0.3</td><td>2.1 &#177; 0.2</td><td>2.7 &#177; 0.6</td><td>2.3 &#177; 0.3</td><td>2.8 &#177; 0.5</td><td>2.6 &#177; 0.3</td></tr></table>
929170bb2d654bb7cdc3f441e7a0c40358518e9efd3902f42b79b48ab5e2b819.png
complex
<table><tr><td>Gene</td><td>Primer</td><td>Annealing Temp (&#176; C)</td></tr><tr><td rowspan="2">Fshr</td><td>F: TGGAGGCGGCAAACCTCTGAAC</td><td rowspan="2">65</td></tr><tr><td>R: TCTGGCTTTGGCGAGCAGGTC</td></tr><tr><td rowspan="2">Oct-4A</td><td>F: CCATGTCCGCCCGCATACGA</td><td rowspan="2">61</td></tr><tr><td>R: GGGCTTTCATGTCCTGGGACTCCT</td></tr><tr><td>Total</td><td>F: CCTGGGCGTTCTCTTTGGAAAGGTG</td><td rowspan="2">68</td></tr><tr><td>Oct-4</td><td>R: GCCTGCACCAGGGTCTCCGA</td></tr><tr><td rowspan="2">Nanog[34]</td><td>F: CAGGAGTTTGAGGGTAGCTC</td><td rowspan="2">61</td></tr><tr><td>R: CGGTTCATCATGGTACAGTC</td></tr><tr><td rowspan="2">Stella</td><td>F: ACGCTTTGGATGATACAGACGTCC</td><td rowspan="2">67</td></tr><tr><td>R: GCGCTTTGAACTTCCCTCCGGA</td></tr><tr><td rowspan="2">Fragilis</td><td>F: GGGGTGACTGAGCTGGGGGAA</td><td rowspan="2">65</td></tr><tr><td>R: TGTCCCTAGACTTCACAGAGTAGGC</td></tr><tr><td rowspan="2">Nobox</td><td>F: AGGGTGCTGAGAGGGTGGCAG</td><td rowspan="2">66</td></tr><tr><td>R: GGCGATACTAGTGCCCCAGGAC</td></tr><tr><td rowspan="2">HoxA10</td><td>F:CACTTGTCCGGCACCCCTTCG</td><td rowspan="2">65</td></tr><tr><td>R: TTCGCCTTTGGAACTGCCTTGAC</td></tr><tr><td rowspan="2">Mvh</td><td>F: AGTGGAAGTGGTCGAGGTGGT</td><td rowspan="2">61</td></tr><tr><td>R: TGCCGGTGGTGCATCATGTCC</td></tr><tr><td rowspan="2">Scp3</td><td>F: TGTTGCAGCAGTGGGAACTGGAT</td><td rowspan="2">68</td></tr><tr><td>R: CCATCTCTTGCTGCTGAGTTTCCA</td></tr><tr><td rowspan="2">Dmc-1</td><td>F: TGGGGAATTGGCTGAACGCC</td><td rowspan="2">68</td></tr><tr><td>R: CAGGCATCTCGGGGCTGTCATAA</td></tr><tr><td rowspan="2">Stra8</td><td>F: GTTTCCTGCGTGTTCCACAAG</td><td rowspan="2">61</td></tr><tr><td>R: CACCCGAGGCTCAAGCTTC</td></tr><tr><td rowspan="2">18s</td><td>F:GGAGAGGGAGCCTGAGAAAC</td><td rowspan="2">61</td></tr><tr><td>R: CCTCCAATGGATCCTCGTTA</td></tr><tr><td>Gapdh[34]</td><td>F: GTCCCGTAGACAAAATGGTGA</td><td>58</td></tr><tr><td> </td><td>R: TGCATTGCTGACAATCTTGAG</td><td> </td></tr></table>
673423625975b7ec88e03679d1b5f0341521351ff04b09ac2b2eacbb4773bf32.png
complex
<table><tr><td></td><td>Cohorta</td><td>Age (years)</td><td>Effect</td><td>Measurement</td><td>Reference</td></tr><tr><td colspan="6">Verbal functions</td></tr><tr><td> Vocabulary</td><td>Oswego</td><td>3</td><td>&#8595;</td><td>MSCA Word Knowledge</td><td>Stewart et al. 2003b</td></tr><tr><td></td><td></td><td>4.5</td><td>&#8211;</td><td>MSCA Word Knowledge</td><td>Stewart et al. 2003b</td></tr><tr><td></td><td>Michigan</td><td>4</td><td>&#8211;</td><td>PPVT</td><td>Jacobson et al. 1990</td></tr><tr><td></td><td></td><td>11</td><td>&#8595;</td><td>WISC-R Vocabulary</td><td>Jacobson and Jacobson 1996</td></tr><tr><td></td><td></td><td>11</td><td>&#8595;</td><td>WRMT Word Comprehension</td><td>Jacobson and Jacobson 1996</td></tr><tr><td></td><td>Faroe Islands</td><td>7</td><td>&#8211;b</td><td>BNT</td><td>Grandjean et al. 2001</td></tr><tr><td> Verbal comprehension</td><td>Netherlands</td><td>3.5</td><td>&#8595;c</td><td>RLDS</td><td>Patandin et al. 1999b</td></tr><tr><td> Reading comprehension</td><td>Michigan</td><td>11</td><td>&#8595;</td><td>WRMT Reading Comprehension</td><td>Jacobson and Jacobson 1996</td></tr><tr><td> Verbal abstraction</td><td>Michigan</td><td>11</td><td>&#8595;</td><td>WISC-R Similitudes</td><td>Jacobson and Jacobson 1996</td></tr><tr><td></td><td>Faroe Islands</td><td>7</td><td>&#8211;</td><td>WISC-R Similitudes</td><td>Grandjean et al. 2001</td></tr><tr><td colspan="6">Visual&#8211;spatial functions</td></tr><tr><td> Visuo-motor integration</td><td>Oswego</td><td>3</td><td>&#8595;</td><td>MSCA Block Building</td><td>Stewart et al. 2003b</td></tr><tr><td></td><td></td><td>4.5</td><td>&#8211;</td><td>MSCA Block Building</td><td>Stewart et al. 2003b</td></tr><tr><td></td><td>Michigan</td><td>4</td><td>&#8211;</td><td>BTVMI</td><td>Jacobson et al. 1990</td></tr><tr><td></td><td>Netherlands</td><td>9</td><td>&#8211;</td><td>Rey Complex Figure Test copy</td><td>Vreugdenhil et al. 2004a</td></tr><tr><td></td><td>Faroe Islands</td><td>7</td><td>&#8211;</td><td>WISC Block Design</td><td>Grandjean et al. 2001</td></tr><tr><td> Mental rotation</td><td>Michigan</td><td>11</td><td>&#8211;</td><td>Mental Rotation</td><td>Jacobson and Jacobson 2003</td></tr><tr><td> Visual discrimination</td><td>Michigan</td><td>4</td><td>&#8211;</td><td>KMFF</td><td>Jacobson et al. 1992</td></tr></table>
96da0e6255aba28ea723141f76cf1bef1ffeea974767130eb0f638eb38dd9c67.png
complex
<table><tr><td rowspan="2">Period</td><td colspan="4">Experimental Station</td><td colspan="4">Control Station</td></tr><tr><td>Male</td><td>Female</td><td>Total</td><td>Number of trains</td><td>Male</td><td>Female</td><td>Total</td><td>Number of trains</td></tr><tr><td>Pre</td><td>666</td><td>575</td><td>1,241</td><td>257</td><td>290</td><td>216</td><td>506</td><td>239</td></tr><tr><td>Intervention</td><td>1,115</td><td>1,164</td><td>2,279</td><td>247</td><td>243</td><td>216</td><td>459</td><td>246</td></tr><tr><td>Post</td><td>585</td><td>555</td><td>1,140</td><td>254</td><td>254</td><td>199</td><td>453</td><td>253</td></tr></table>
b6178392a1ff35ac9e1cd753ed67f3f14a9ed80a55e46e6c9d801dff82165dd9.png
complex
<table><tr><td>Characteristics</td><td>Values</td></tr><tr><td colspan="2">Sex</td></tr><tr><td>Male</td><td>41 (41.4%)</td></tr><tr><td>Female</td><td>58 (58.6%)</td></tr><tr><td colspan="2">Profession</td></tr><tr><td>Medical Staff</td><td>31 (31.3%)</td></tr><tr><td>Nursing Staff</td><td>68 68.7%)</td></tr><tr><td colspan="2">Age</td></tr><tr><td>Years 20 &#8211; 29</td><td>59 (59.6%)</td></tr><tr><td>Years 30 &#8211; 39</td><td>37 (37.4%)</td></tr><tr><td>Years 40 &#8211; 49</td><td>2 (2.0%)</td></tr></table>
128019591ee9b5a5849d573796f89e7a6389d23e18a373d621be141a93d71ed3.png
complex
<table><tr><td rowspan="2">Drug</td><td colspan="3">Theoretical Plates (n=6)</td><td colspan="3">Tailing Factor (n=6)</td><td colspan="3">Capacity Factor (n=6)</td></tr><tr><td>SD</td><td>Mean</td><td>R.S.D</td><td>SD</td><td>Mean</td><td>R.S.D</td><td>SD</td><td>Mean</td><td>R.S.D</td></tr><tr><td>TRZ</td><td>7.11</td><td>7029.16</td><td>0.101</td><td>0.00548</td><td>1.055</td><td>0.519</td><td>0.0131</td><td>2.3575</td><td>0.558</td></tr><tr><td>PRZ</td><td>12.72</td><td>6034.16</td><td>0.210</td><td>0.00837</td><td>1.105</td><td>0.757</td><td>0.0336</td><td>5.569</td><td>0.604</td></tr><tr><td>DXZ</td><td>24.77</td><td>5930.16</td><td>0.417</td><td>0.00837</td><td>1.085</td><td>0.771</td><td>0.0843</td><td>9.535</td><td>0.884</td></tr></table>
c3705501991f82d6a38e204beddc40c56d40e55e1047f46cabf804718eec5738.png
simple
<table><tr><td>Technique</td><td>Detection capability (mutant DNA/total DNA) (%)</td></tr><tr><td>Sanger sequencing</td><td>&gt;10</td></tr><tr><td>Pyrosequencing</td><td>10</td></tr><tr><td>Next-generation sequencing</td><td>&gt;1</td></tr><tr><td>Real-time</td><td>1</td></tr><tr><td>ARMS</td><td>0.1</td></tr><tr><td>Digital droplet PCR, BEAMing, PAP, TAM-seq, Safe-SeqS, CAPP-seq, PARE</td><td>&lt;0.01</td></tr></table>
51e52cdbc17884fcd9368d2261f13ae6d1bace6385137383286bb1ab2e0161f7.png
complex
<table><tr><td></td><td colspan="3">dry season</td><td colspan="3">wet season</td></tr><tr><td></td><td><i>n</i></td><td colspan="2">g kg<sup>&#8722;1</sup> DM</td><td><i>n</i></td><td colspan="2">g kg<sup>&#8722;1</sup> DM</td></tr><tr><td>greater kudu (<i>Tragelaphus scriptus</i>)</td><td>14</td><td>22</td><td>&#177;6</td><td>20</td><td>26</td><td>&#177;16</td></tr><tr><td>giraffe (<i>Giraffa camelopardalis</i>)</td><td>13</td><td>20</td><td>&#177;6</td><td>18</td><td>24</td><td>&#177;11</td></tr><tr><td>nyala (<i>Tragelaphus angasi</i>)</td><td>9</td><td>46</td><td>&#177;12</td><td>6</td><td>30</td><td>&#177;14</td></tr><tr><td>impala (<i>Aepyceros melampus</i>)</td><td>15</td><td>99</td><td>&#177;28</td><td>20</td><td>147</td><td>&#177;70</td></tr><tr><td>waterbuck (<i>Kobus ellipsiprymnus</i>)</td><td>5</td><td>117</td><td>&#177;31</td><td>19</td><td>117</td><td>&#177;32</td></tr><tr><td>sable antelope (<i>Hippotragus niger</i>)</td><td>8</td><td>59</td><td>&#177;6</td><td>9</td><td>52</td><td>&#177;10</td></tr><tr><td>roan antelope (<i>Hippotragus equinus</i>)</td><td>5</td><td>128</td><td>&#177;10</td><td>7</td><td>95</td><td>&#177;29</td></tr><tr><td>blue wildebeest (<i>Connochaetes taurinus</i>)</td><td>15</td><td>138</td><td>&#177;11</td><td>19</td><td>132</td><td>&#177;18</td></tr><tr><td>tsessebe (<i>Damaliscus lunatus</i>)</td><td>3</td><td>140</td><td>&#177;28</td><td>16</td><td>131</td><td>&#177;23</td></tr><tr><td>African buffalo (<i>Synceros caffer</i>)</td><td>15</td><td>146</td><td>&#177;24</td><td>20</td><td>121</td><td>&#177;20</td></tr><tr><td>black rhino (<i>Diceros bicornis</i>)</td><td>10</td><td>17</td><td>&#177;6</td><td>&#8212;</td><td>&#8212;</td><td></td></tr><tr><td>African elephant (<i>Loxodonta africana</i>)</td><td>20</td><td>47</td><td>&#177;7</td><td>20</td><td>59</td><td>&#177;14</td></tr><tr><td>warthog (<i>Phacochoerus aethiopicus</i>)</td><td>6</td><td>100</td><td>&#177;12</td><td>6</td><td>163</td><td>&#177;57</td></tr><tr><td>plains zebra (<i>Equus burchelli</i>)</td><td>6</td><td>126</td><td>&#177;19</td><td>6</td><td>126</td><td>&#177;16</td></tr><tr><td>white rhino (<i>Ceratotherium simum</i>)</td><td>10</td><td>75</td><td>&#177;13</td><td>&#8212;</td><td>&#8212;</td><td></td></tr></table>
37c43771f80cc895ecb9dd19d27a8ce9b8c83dedb1fca8e0cd477c62a7b4b8f0.png
complex
<table><tr><td>Data set (training number, category)</td><td> </td><td>MHW-KELM</td><td>Gauss-KELM</td><td>Poly-KELM</td><td>Original ELM</td><td>SCG-BP</td></tr><tr><td rowspan="4">Wine Quality (2000, 7)</td><td>Mean</td><td>54.59</td><td>49.69</td><td>52.14</td><td>45.79</td><td>&lt;10</td></tr><tr><td>Std.</td><td>&#177;0.35</td><td>&#177;0.52</td><td>&#177;0.28</td><td>&#177;0.85</td><td> </td></tr><tr><td><i>p</i> value</td><td>1.00</td><td>1.04<i>e</i> &#8722; 06</td><td>7.82<i>e</i> &#8722; 03</td><td>3.27<i>e</i> &#8722; 09</td><td>0</td></tr><tr><td>Time</td><td><i>1.159</i></td><td>1.133</td><td>1.372</td><td>3.520</td><td>7.159</td></tr></table>
5d26929a82225689ba90e41aa4c7d5f024abacd1198719479c1903fef647dcc0.png
simple
<table><tr><td>Author, Year</td><td>Country</td><td>Study Design</td><td>Sample Size</td><td>Exposure Assessment</td><td>Outcome</td><td>Confounding Factors</td><td>Potential for Bias</td><td>Effect Size</td><td>Quality Score</td></tr><tr><td>Preterm birth and Birth weight</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Ando and Hattori, 1973 [10]</td><td>Japan</td><td>Case-control study</td><td>713</td><td>Objective assessment, aircraft noise, ECPNL (dB)</td><td>LBW (&lt;2500 g)</td><td>Gender, maternal age, occupation, parity</td><td>High</td><td>Higher rate of LBW in noisy area above 75 dBA</td><td>8</td></tr><tr><td>Knipschild et al., 1981 [11]</td><td>Netherlands</td><td>Case-control study</td><td>1840</td><td>Objective assessment, aircraft noise, 3 subgroups Ldn &lt; 65 dBA, Ldn 65&#8211;70 dBA, Ldn &gt; 70 dBA</td><td>LBW</td><td>Gender, parental income</td><td>High</td><td>18% LBW in low noise exposed group, 24% LBW in high noise exposed group, 29% in noise exposed above 70 dBA Dose response relationship between aircraft noise and LBW</td><td>8</td></tr><tr><td>Schell, 1981 [12]</td><td>USA</td><td>Cross-sectional study</td><td>115</td><td>Objective assessment, aircraft noise, SEL = 75&#8211;100 dBA</td><td>Birth weight Gestational length</td><td>Maternal age, obstetric history, parental weight and height, education, smoking, family income</td><td>High</td><td>r = &#8722;0.04, <i>p</i> = 0.76 males r = &#8722;0.22, <i>p</i> = 0.014 females r = &#8722;0.18, <i>p</i> = 0.16 males r = &#8722;0.38, <i>p</i> = 0.008 females</td><td>11</td></tr><tr><td>Matsui et al., 2003 [13]</td><td>Japan</td><td>Survey</td><td>160,460 births</td><td>Objective assessment, aircraft noise, WECPNL (dB) Control group &lt;75 dBA Exposed subgroups 75&#8211;80 dBA, 81&#8211;85 dBA, &gt;85 dBA</td><td>LBW (&lt;2500 g) Preterm birth (&lt;37 weeks)</td><td>Gender, maternal age, socio-economic status, live birth order No adjustment for smoking</td><td>High</td><td>OR = 1.32 (95% CI 1.18&#8211;1.48), <i>p</i> = 0.0001 in the highest level of exposure compared to control group OR = 1.25 (95% CI 1.1&#8211;1.4), <i>p</i> = 0.0018 in the highest level of exposure compared to control group</td><td>10</td></tr><tr><td>Congenital malformations</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Jones and Tauscher, 1978 [14]</td><td>USA</td><td>Ecological study</td><td>225146 births 2105 defects</td><td>Above vs. below &gt;90 dBA</td><td>Birth defects</td><td>Information not provided</td><td>High</td><td>1185 vs. 737 per 100,000 births <i>p</i> &lt; 0.02</td><td>8</td></tr><tr><td>Edmonds et al., 1979 [15]</td><td>USA</td><td>Survey</td><td>1745 birth defects</td><td>Objective assessment, aircraft noise, high noise level exposure above 65 dBA Ldn</td><td>17 categories of birth defects</td><td>Socioeconomic status, race</td><td>High</td><td>Non significant differences in rates of birth defects in exposed and non-exposed groups</td><td>10</td></tr></table>
c1aef210332dcdcd2e150451d5c98d9d38151f8769365ea4153285fba992f505.png
complex
<table><tr><td></td><td>Milk Fat</td><td>Fish Oil</td><td>Nanno</td><td>Schyzo</td></tr><tr><td colspan="5">Ingredients (%)</td></tr><tr><td> Casein</td><td>14.0</td><td>14.0</td><td>10.8</td><td>12.5</td></tr><tr><td> Corn starch</td><td>37.8</td><td>37.8</td><td>39.2</td><td>38.4</td></tr><tr><td> Maltodextrin</td><td>7.0</td><td>7.0</td><td>7.3</td><td>7.1</td></tr><tr><td> Sucrose</td><td>10.0</td><td>10.0</td><td>10.4</td><td>10.1</td></tr><tr><td> Cellulose</td><td>5.0</td><td>5.0</td><td>5.2</td><td>5.1</td></tr><tr><td> Soybean oil</td><td>8.0</td><td>4.0</td><td>5.9</td><td>6.5</td></tr><tr><td> Milk fat</td><td>12.0</td><td>12.0</td><td>12.5</td><td>12.2</td></tr><tr><td> Fish oil</td><td>0</td><td>4.0</td><td>0</td><td>0</td></tr><tr><td> Nanno oil</td><td>0</td><td>0</td><td>2.4</td><td>0</td></tr><tr><td> Schyzo oil</td><td>0</td><td>0</td><td>0</td><td>1.8</td></tr><tr><td> Cholesterol</td><td>1.25</td><td>1.25</td><td>1.30</td><td>1.27</td></tr><tr><td> L-cysteine</td><td>0.20</td><td>0.20</td><td>0.20</td><td>0.20</td></tr><tr><td> Mineral AIN-93 M Mix</td><td>3.50</td><td>3.50</td><td>3.60</td><td>3.60</td></tr><tr><td> Vitamin AIN-93 M Mix</td><td>1.00</td><td>1.00</td><td>1.00</td><td>1.00</td></tr><tr><td> Choline bitartarate</td><td>0.20</td><td>0.20</td><td>0.30</td><td>0.30</td></tr><tr><td> TBHQ (antioxidant)</td><td>0.001</td><td>0.001</td><td>0.001</td><td>0.001</td></tr><tr><td colspan="5">Chemical composition (g/100 g)</td></tr><tr><td> Crude protein</td><td>12.3</td><td>12.1</td><td>14.7</td><td>12.6</td></tr><tr><td> Crude fat</td><td>19.2</td><td>20.2</td><td>17.0</td><td>21.6</td></tr><tr><td> Crude fibre</td><td>3.80</td><td>3.80</td><td>3.80</td><td>3.80</td></tr><tr><td> Moisture</td><td>5.60</td><td>5.60</td><td>5.60</td><td>5.60</td></tr><tr><td> Crude ash</td><td>3.57</td><td>3.50</td><td>3.82</td><td>3.60</td></tr><tr><td> Carbohydrates</td><td>55.6</td><td>54.8</td><td>55.0</td><td>52.9</td></tr><tr><td> Total FAME (mg/g)</td><td>220</td><td>202</td><td>236</td><td>185</td></tr><tr><td> Energy (kcal/100 g)</td><td>444</td><td>449</td><td>432</td><td>456</td></tr><tr><td colspan="5">Fatty acid profile (%)</td></tr><tr><td> 14:0</td><td>9.81</td><td>11.1</td><td>10.0</td><td>9.32</td></tr><tr><td> 16:0</td><td>28.5</td><td>28.8</td><td>28.9</td><td>29.0</td></tr><tr><td> 18:0</td><td>6.95</td><td>6.87</td><td>6.32</td><td>6.67</td></tr><tr><td> 18:1<i>n</i>-9</td><td>20.3</td><td>19.1</td><td>18.0</td><td>17.0</td></tr><tr><td> 18:2<i>n</i>-6</td><td>21.2</td><td>12.3</td><td>15.7</td><td>16.3</td></tr><tr><td> 18:3<i>n</i>-3</td><td>2.56</td><td>1.59</td><td>1.88</td><td>2.04</td></tr><tr><td> 18:4<i>n</i>-3</td><td>0.190</td><td>0.410</td><td>0.189</td><td>0.187</td></tr><tr><td> 20:4<i>n</i>-6</td><td>0.086</td><td>0.138</td><td>0.587</td><td>0.110</td></tr><tr><td> 20:5<i>n</i>-3</td><td>ND</td><td>1.15</td><td>3.16</td><td>0.10</td></tr><tr><td> 22:6<i>n</i>-3</td><td>ND</td><td>1.19</td><td>ND</td><td>3.30</td></tr><tr><td colspan="5">Partial sums and ratios</td></tr><tr><td> Total SFA</td><td>51.1</td><td>52.9</td><td>51.2</td><td>52.1</td></tr><tr><td> Total MUFA</td><td>22.0</td><td>26.6</td><td>23.8</td><td>20.4</td></tr><tr><td> Total PUFA</td><td>24.3</td><td>17.8</td><td>21.9</td><td>23.7</td></tr><tr><td> Total <i>n</i>-3</td><td>2.75</td><td>4.64</td><td>5.23</td><td>5.72</td></tr><tr><td> Total <i>n</i>-6</td><td>21.4</td><td>12.7</td><td>16.4</td><td>17.8</td></tr><tr><td> <i>n</i>-3/<i>n</i>-6</td><td>0.129</td><td>0.366</td><td>0.320</td><td>0.321</td></tr></table>
9dba94606ef3a5b1b3baeba5c2753c7a4892d44ec588363180a923a034f51d33.png
complex
<table><tr><td>Research site identifier</td><td>Site A</td><td>Site B</td><td>Site C</td><td>Site D</td></tr><tr><td colspan="5">Telehealth deployment</td></tr><tr><td>Year of introduction</td><td>2007</td><td>2009</td><td>2006</td><td>2010</td></tr><tr><td>Equipment purchased (P) or leased (L)</td><td>P</td><td>P</td><td>L</td><td>P</td></tr><tr><td>No. of telehealth units available for use<sup>a</sup></td><td>165</td><td>79</td><td>n/a</td><td>40</td></tr><tr><td>No. of telehealth units in use<sup>b</sup></td><td>104</td><td>39</td><td>200</td><td>34</td></tr><tr><td colspan="5">Referral routes into telehealth</td></tr><tr><td>Community matrons</td><td>&#10003;</td><td>&#10003;</td><td>&#10003;</td><td>&#10003;</td></tr><tr><td>Case managers</td><td>&#10003;</td><td></td><td></td><td>&#10003;</td></tr><tr><td>Specialist respiratory nurses</td><td>&#10003;</td><td>&#10003;</td><td>&#10003;</td><td></td></tr><tr><td>Specialist heart failure nurses</td><td>&#10003;</td><td>&#10003;</td><td>&#10003;</td><td></td></tr><tr><td>GPs</td><td>&#10003;</td><td></td><td></td><td></td></tr><tr><td colspan="5">Telehealth stakeholders</td></tr><tr><td>NHS community healthcare provider</td><td>&#10003;</td><td></td><td>&#10003;</td><td>&#10003;</td></tr><tr><td>NHS hospital trust</td><td>&#10003;</td><td></td><td></td><td>&#10003;</td></tr><tr><td>Clinical commissioning group</td><td></td><td>&#10003;</td><td>&#10003;</td><td></td></tr><tr><td>Equipment manufacturer</td><td>&#10003;</td><td>&#10003;</td><td>&#10003;</td><td>&#10003;</td></tr><tr><td>Local authority</td><td>&#10003;</td><td>&#10003;</td><td>&#10003;</td><td></td></tr><tr><td>Community interest company</td><td></td><td>&#10003;</td><td>&#10003;</td><td></td></tr><tr><td>Private company</td><td></td><td>&#10003;</td><td>&#10003;</td><td></td></tr></table>
4fe684085de2808df17a6b1941b662829198f428cc1f66e16c40512fa339e6b9.png
simple
<table><tr><td>Populations</td><td>ACH</td><td>SRL</td><td>MON</td><td>TUR</td><td>NUQ</td><td>BUE</td><td>STU</td><td>MTU</td></tr><tr><td>ACH</td><td>__</td><td>59</td><td>31</td><td>13</td><td>6</td><td>9</td><td>4</td><td>7</td></tr><tr><td>SRL</td><td>0.00834</td><td>__</td><td>56</td><td>38</td><td>8</td><td>11</td><td>5</td><td>10</td></tr><tr><td>MON</td><td>0.01602*</td><td>0.00889</td><td>__</td><td>26</td><td>10</td><td>15</td><td>5</td><td>11</td></tr><tr><td>TUR</td><td>0.03596***</td><td>0.01286*</td><td>0.01880**</td><td>__</td><td>47</td><td>22</td><td>12</td><td>24</td></tr><tr><td>NUQ</td><td>0.08121***</td><td>0.05584***</td><td>0.04891***</td><td>0.01046</td><td>__</td><td>18</td><td>41</td><td>35</td></tr><tr><td>BUE</td><td>0.05404***</td><td>0.04186***</td><td>0.03227***</td><td>0.02211**</td><td>0.02697**</td><td>__</td><td>10</td><td>35</td></tr><tr><td>STU</td><td>0.11405***</td><td>0.09112***</td><td>0.09023***</td><td>0.04015***</td><td>0.01188</td><td>0.04721***</td><td>__</td><td>15</td></tr><tr><td>MTU</td><td>0.06623***</td><td>0.04589**</td><td>0.04233***</td><td>0.02050*</td><td>0.01439</td><td>0.01421</td><td>0.03274*</td><td>__</td></tr></table>
04984e9179a4509c85637cf9adec024f8e2812ee2f604ce8bcfa96ce3a9e701a.png
complex
<table><tr><td rowspan="3" colspan="2">Category</td><td rowspan="3">n (%)</td><td colspan="2">Total</td><td colspan="2">Asthma</td><td colspan="2">Medication for Asthma</td><td rowspan="3">p</td></tr><tr><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td></tr><tr><td rowspan="3">Age (years)</td><td>&lt; 20</td><td>21 (19.4)</td><td>744.60</td><td>175.82</td><td>601.58</td><td>158.36</td><td>234.55</td><td>109.62</td><td>0.000<sup>a</sup></td></tr><tr><td>20&#8211;59</td><td>61 (56.5)</td><td>1,584.39</td><td>966.73</td><td>1,461.20</td><td>964.47</td><td>692.66</td><td>366.14</td><td>0.000<sup>b</sup></td></tr><tr><td>&#8805; 60</td><td>26 (24.1)</td><td>984.67</td><td>287.72</td><td>483.58</td><td>258.54</td><td>601.50</td><td>179.45</td><td> </td></tr><tr><td rowspan="2">Sex</td><td>Male</td><td>29 (26.8)</td><td>1,522.99</td><td>1,030.99</td><td>832.08</td><td>1,032.46</td><td>553.95</td><td>332.62</td><td>0.52<sup>a</sup></td></tr><tr><td>Female</td><td>79 (73.2)</td><td>1,186.32</td><td>637.22</td><td>608.07</td><td>629.19</td><td>591.80</td><td>295.19</td><td>0.40<sup>b</sup></td></tr><tr><td rowspan="3">Family income</td><td>&#8804; 1 minimum wage</td><td>25 (23.1)</td><td>1,315.72</td><td>553.62</td><td>709.37</td><td>560.46</td><td>731.36</td><td>388.32</td><td>0.58<sup>a</sup></td></tr><tr><td>&gt; 1 to 3 minimum wages</td><td>53 (49.1)</td><td>1,239.81</td><td>754.53</td><td>637.39</td><td>750.85</td><td>524.78</td><td>268.44</td><td>0.38<sup>a</sup></td></tr><tr><td>&gt; 3 minimum wages</td><td>30 (27.8)</td><td>1,318.38</td><td>919.68</td><td>696.35</td><td>911.32</td><td>576.24</td><td>294.78</td><td> </td></tr><tr><td rowspan="3">Education level</td><td>Elementary school</td><td>76 (70.4)</td><td>1,164.34</td><td>592.57</td><td>611.44</td><td>591.90</td><td>556.90</td><td>263.78</td><td>0.92<sup>a</sup></td></tr><tr><td>High School</td><td>25 (23.1)</td><td>1,614.84</td><td>1,131.14</td><td>827.46</td><td>1,126.16</td><td>583.42</td><td>358.14</td><td>0.55<sup>b</sup></td></tr><tr><td>Higher education</td><td>7 (6.5)</td><td>1,289.27</td><td>780.29</td><td>715.99</td><td>790.14</td><td>843.79</td><td>476.14</td><td> </td></tr><tr><td rowspan="3">Asthma duration</td><td>&#8804; 10</td><td>36 (33.4)</td><td>647.43</td><td>872.90</td><td>345.53</td><td>875.32</td><td>256.91</td><td>321.30</td><td>0.30<sup>a</sup></td></tr><tr><td>&gt; 10&#8211;20</td><td>26 (24.1)</td><td>602.62</td><td>614.11</td><td>294.57</td><td>598.50</td><td>268.31</td><td>305.28</td><td>0.008<sup>b</sup></td></tr><tr><td>&gt; 20</td><td>46 (42.5)</td><td>651.47</td><td>756.80</td><td>348.69</td><td>752.14</td><td>330.08</td><td>290.30</td><td> </td></tr><tr><td rowspan="4">Asthma severity <sup>c</sup></td><td>Intermittent</td><td>42 (38.9)</td><td>432.12</td><td>487.14</td><td>224.10</td><td>472.31</td><td>161.61</td><td>130.37</td><td> </td></tr><tr><td>Mild</td><td>24 (22.2)</td><td>448.34</td><td>267.24</td><td>220.73</td><td>237.82</td><td>217.85</td><td>163.01</td><td>0.000<sup>a</sup></td></tr><tr><td>Moderate</td><td>31 (28.7)</td><td>656.08</td><td>888.60</td><td>345.91</td><td>886.33</td><td>283.11</td><td>171.84</td><td>0.000<sup>b</sup></td></tr><tr><td>Severe</td><td>11 (10.2)</td><td>1,403.84</td><td>1,180.52</td><td>790.73</td><td>1,184.74</td><td>750.39</td><td>570.27</td><td> </td></tr><tr><td rowspan="3">Asthma control <sup>c</sup></td><td>Controlled</td><td>53 (49.1)</td><td>419.48</td><td>175.56</td><td>212.12</td><td>171.66</td><td>193.14</td><td>118.63</td><td>0.000<sup>a</sup></td></tr><tr><td>Partially controlled</td><td>42 (38.9)</td><td>637.54</td><td>743.01</td><td>326.06</td><td>738.18</td><td>280.76</td><td>212.00</td><td>0.000<sup>b</sup></td></tr><tr><td>Uncontrolled</td><td>13 (12.0)</td><td>1,283.75</td><td>1,225.45</td><td>713.82</td><td>1,234.49</td><td>611.06</td><td>554.65</td><td> </td></tr><tr><td rowspan="3">Nutritional status</td><td>Normal weight</td><td>44 (40.7)</td><td>1,027.68</td><td>626.53</td><td>510.74</td><td>609.78</td><td>398.82</td><td>160.62</td><td>0.001<sup>a</sup></td></tr><tr><td>Overweight</td><td>35 (32.4)</td><td>1,259.93</td><td>575.37</td><td>675.81</td><td>566.16</td><td>626.19</td><td>322.12</td><td>0.000<sup>b</sup></td></tr><tr><td>Obese</td><td>29 (26.9)</td><td>1,674.86</td><td>1,066.88</td><td>897.98</td><td>1,077.41</td><td>805.24</td><td>399.63</td><td> </td></tr><tr><td rowspan="2">Rhinitis</td><td>Yes</td><td>90 (83.3)</td><td>636.06</td><td>749.83</td><td>325.99</td><td>746.12</td><td>261.23</td><td>279.86</td><td>0.03<sup>a</sup></td></tr><tr><td>No</td><td>18 (16.7)</td><td>649.85</td><td>843.33</td><td>377.69</td><td>838.13</td><td>438.75</td><td>379.39</td><td>0.0001<sup>b</sup></td></tr></table>
61f99f372f8062b354c4a69a3cb87937023e6b396094dffdbaa3f9c03675207c.png
simple
<table><tr><td>Mutation</td><td>Gene</td><td>Mutation type</td><td>AA</td><td>References</td></tr><tr><td>m.3730T&gt;Y</td><td><i>ND1</i></td><td>Point mutation</td><td>Y142H</td><td>[39,48]</td></tr><tr><td>m.3425T&gt;Y</td><td><i>ND1</i></td><td>Point mutation</td><td>V40A</td><td>[39,48]</td></tr><tr><td>m.5212T&gt;C</td><td><i>ND2</i></td><td>Point mutation</td><td>L248P</td><td>[39]</td></tr><tr><td>m.10844A&gt;C</td><td><i>ND4</i></td><td>Point mutation</td><td>T29P</td><td>[39]</td></tr><tr><td>m.14510delA</td><td><i>ND6</i></td><td>Point mutation</td><td>-</td><td>[39]</td></tr></table>
948fe2d62ac85d3ef13e9a24ab708d244c0b1f81dd35c40c65e35e5c3f0a7ec0.png
complex
<table><tr><td></td><td colspan="4">A</td><td colspan="4">B</td></tr><tr><td></td><td colspan="2">ARACNE</td><td colspan="2">BANJO</td><td colspan="2">ARACNE</td><td colspan="2">BANJO</td></tr><tr><td></td><td>PPV</td><td>Se</td><td>PPV</td><td>Se</td><td>PPV</td><td>Se</td><td>PPV</td><td>Se</td></tr><tr><td>Keloid RMA</td><td>0.238</td><td>0.556</td><td>0.3</td><td>0.667</td><td>0.6</td><td>1</td><td>0.4</td><td>0.667</td></tr><tr><td>Normal RMA</td><td>0.1875</td><td>0.333</td><td>0.3125</td><td>0.556</td><td>0.5</td><td>0.667</td><td>0.4</td><td>0.667</td></tr><tr><td>Keloid MAS5</td><td>0.214</td><td>0.333</td><td>0.286</td><td>0.667</td><td>0.5</td><td>0.667</td><td>0.75</td><td>1</td></tr><tr><td>Normal MAS5</td><td>0.25</td><td>0.667</td><td>0.304</td><td>0.778</td><td>0.75</td><td>1</td><td>0.6</td><td>1</td></tr><tr><td>Random</td><td colspan="4">0.389</td><td colspan="4">0.5</td></tr><tr><td></td><td colspan="4">C</td><td colspan="4">D</td></tr><tr><td></td><td colspan="2">ARACNE</td><td colspan="2">BANJO</td><td colspan="2">ARACNE</td><td colspan="2">BANJO</td></tr><tr><td></td><td>PPV</td><td>Se</td><td>PPV</td><td>Se</td><td>PPV</td><td>Se</td><td>PPV</td><td>Se</td></tr><tr><td>Keloid RMA</td><td>0.8</td><td>1</td><td>0.75</td><td>0.75</td><td>0.5</td><td>0.6</td><td>0.5</td><td>0.8</td></tr><tr><td>Normal RMA</td><td>1</td><td>0.75</td><td>0.8</td><td>1</td><td>0.5</td><td>0.6</td><td>0.2</td><td>0.2</td></tr><tr><td>Keloid MAS5</td><td>0.5</td><td>0.25</td><td>0.6</td><td>0.75</td><td>0.5</td><td>0.6</td><td>0.625</td><td>1</td></tr><tr><td>Normal MAS5</td><td>0.667</td><td>0.5</td><td>0.5</td><td>0.5</td><td>0.333</td><td>0.4</td><td>0.5</td><td>0.8</td></tr><tr><td>Random</td><td colspan="4">0.667</td><td colspan="4">0.5</td></tr><tr><td></td><td colspan="4">E</td><td colspan="4">F</td></tr><tr><td></td><td colspan="2">ARACNE</td><td colspan="2">BANJO</td><td colspan="2">ARACNE</td><td colspan="2">BANJO</td></tr><tr><td></td><td>PPV</td><td>Se</td><td>PPV</td><td>Se</td><td>PPV</td><td>Se</td><td>PPV</td><td>Se</td></tr><tr><td>Keloid RMA</td><td>0.375</td><td>0.6</td><td>0.364</td><td>0.8</td><td>0.375</td><td>0.75</td><td>0.5</td><td>1</td></tr><tr><td>Normal RMA</td><td>0.444</td><td>0.8</td><td>0.444</td><td>0.8</td><td>0.5</td><td>0.75</td><td>0.5</td><td>1</td></tr><tr><td>Keloid MAS5</td><td>0.286</td><td>0.4</td><td>0.273</td><td>0.6</td><td>0.286</td><td>0.5</td><td>0.429</td><td>0.75</td></tr><tr><td>Normal MAS5</td><td>0.333</td><td>0.6</td><td>0.364</td><td>0.8</td><td>0.2</td><td>0.25</td><td>0.429</td><td>0.75</td></tr><tr><td>Random</td><td colspan="4">0.333</td><td colspan="4">0.4</td></tr><tr><td></td><td colspan="4">G</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td colspan="2">ARACNE</td><td colspan="2">BANJO</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>PPV</td><td>Se</td><td>PPV</td><td>Se</td><td></td><td></td><td></td><td></td></tr><tr><td>Keloid RMA</td><td>0.5</td><td>0.5</td><td>0.714</td><td>0.833</td><td></td><td></td><td></td><td></td></tr><tr><td>Normal RMA</td><td>0.667</td><td>0.667</td><td>0.625</td><td>0.833</td><td></td><td></td><td></td><td></td></tr><tr><td>Keloid MAS5</td><td>0.4</td><td>0.333</td><td>0.429</td><td>0.5</td><td></td><td></td><td></td><td></td></tr><tr><td>Normal MAS5</td><td>0.833</td><td>0.833</td><td>0.5</td><td>0.5</td><td></td><td></td><td></td><td></td></tr><tr><td>Random</td><td colspan="4">0.6</td><td></td><td></td><td></td><td></td></tr></table>
64192f238c9022f54cb86016aa1faa11a99f77a4b0a242c5dc61d5c65cdfc9d5.png
simple
<table><tr><td>Gene</td><td>No. positive (%)</td></tr><tr><td><i>msp-1</i></td><td>43 (86)</td></tr><tr><td>K1</td><td>40 (80)</td></tr><tr><td>MAD20</td><td>24 (48)</td></tr><tr><td>RO33</td><td>26 (52)</td></tr><tr><td><i>msp-2</i></td><td>47 (94)</td></tr><tr><td>FC27</td><td>44 (88)</td></tr><tr><td>IC/3D7</td><td>38 (76)</td></tr><tr><td><i>glurp</i></td><td>24 (48)</td></tr></table>
9f0c56bc8de118bfdf445c3cda3c619d4fa7f7260a8eb6d9b37b6fb0b1759200.png
complex
<table><tr><td colspan="2">Region ITS1</td><td colspan="2">Region ITS2</td></tr><tr><td>Species</td><td>Controls</td><td>Species</td><td>Controls</td></tr><tr><td><i>Candida albicans</i></td><td>C7</td><td><i>Candida albicans</i></td><td>C7</td></tr><tr><td><i>Candida glabrata</i></td><td>C11SC</td><td><i>Cladosporium</i> sp.</td><td>C11LF, C11SC</td></tr><tr><td><i>Cladosporium</i> sp.</td><td>C12ERH,</td><td><i>Fusarium oxysporum</i></td><td>C3, C8, C10MD</td></tr><tr><td><i>Fungal</i> sp.</td><td>C6</td><td><i>Malassezia restricta</i></td><td>C8, C12ERH</td></tr><tr><td><i>Fusarium oxysporum</i></td><td>C3, C4, C5, C8, C10MD</td><td><i>Penicillium crustosum</i></td><td>C11ERH</td></tr><tr><td><i>Malassezia globosa</i></td><td>C13MD</td><td><i>Phoma</i> sp.</td><td>C13ERH</td></tr><tr><td><i>Malassezia restricta</i></td><td>C11SD, C12SC</td><td><i>Saccharomyces cerevisiae</i></td><td>C2</td></tr><tr><td><i>Penicillium crustosum</i></td><td>C11ERH</td><td><i>Uncultured eukaryote</i></td><td>C7</td></tr><tr><td><i>Phoma</i> sp.</td><td>C13ERH</td><td><i>Uncultured fungus</i></td><td>C11SC</td></tr><tr><td><i>Rhodotorula mucilaginosa</i></td><td>C12SC</td><td><i>Uncultured malassezia</i></td><td>C11MD, C11SC, C12SC, C13LF</td></tr><tr><td><i>Uncultured fungus</i></td><td>C1, C10ERH, C11SC, C13LFC, C13MD</td><td><i>Pichia membranifaciens</i></td><td>C11MD</td></tr><tr><td><i>Uncultured malassezia</i></td><td>C11MD, C13SC</td><td></td><td></td></tr><tr><td><i>Uncultured rhodotorula</i></td><td>C11LF</td><td></td><td></td></tr></table>
e82eaa2cf8776f96b78e2903afa468ffe0d3fa0364b719cee03b290c29eb7c96.png
simple
<table><tr><td></td><td>Dummy variable of Hospital C</td><td>Educational background</td><td>Research experience</td><td>Knowledge on EBN </td></tr><tr><td>Setting </td><td>B=1.331 t=2.807 P= 0.005</td><td></td><td></td><td>B=-1.151 t=2.807 P=0.005</td></tr><tr><td>Nurse </td><td></td><td>B=-0.995 t=-2.048 P= 0.041</td><td></td><td></td></tr><tr><td>Presentation </td><td>B=0.951 t=2.318 P= 0.021</td><td></td><td>B=-2.398 t=-4.716 P= 0.000</td><td></td></tr><tr><td>Barriers scale</td><td>B=3.396 t=2.415 P= 0.016</td><td></td><td>B=-4.234 t=-2.429 P= 0.015</td><td></td></tr><tr><td>Facilitators scale</td><td>B=0.925 t=2.417 P=0.016</td><td></td><td></td><td></td></tr></table>
2b286d360dbb513bcd697872c165d7249cabac124bb99b665318070c5c6c276f.png
simple
<table><tr><td> </td><td>DRC*</td><td>Zambia</td><td>Kenya</td><td>Guatemala</td><td>Pakistan</td><td>Nagpur, India</td><td>Belgaum, India</td></tr><tr><td>Number births</td><td>14,306</td><td>16,352</td><td>18,319</td><td>10,590</td><td>34,379</td><td>15,022</td><td>34,509</td></tr><tr><td><underline>Birth location</underline></td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Home (%)</td><td>74.4</td><td>52.7</td><td>64.7</td><td>71.0</td><td>56.6</td><td>14.0</td><td>16.3</td></tr><tr><td>Health ctr(%)</td><td>23.6</td><td>41.7</td><td>9.4</td><td>3.1</td><td>21.9</td><td>25.7</td><td>23.2</td></tr><tr><td>Hospital(%)</td><td>1.0</td><td>5.6</td><td>25.9</td><td>25.9</td><td>21.1</td><td>53.5</td><td>60.3</td></tr><tr><td><underline>Birth attendant</underline></td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Family/home (%)</td><td>3.0</td><td>20.1</td><td>12.8</td><td>0.2</td><td>2.0</td><td>3.9</td><td>7.1</td></tr><tr><td>HBA** (%)</td><td>75.3</td><td>34.2</td><td>51.4</td><td>70.6</td><td>54.1</td><td>9.6</td><td>8.2</td></tr><tr><td>Nurse/midwife (%)</td><td>21.6</td><td>43.1</td><td>34.1</td><td>1.4</td><td>23.8</td><td>33.1</td><td>29.9</td></tr><tr><td>Physician (%)</td><td>0.1</td><td>2.6</td><td>1.7</td><td>27.8</td><td>20.0</td><td>53.5</td><td>37.9</td></tr></table>
b71630909cf8163a5c1d8f8a36aca960ecc80386c40b2265fc3e848def2476cb.png
simple
<table><tr><td><i>Pseudomonas aeruginosa</i> strains</td><td>Bacteriocidal (+)</td><td>Bacteriostatic (&#8722;)</td></tr><tr><td>PAO1</td><td>+</td><td> </td></tr><tr><td>PA103</td><td>+</td><td> </td></tr><tr><td>PA14</td><td> </td><td>&#8722;</td></tr><tr><td>Clinical strain</td><td> </td><td>&#8722;</td></tr></table>
c913fb6af5067046cfb659b29a9280cf1e879ed9961daa1ff0a357418ae42205.png
complex
<table><tr><td>Accession</td><td>Transcription factor family</td><td>Log2 fold</td></tr><tr><td colspan="2">Up-regulated genes</td></tr><tr><td>AK322452</td><td>DREB3</td><td>2.5</td></tr><tr><td>BP893968</td><td>AP2d</td><td>2.7</td></tr><tr><td>AK320001</td><td>RAV2</td><td>2.7</td></tr><tr><td>AK319979</td><td>Pti4</td><td>3.4</td></tr><tr><td>AW034241</td><td>ERF2</td><td>4.3</td></tr><tr><td>AW651406</td><td>bZIP</td><td>2.6</td></tr><tr><td>AK224603</td><td>bZIP</td><td>2.8</td></tr><tr><td>AK326827</td><td>bZIP</td><td>3.1</td></tr><tr><td>EU636698</td><td>CONSTANS-like Zinc Finger</td><td>3.5</td></tr><tr><td>AJ784616</td><td>Stress-associated protein 6 (Zinc finger)</td><td>6.7</td></tr><tr><td>BG627283</td><td>BTF3-like (NAC)</td><td>2.9</td></tr><tr><td>AK324393</td><td>NAM-like</td><td>5</td></tr><tr><td>BM412776</td><td>WRKY</td><td>5.8</td></tr><tr><td>AK322575</td><td>WRKY3</td><td>14.5</td></tr><tr><td>TC239950</td><td>TCP</td><td>2.5</td></tr><tr><td>AK319300</td><td>TCP transcription factor 14</td><td>3</td></tr><tr><td>TA41176_4081</td><td>GRAS 6</td><td>3.3</td></tr><tr><td>AK325371</td><td>Putative transcription factor</td><td>3.4</td></tr><tr><td>BP879218</td><td>Putative Squamosa promoter-binding protein</td><td>3.5</td></tr><tr><td colspan="2">Down-regulated genes</td></tr><tr><td>DB690655</td><td>CONSTANS-LIKE 16 Zinc Finger</td><td>3.9</td></tr><tr><td>DB697244</td><td>CONSTANS-LIKE 9 Zinc Finger</td><td>5.5</td></tr><tr><td>AW624869</td><td>CONSTANS-LIKE 10 Zinc Finger</td><td>6.8</td></tr><tr><td>AW622759</td><td>WRKY</td><td>3.9</td></tr><tr><td>AK247980</td><td>WRKY</td><td>5.2</td></tr><tr><td>AK247135</td><td>PIF1 (bHLH)</td><td>2.5</td></tr><tr><td>BI935893</td><td>putative bHLH</td><td>2.4</td></tr><tr><td>AK327992</td><td>MADS box</td><td>4</td></tr><tr><td>AK327530</td><td>PHD finger</td><td>2.2</td></tr><tr><td>BI925618</td><td>Bell-like homeodomain protein 2 (POX domain)</td><td>2.2</td></tr><tr><td>BI921917</td><td>Tubby-like F-box protein</td><td>2.6</td></tr></table>
7bf1d5d1b3771fdffd2dab2f291878163e943b25086d88434c7d03346f806787.png
complex
<table><tr><td>REACH category and action</td><td>Identified priority programmes</td></tr><tr><td>Livestock and fisheries</td><td></td></tr><tr><td rowspan="7">Animal husbandry, fisheries, and insect farming</td><td>&#8226; Backyard poultry production in Nepal</td></tr><tr><td>&#8226; Household animal and horticulture production in Ghana</td></tr><tr><td>&#8226; Aquaculture development in Uganda</td></tr><tr><td>&#8226; Aquaculture development and nutrition education in Uganda</td></tr><tr><td>&#8226; School livestock programme in Ethiopia</td></tr><tr><td>&#8226; Conditional livestock transfer in Ethiopia</td></tr><tr><td>&#8226; Targeted cash and chicken transfer in Uganda</td></tr><tr><td>Crops/horticulture</td><td></td></tr><tr><td rowspan="5">Diversification and locally adapted varieties</td><td>&#8226; Home gardens in India</td></tr><tr><td>&#8226; Kitchen gardens in Bangladesh</td></tr><tr><td>&#8226; School&#8208;based fruit production in Tanzania</td></tr><tr><td>&#8226; Home gardens and small livestock production in Uganda</td></tr><tr><td>&#8226; Home gardens and small livestock production in Bangladesh</td></tr><tr><td>Food processing, fortification, and storage</td><td></td></tr><tr><td>Food processing (excl. fortification)</td><td>&#8226; Complementary food processing programme in Ghana</td></tr><tr><td rowspan="5">Fortification (including salt iodization and fortification of complementary foods)</td><td>&#8226; Point of consumption fortification in Nepal</td></tr><tr><td>&#8226; Micronutrient sachets for home fortification in India</td></tr><tr><td>&#8226; Home&#8208;based fortified flour production in Nepal</td></tr><tr><td>&#8226; Complementary food production in Ethiopia</td></tr><tr><td>&#8226; Mass media campaign on fortification with dried fish in Nigeria</td></tr><tr><td>Food consumption practices for healthy diets</td><td></td></tr><tr><td rowspan="5">Food&#8208;based nutrition education</td><td>&#8226; School&#8208;based feeding and nutrition education in Ethiopia</td></tr><tr><td>&#8226; Adolescent health and nutrition education in South Asia</td></tr><tr><td>&#8226; School&#8208;based nutrition education in Ghana</td></tr><tr><td>&#8226; School&#8208;based nutrition education in Uganda</td></tr><tr><td>&#8226; School&#8208;based agriculture education in Ghana</td></tr><tr><td rowspan="2">Creating supportive environments to promote healthy diets in different settings</td><td>&#8226; School snack programme in Nepal</td></tr><tr><td>&#8226; Preschool feeding in Bangladesh</td></tr><tr><td>Enabling environment</td><td></td></tr><tr><td rowspan="5">Fiscal policy</td><td>&#8226; Milk transport subsidy in Nepal (livestock and fisheries)</td></tr><tr><td>&#8226; Decreasing transport costs in Tanzania (food consumption)</td></tr><tr><td>&#8226; Rice subsidy in Nigeria (food processing, fortification, and storage)</td></tr><tr><td>&#8226; Food tax and subsidy in Ghana (food consumption)</td></tr><tr><td>&#8226; Solar drier subsidy in Nepal (food processing, fortification, and storage)</td></tr><tr><td rowspan="6">Legislation, regulations/standards, protocols, and guidelines</td><td>&#8226; Food marketing association in Ghana (food consumption)</td></tr><tr><td>&#8226; Improved traditional wet markets in Tanzania (food consumption)</td></tr><tr><td>&#8226; Local market development in Nepal (food consumption)</td></tr><tr><td>&#8226; Quality assurance for infant complementary food (food consumption)</td></tr><tr><td>&#8226; Government quality certification seal (food consumption)</td></tr><tr><td>&#8226; Integrating nutrition into agriculture and health services in Tanzania (crops/horticulture)</td></tr><tr><td rowspan="6">Social norms: Education/sensitization, behaviour change communication, and social marketing</td><td>&#8226; Technology&#8208;enabled behaviour change communication in Nigeria (food consumption)</td></tr><tr><td>&#8226; Nutrition education and media campaign in India (food consumption)</td></tr><tr><td>&#8226; Diet diversity media campaign in India (food consumption)</td></tr><tr><td>&#8226; Maternal nutrition media campaign in India (food consumption)</td></tr><tr><td>&#8226; Media and education campaign in Ethiopia (food consumption)</td></tr><tr><td>&#8226; Edutainment in Ethiopia (food consumption)</td></tr><tr><td colspan="2">Vouchers or transfers (not defined by REACH)</td></tr><tr><td></td><td>&#8226; Targeted and conditional cash transfer in India</td></tr><tr><td></td><td>&#8226; Conditional cash transfer in Nigeria</td></tr><tr><td></td><td>&#8226; Conditional cash and food transfers in Bangladesh</td></tr><tr><td></td><td>&#8226; Food vouchers in India</td></tr><tr><td></td><td>&#8226; Food vouchers in Tanzania</td></tr><tr><td></td><td>&#8226; Conditional food transfer in Ethiopia</td></tr></table>
527ee1fddfc97655b5854f4f8ae59f452fb6fc48fcb8a0983969cff9b951ebf2.png
complex
<table><tr><td></td><td colspan="3">Study wave</td><td colspan="3">Study region (canton)</td></tr><tr><td></td><td>MONICA I</td><td>MONICA II</td><td>MONICA III</td><td>Vaud*</td><td>Fribourg*</td><td>Ticino</td></tr><tr><td>Participants (n)</td><td>3,442</td><td>3,466</td><td>3,252</td><td>4,263</td><td>1,378</td><td>4,519</td></tr><tr><td>Age of inclusion (years)</td><td>25-74</td><td>25-74</td><td>25-74</td><td>25-74</td><td>25-74</td><td>35-64</td></tr><tr><td>Women (%)</td><td>49.1</td><td>48.6</td><td>51.4</td><td>49.9</td><td>48.8</td><td>49.8</td></tr><tr><td>Foreign nationals (%)</td><td>14.7</td><td>18.6</td><td>21.2</td><td>17.7</td><td>7.4</td><td>21.8</td></tr><tr><td>Age (in years, mean)</td><td>47.6</td><td>47.8</td><td>47.8</td><td>47.0</td><td>45.7</td><td>49.0</td></tr><tr><td>University education (%)</td><td>6.5</td><td>7.7</td><td>8.5</td><td>9.0</td><td>6.5</td><td>6.5</td></tr><tr><td>Tertiary education (%)</td><td>14.0</td><td>10.2</td><td>11.6</td><td>16.5</td><td>12.8</td><td>7.4</td></tr><tr><td>Upper secondary education (%)</td><td>44.7</td><td>50.4</td><td>50.6</td><td>48.3</td><td>45.1</td><td>49.8</td></tr><tr><td>Mandatory education (%)</td><td>34.8</td><td>31.8</td><td>29.3</td><td>26.1</td><td>35.6</td><td>36.4</td></tr><tr><td>Never married (%)</td><td>13.4</td><td>12.0</td><td>12.1</td><td>13.6</td><td>15.8</td><td>10.5</td></tr><tr><td>Married (%)</td><td>76.8</td><td>76.9</td><td>76.0</td><td>73.7</td><td>77.4</td><td>79.0</td></tr><tr><td>Widowed (%)</td><td>4.2</td><td>4.1</td><td>3.7</td><td>4.2</td><td>3.6</td><td>4.0</td></tr><tr><td>Divorced (%)</td><td>5.6</td><td>6.9</td><td>8.2</td><td>8.5</td><td>3.3</td><td>6.5</td></tr><tr><td>Start of examination VD/FR**</td><td>29.10.1984</td><td>02.11.1988</td><td>23.11.1992</td><td></td><td></td><td></td></tr><tr><td>Duration VD/FR (days)</td><td>222</td><td>240</td><td>215</td><td></td><td></td><td></td></tr><tr><td>Start of examination TI**</td><td>11.11.1985</td><td>24.10.1988</td><td>28.10.1992</td><td></td><td></td><td></td></tr><tr><td>Duration TI (days)</td><td>198</td><td>185</td><td>210</td><td></td><td></td><td></td></tr></table>
e5292cac85ac40c01e8ea833aa4e1ebb31681515a693e2a39cbeefe8284318ed.png
simple
<table><tr><td>Source of variance</td><td>SS</td><td>df</td><td>Means square</td><td><i>F </i></td><td><i>P</i> value</td><td>Partial eta squared (<i>n</i>)</td><td>Power</td></tr><tr><td>Within subjects</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Time</td><td>38.50</td><td>2</td><td>19.25</td><td>0.32</td><td>0.73</td><td>0.005</td><td>0.10</td></tr><tr><td> Time &#215; age</td><td>31.06</td><td>2</td><td>15.53</td><td>0.26</td><td>0.77</td><td>0.004</td><td>0.90</td></tr><tr><td> Time &#215; group</td><td>272.87</td><td>2</td><td>136.43</td><td>2.25</td><td>0.11</td><td>0.036</td><td>0.45</td></tr><tr><td> Error </td><td>7387.84</td><td>122</td><td>60.56</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Between subjects</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Intercept </td><td>4134.92</td><td>1</td><td>4134.92</td><td>14.55</td><td>0.00</td><td>0.19</td><td>0.96</td></tr><tr><td> Age</td><td>266.00</td><td>1</td><td>266.00</td><td>0.94</td><td>0.34</td><td>0.02</td><td>0.16</td></tr><tr><td> Group</td><td>472.18</td><td>1</td><td>472.18</td><td>1.66</td><td>0.20</td><td>0.03</td><td>0.25</td></tr><tr><td> Error </td><td>17337.94</td><td>61</td><td>264.23</td><td> </td><td> </td><td> </td><td> </td></tr></table>
28d760845f95849f6c074919951d8426b8177f0554eb32cb921f4bc6d57189d4.png
complex
<table><tr><td></td><td colspan="6"><i>Candida albicans</i></td><td colspan="6">Non-<i>Candida albicans</i></td></tr><tr><td>Antifungals</td><td colspan="2">S<sup>a</sup></td><td colspan="2">DDS<sup>b</sup></td><td colspan="2">R<sup>c</sup></td><td colspan="2">S</td><td colspan="2">DDS</td><td colspan="2">R</td></tr><tr><td></td><td><i>n</i></td><td>%</td><td><i>n</i></td><td>%</td><td><i>n</i></td><td>%</td><td><i>n</i></td><td>%</td><td><i>n</i></td><td>%</td><td><i>n</i></td><td>%</td></tr><tr><td>FLU</td><td>55</td><td>94.8</td><td>3</td><td>5.2</td><td>&#8212;</td><td>&#8212;</td><td>26</td><td>83.9</td><td>5</td><td>16.1</td><td>&#8212;</td><td>&#8212;</td></tr><tr><td>ITRA</td><td>48</td><td>82.8</td><td>4</td><td>6.9</td><td>6</td><td>10.3</td><td>18</td><td>58.1</td><td>4</td><td>12.9</td><td>9</td><td>29.0</td></tr><tr><td>KETO</td><td>20</td><td>34.5</td><td>23</td><td>9.7</td><td>15</td><td>25.8</td><td>9</td><td>29.0</td><td>7</td><td>22.6</td><td>15</td><td>48.4</td></tr><tr><td>MICO</td><td>42</td><td>72.4</td><td>14</td><td>24.1</td><td>2</td><td>3.5</td><td>6</td><td>19.4</td><td>20</td><td>64.5</td><td>5</td><td>16.1</td></tr><tr><td>VORI</td><td>57</td><td>98.3</td><td>1</td><td>1.7</td><td>&#8212;</td><td>&#8212;</td><td>30</td><td>96.8</td><td>1</td><td>3.2</td><td>&#8212;</td><td>&#8212;</td></tr><tr><td>AMB</td><td>57</td><td>98.3</td><td>&#8212;</td><td>&#8212;</td><td>1</td><td>1.7</td><td>31</td><td>100.0</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td></tr></table>
027b7e94b38cd02b5950f891a97359e5a38335788867136d47d3d7fef5549f62.png
simple
<table><tr><td></td><td>Family history of AA</td><td>Coronary heart disease</td><td>Hypertension</td><td>Cerebrovascular disease</td><td>Diabetes</td></tr><tr><td>AA (<i>n</i> = 169)</td><td>2</td><td>68</td><td>103</td><td>22</td><td>17</td></tr><tr><td>Non-AA (<i>n</i> = 156)</td><td>0</td><td>27</td><td>38</td><td>2</td><td>10</td></tr><tr><td><i>p</i> value</td><td></td><td>0.000*</td><td>0.000*</td><td>0.000*</td><td>0.234</td></tr></table>
00f25d1b65b1a6d03bd1c562cb9680f000a7a1b62610e886861be9d543e4116d.png
simple
<table><tr><td>Gene</td><td>Main associated phenotype</td><td>Gene product</td><td>Inheritance</td><td>Age of onset</td><td>Diagnostic clues</td></tr><tr><td><i>ADCY5</i></td><td><i>ADCY5</i>-related chorea</td><td>Adenylate cyclase 5</td><td>AD/de novo</td><td>Infancy to childhood</td><td>Axial hypotonia and delayed milestonesDiurnal and sleep-related MD exacerbationsDystonia and myoclonus prominent in some cases</td></tr><tr><td><i>PDE10A</i></td><td><i>PDE10A</i>-related chorea</td><td>Phosphodiesterase 10A</td><td>De novo/AD/AR</td><td>Infancy to childhood</td><td>Delayed motor-language milestones and dysarthria in recessive casesMRI: symmetrical T2-hyperintense bilateral striatal lesions in cases with heterozygous de novo mutations</td></tr><tr><td><i>FOXG1</i></td><td>Congenital Rett disease</td><td>Forkhead Box G1</td><td>De novo</td><td>Infancy to early childhood</td><td>Severe ID, absent language, acquired microcephalyMRI: corpus callosum aplasia/hypoplasia, delayed myelination, simplified gyration</td></tr><tr><td><i>ARX</i></td><td>Early infantile epileptic encephalopathy-type 1;X-linked mental retardation</td><td>Aristaless-related homeobox protein</td><td>XL</td><td>Infancy</td><td>Ohtahara/West syndrome, severe mental retardation, generalized dystonia/dyskinesias with recurrent status dystonicus</td></tr><tr><td><i>STXBP1</i></td><td>Early infantile epileptic encephalopathy-type 4</td><td>Syntaxin-binding protein 1</td><td>De novo</td><td>Early infancy to childhood</td><td>Onset of seizures within one year of age. Developmental delay, ID, autistic-like features, ataxia with or without dyskinesias/dystonia</td></tr><tr><td><i>SYT1</i></td><td>Severe motor delay and intellectual disability</td><td>Synaptotagmin-1</td><td>De novo</td><td>Infancy</td><td>Severely delayed motor development without seizures</td></tr><tr><td><i>UNC13A</i></td><td>Congenital encephalopathy with dyskinesias</td><td>Unc-13 homolog A</td><td>De novo</td><td>Congenital</td><td>Developmental and speech delay; ID, congenital dyskinesias with intention tremor, rare febrile seizures</td></tr><tr><td><i>GNAO1</i></td><td>Early infantile epileptic encephalopathy type 17/Ohtahara syndrome</td><td>G&#945;o subunit of GPCR</td><td>De novo</td><td>Infancy to childhood</td><td>Developmental delay and IDLong-lasting MD exacerbations not related to sleepEpilepsy can be absent or well controlled</td></tr><tr><td><i>GRIN1</i></td><td>Mental retardation, autosomal dominant 8</td><td>GluN1 subunit of NMDAR</td><td>De novo/AR</td><td>Infancy</td><td>Severe developmental delay and IDEarly-onset epileptic seizuresOculogyric crisesCortical blindness, dysmorphic traits, microcephaly</td></tr><tr><td><i>FRRS1L</i></td><td>Early infantile epileptic encephalopathy-type 37</td><td>Ferric Chelate Reductase 1-like</td><td>AR</td><td>Infancy</td><td>Psychomotor regression after normal developmentSevere encephalopathic epilepsyChoreo-athetosis in infancy/childhood, parkinsonism in adolescence</td></tr><tr><td><i>TBC1D24</i></td><td>Early infantile epileptic encephalopathy type 16</td><td>TBC1 domain family, member 24</td><td>AR</td><td>Infancy</td><td>Early-onset myoclonic seizuresVariable degrees of IDDystonia</td></tr><tr><td><i>GPR88</i></td><td><i>GPR88-</i>related chorea</td><td>G protein-coupled receptor 88</td><td>AR</td><td>Infancy to childhood</td><td>Developmental and language delaySevere mental retardationScarcely progressive chorea</td></tr><tr><td><i>KMT2B</i></td><td>DYT28 dystonia</td><td>lysine-specific histone methyltransferase 2B</td><td>De novo/AD</td><td>Childhood-adolescence</td><td>Onset in lower limbs and prominent oro-mandibular/laryngeal involvementMild dysmorphic traits; mild IDGood and sustained response to pallidal DBS</td></tr><tr><td><i>ATP1A3</i></td><td>AHCRDPCAPOS syndrome</td><td>Na<sup>+</sup>/K<sup>+</sup> ATPase, &#945;3 subunit</td><td>De novo/AD</td><td>Infancy to fifth decade</td><td>Abrupt onset of neurological signs (dystonia, muscular weakness, ataxia)Initial hemisomatic distributionIdentifiable triggering factors</td></tr></table>
7473e37e606204306a56206cf3103de2be10a5fc9c7690b199c2c9ccfabffd85.png
simple
<table><tr><td></td><td>Number of events</td><td>Event rate per 100 person years (95% CI)</td></tr><tr><td>Any Stroke</td><td>22</td><td>4.0 (2.3&#8211;5.6)</td></tr><tr><td>Posterior circulation stroke</td><td>12</td><td>2.1 (0.9&#8211;3.3)</td></tr><tr><td>Any stroke or TIA</td><td>41</td><td>7.9 (5.5&#8211;10.4)</td></tr><tr><td>Posterior circulation stroke or TIA</td><td>26</td><td>4.8 (3.0&#8211;6.7)</td></tr></table>
8f47e2ba5929d424f3763e7253bf019b6fd6b50f9024eff156d273e429b9eb93.png
simple
<table><tr><td> </td><td>Parasite density based on assumed WBC count</td><td>Parasite density based on measured WBC count</td><td><i>P </i>value*</td></tr><tr><td><i>P. falciparum</i> (n = 143)</td><td>15,208 (9,320-19,470)</td><td>13,213 (7,680-16,273)</td><td>0.49</td></tr><tr><td><i>P. vivax</i> (n = 33)</td><td>5,364 (644-10,109)</td><td>3,538 (595-12,698)</td><td>0.96</td></tr></table>
3f76e373f92f29028f9ff04b3a4a160d0e6de5ab5b47b7dd17114003110c755b.png
simple
<table><tr><td> </td><td>AUCg1</td><td>AUCg2</td><td>AvgAUCg</td><td>Height <i>cm</i></td><td>Weight <i>kg</i></td><td>WC <i>cm</i></td><td>BMI <i>kg/m</i><sup><i>2</i></sup></td><td>vWSR</td><td>TR <i>years</i></td><td>Age <i>years</i></td><td>LI</td></tr><tr><td>AUCg1</td><td>1</td><td>0.571**</td><td>0.861***</td><td>.182</td><td>&#8722;0.018</td><td>&#8722;0.167</td><td>&#8722;0.109</td><td>&#8722;0.237</td><td>0.237</td><td>&#8722;0.440*</td><td>0.063</td></tr><tr><td>AUCg2</td><td> </td><td>1</td><td>0.909***</td><td>&#8722;0.033</td><td>&#8722;0.195</td><td>&#8722;0.134</td><td>&#8722;0.237</td><td>&#8722;0.145</td><td>&#8722;0.018</td><td>&#8722;0.343</td><td>&#8722;0.272</td></tr><tr><td>AvgAUCg</td><td> </td><td> </td><td>1</td><td>0.071</td><td>&#8722;0.130</td><td>&#8722;0.168</td><td>&#8722;0.202</td><td>&#8722;0.210</td><td>0.110</td><td>&#8722;0.436*</td><td>&#8722;0.139</td></tr><tr><td>Height (<i>cm</i>)</td><td> </td><td> </td><td> </td><td>1</td><td>0.559**</td><td>0.431*</td><td>0.1270</td><td>0.145</td><td>&#8722;0.323</td><td>&#8722;0.329</td><td>0.062</td></tr><tr><td>Weight (<i>kg</i>)</td><td> </td><td> </td><td> </td><td> </td><td>1</td><td>0.870***</td><td>0.888***</td><td>0.767***</td><td>0.073</td><td>0.121</td><td>&#8722;0.012</td></tr><tr><td>WC (<i>cm</i>)</td><td> </td><td> </td><td> </td><td> </td><td> </td><td>1</td><td>0.813***</td><td>0.954***</td><td>0.246</td><td>0.147</td><td>&#8722;0.047</td></tr><tr><td>BMI (<i>kg/m</i><sup><i>2</i></sup>)</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td>1</td><td>0.849***</td><td>0.350</td><td>0.283</td><td>&#8722;0.061</td></tr><tr><td>WSR</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td>1</td><td>0.279</td><td>0.387</td><td>&#8722;0.078</td></tr><tr><td>TR (<i>years</i>)</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td>1</td><td>0.394</td><td>0.321</td></tr><tr><td>Age (years)</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td>1</td><td>0.521*</td></tr><tr><td>LI</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td>1</td></tr></table>
ad52fa7963bf310ef89ac3b27db31443501220fd0a5befcc2564b9074152a41d.png
simple
<table><tr><td>Premature Ejaculation Profile Questions</td><td>Tramadol</td><td>Paroxetine</td><td>Placebo</td></tr><tr><td>Satisfaction with sexual intercourse (Z)</td><td>&#8722;5.31</td><td>&#8722;3.55</td><td>&#8722;1.10</td></tr><tr><td>p-value</td><td>0.0001</td><td>0.0001</td><td>0.270</td></tr><tr><td>Control over ejaculation (Z)</td><td>&#8722;5.39</td><td>&#8722;2.22</td><td>&#8722;0.09</td></tr><tr><td>p-value</td><td>0.0001</td><td>0.026</td><td>0.923</td></tr><tr><td>Ejaculation-related interpersonal difficulty (Z)</td><td>&#8722;4.001</td><td>&#8722;2.34</td><td>&#8722;1.90</td></tr><tr><td>p-value</td><td>0.0001</td><td>0.019</td><td>0.057</td></tr><tr><td>Ejaculation-related distress (Z)</td><td>&#8722;3.97</td><td>&#8722;2.29</td><td>&#8722;0.81</td></tr><tr><td>p-value</td><td>0.0001</td><td>0.022</td><td>0.417</td></tr></table>
79c4d2df10f33f5ea59542d968fa21215be9173890c6f95423c48dfd45778ba7.png
simple
<table><tr><td></td><td>Age<sup>1</sup></td><td>Sex F vs. M<sup>2</sup></td><td>Current Smoker vs. Not<sup>2</sup></td><td>FEV<sub>1 </sub>(% predicted)<sup>1</sup></td><td>Exacerbation Frequency (previous yr)<sup>3</sup></td></tr><tr><td>Mean Heart Rate (min<sup>-1</sup>)</td><td>r = -0.28</td><td>80 vs. 77</td><td>77 vs. 78</td><td>r = -0.26</td><td>rho = 0.23</td></tr><tr><td></td><td>p = 0.134</td><td>p = 0.525</td><td>p = 0.862</td><td>p = 0.164</td><td>p = 0.207</td></tr><tr><td>SD Heart Rate (min<sup>-1</sup>)</td><td>r = -0.39</td><td>4.7 vs. 5.0</td><td>4.5 vs. 4.9</td><td>r = -0.35</td><td>rho = -0.05</td></tr><tr><td></td><td>p = 0.030*</td><td>p = 0.724</td><td>p = 0.713</td><td>p = 0.054</td><td>p = 0.797</td></tr><tr><td>Mean Oxygen Saturation (%)</td><td>r = 0.08</td><td>94 vs. 95</td><td>95 vs. 95</td><td>r = 0.14</td><td>rho = 0.21</td></tr><tr><td></td><td>p = 0.688</td><td>p = 0.358</td><td>p = 0.644</td><td>p = 0.470</td><td>p = 0.266</td></tr><tr><td>SD Oxygen Saturation (%)</td><td>r = 0.17</td><td>1.2 vs. 0.9</td><td>1.0 vs. 1.0</td><td>r = -0.21</td><td>rho = -0.03</td></tr><tr><td></td><td>p = 0.350</td><td>p = 0.027*</td><td>p = 0.769</td><td>p = 0.267</td><td>p = 0.862</td></tr><tr><td>Mean PEF (lmin<sup>-1</sup>)</td><td>r = -0.03</td><td>198 vs. 248</td><td>258 vs. 225</td><td>r = 0.25</td><td>rho = 0.09</td></tr><tr><td></td><td>p = 0.858</td><td>p = 0.085</td><td>p = 0.378</td><td>p = 0.172</td><td>p = 0.647</td></tr><tr><td>SD PEF (lmin<sup>-1</sup>)</td><td>r = -0.02</td><td>12 vs. 11</td><td>10 vs. 12</td><td>r = 0.10</td><td>rho = 0.00</td></tr><tr><td></td><td>p = 0.921</td><td>p = 0.834</td><td>p = 0.446</td><td>p = 0.608</td><td>p = 0.982</td></tr></table>
d6174cd69ca24a72573ac7a6745caa49be5de439d371d788c6946c33b2aaeb5a.png
simple
<table><tr><td>Patient Characteristics</td><td>Univariate Analysis HR (95% CI)</td><td><i>p</i>-Value</td><td>Multivariate Analysis HR (95% CI)</td><td><i>p</i>-Value</td></tr><tr><td>Sex</td><td>0.853 (0.549&#8211;1.326)</td><td>0.481</td><td>-</td><td>-</td></tr><tr><td>Age (years)</td><td>1.326 (0.872&#8211;2.018)</td><td>0.187</td><td>-</td><td>-</td></tr><tr><td>Smoking Behaviour</td><td>0.777 (0.476&#8211;1.268)</td><td>0.313</td><td>-</td><td>-</td></tr><tr><td>Family History</td><td>0.808 (0.391&#8211;1.672)</td><td>0.566</td><td>-</td><td>-</td></tr><tr><td>Pathological Stage</td><td>3.666 (2.694&#8211;4.988)</td><td>&lt;0.001</td><td>3.118 (2.044&#8211;4.756)</td><td>&lt;0.001</td></tr><tr><td>Lymph Node Metastasis (N)</td><td>1.988 (1.375&#8211;2.874)</td><td>&lt;0.001</td><td>0.831 (0.554&#8211;1.247)</td><td>0.371</td></tr><tr><td>Distant Metastases</td><td>5.286 (3.360&#8211;8.316)</td><td>&lt;0.001</td><td>1.957 (1.119&#8211;3.422)</td><td>0.019</td></tr><tr><td>Tumor Location</td><td>0.746 (0.581&#8211;0.957)</td><td>0.021</td><td>0.852 (0.646&#8211;1.123)</td><td>0.255</td></tr><tr><td>Maximun Tumor Diameter (cm)</td><td>2.528 (1.660&#8211;3.848)</td><td>&lt;0.001</td><td>1.180 (0.752&#8211;1.852)</td><td>0.472</td></tr><tr><td>Serous Infiltration</td><td>2.038 (1.587&#8211;2.618)</td><td>&lt;0.001</td><td>0.972 (0.708&#8211;1.334)</td><td>0.860</td></tr><tr><td>ALB (g/L)</td><td>0.485 (0.264&#8211;0.892)</td><td>0.020</td><td>0.776 (0.247&#8211;2.438)</td><td>0.664</td></tr><tr><td>ALT (U/L)</td><td>0.814 (0.535&#8211;1.239)</td><td>0.337</td><td>-</td><td>-</td></tr><tr><td>AST (U/L)</td><td>0.965 (0.636&#8211;1.466)</td><td>0.869</td><td>-</td><td>-</td></tr><tr><td>LSR (ALT/AST)</td><td>0.565 (0.368&#8211;0.868)</td><td>0.009</td><td>0.610 (0.388&#8211;0.958)</td><td>0.032</td></tr><tr><td>CRP (mg/L)</td><td>1.351 (0.888&#8211;2.057)</td><td>0.160</td><td>-</td><td>-</td></tr><tr><td>CA19-9 (U/mL)</td><td>1.454 (0.950&#8211;2.224)</td><td>0.085</td><td>0.710 (0.442&#8211;1.139)</td><td>0.155</td></tr><tr><td>CA72-4 (U/mL)</td><td>2.035 (1.318&#8211;3.144)</td><td>0.001</td><td>1.479 (0.941&#8211;2.325)</td><td>0.090</td></tr><tr><td>CEA (ng/mL)</td><td>1.501 (0.983&#8211;2.293)</td><td>0.060</td><td>1.331 (0.811&#8211;2.184)</td><td>0.258</td></tr><tr><td>Fbg (g/L)</td><td>1.530 (1.002&#8211;2.338)</td><td>0.049</td><td>1.070 (0.669&#8211;1.713)</td><td>0.778</td></tr><tr><td>GPS</td><td>1.565 (1.033&#8211;2.373)</td><td>0.035</td><td>0.929 (0.431&#8211;2.004)</td><td>0.851</td></tr><tr><td>p53</td><td>1.212 (1.005&#8211;1.462)</td><td>0.045</td><td>1.128 (0.917&#8211;1.387)</td><td>0.255</td></tr><tr><td>Blood Type</td><td>0.875 (0.741&#8211;1.033)</td><td>0.115</td><td>-</td><td>-</td></tr></table>
bd146d38e8e55734268ef50cf3df669b1ade868983f0ee783f234c7cbfab7505.png
simple
<table><tr><td>Algorithms</td><td>Sensitivity %, (95% CI)</td><td>Specificity %, (95% CI)</td><td>PPV %, (95% CI)</td><td>LR<sup>+</sup> (95% CI)</td></tr><tr><td>A: &#8805;1 ICD-9 code for AVN</td><td>81.9 (72.0&#8211;89.5)</td><td>99.6 (99.4&#8211;99.7)</td><td>66.0 (56.0&#8211;75.1)</td><td>190.0 (134.5&#8211;268.5)</td></tr><tr><td>B: &#8805;2 ICD-9 codes for AVN at least 7 days apart</td><td>57.8 (46.5&#8211;68.6)</td><td>99.9 (99.8&#8211;99.9)</td><td>81.4 (69.1&#8211;90.3)</td><td>426.7 (229.9&#8211;792.1)</td></tr><tr><td>C: &#8805;2 ICD-9 codes for AVN at least 30 days apart</td><td>44.6 (33.7&#8211;55.9)</td><td>99.9 (99.8&#8211;99.9)</td><td>78.7 (64.3&#8211;89.3)</td><td>361.8 (186.2&#8211;703.1)</td></tr><tr><td>D: &#8805;3 ICD-9 codes for AVN at least 30 days apart</td><td>44.6 (33.7&#8211;55.9)</td><td>99.9 (99.8&#8211;100.0)</td><td>82.2 (67.9&#8211;92.0)</td><td>452.3 (217.3&#8211;941.4)</td></tr></table>
cf9015ae193f9ed2f37f11256bccc1c2e4d1a73e1651576e76a6b9327c709f06.png
simple
<table><tr><td>Age Group</td><td>2001</td><td>2002</td><td>2003</td><td>2004</td><td>2005</td><td>2006</td><td>2007</td><td>2008</td></tr><tr><td>20 to 30 years old</td><td>334</td><td>278</td><td>242</td><td>329</td><td>271</td><td>297</td><td>301</td><td>286</td></tr><tr><td>31 to 40 years old</td><td>600</td><td>614</td><td>549</td><td>623</td><td>659</td><td>673</td><td>728</td><td>729</td></tr><tr><td>41 to 50 years old</td><td>714</td><td>644</td><td>598</td><td>681</td><td>748</td><td>843</td><td>844</td><td>898</td></tr><tr><td>51 to 60 years old</td><td>872</td><td>817</td><td>783</td><td>857</td><td>858</td><td>930</td><td>942</td><td>964</td></tr><tr><td>61 to 70 years old</td><td>979</td><td>963</td><td>968</td><td>940</td><td>1.007</td><td>1.074</td><td>1.197</td><td>1.209</td></tr><tr><td>71 to 80 years old</td><td>954</td><td>847</td><td>865</td><td>844</td><td>895</td><td>1.030</td><td>1.024</td><td>1.141</td></tr><tr><td>&#8805;81 years old </td><td>393</td><td>418</td><td>416</td><td>433</td><td>473</td><td>477</td><td>581</td><td>596</td></tr><tr><td>TOTAL</td><td>4.846</td><td>4.581</td><td>4.421</td><td>4.707</td><td>4.911</td><td>5.324</td><td>5.617</td><td>5.823</td></tr></table>
8521a7712652204b2faa11a398c24540f7273a4bf936d297cc00f17354adbdf3.png
simple
<table><tr><td>Variables</td><td>Patients with RVSD (<i>N</i> = 32)</td><td>Patients without RVSD (<i>N</i> = 13)</td><td><i>p</i>-value</td></tr><tr><td>Right atrial end-systolic area, cm<sup>2</sup></td><td>19.7 &#177; 7.6</td><td>15.8 &#177; 8.1</td><td>0.149</td></tr><tr><td>Right atrial length, mm</td><td>42.9 &#177; 10.2</td><td>42.5 &#177; 11.1</td><td>0.916</td></tr><tr><td>Right ventricular basal diameter, mm</td><td>49.6 &#177; 9.3</td><td>47.7 &#177; 10.7</td><td>0.583</td></tr><tr><td>TAPSE, mm</td><td>13.1 &#177; 2.6</td><td>20.3 &#177; 2.2</td><td>&lt;0.001*</td></tr><tr><td>Right ventricular S&#8217;, cm/s</td><td>10.6 &#177; 3.2</td><td>15.3 &#177; 3.9</td><td>&lt;0.001*</td></tr><tr><td>RIMP</td><td>1.09 &#177; 0.60</td><td>1.76 &#177; 1.30</td><td>0.032*</td></tr><tr><td>RV wall thickness, mm</td><td>3.6 &#177; 1.2</td><td>3.5 &#177; 0.8</td><td>0.952</td></tr><tr><td>Tricuspid Valve E:A ratio</td><td>1.21 &#177; 0.44</td><td>0.90 &#177; 0.35</td><td>0.019*</td></tr><tr><td>Tricuspid Valve E/e&#8217;</td><td>5.08 &#177; 2.73</td><td>3.46 &#177; 1.45</td><td>0.023*</td></tr><tr><td>Left atrial diameter, mm</td><td>43.2 &#177; 6.4</td><td>41.9 &#177; 6.2</td><td>0.548</td></tr><tr><td>LV end-diastolic diameter, mm</td><td>62.0 &#177; 7.5</td><td>62.4 &#177; 11.7</td><td>0.910</td></tr><tr><td>LV ejection fraction, %</td><td>32.4 &#177; 9.3</td><td>36.6 &#177; 7.7</td><td>0.127</td></tr><tr><td>LV stroke volume index, L/m<sup>2</sup></td><td>39.9 &#177; 12.3</td><td>51.4 &#177; 17.9</td><td>0.017</td></tr><tr><td>Anti-log<sub>10</sub> mitral valve E:A</td><td>1.50 &#177; 0.62</td><td>1.31 &#177; 0.25</td><td>0.154</td></tr><tr><td>Mitral valve E/e&#8217;</td><td>15.96 &#177; 7.13</td><td>15.61 &#177; 7.06</td><td>0.882</td></tr><tr><td>PA acceleration time, ms</td><td>61.8 &#177; 22.4</td><td>78.9 &#177; 28.0</td><td>0.037*</td></tr><tr><td>PA systolic pressure, mmHg</td><td>47.4 &#177; 19.4</td><td>39.2 &#177; 21.5</td><td>0.246</td></tr><tr><td>Mean PAP, mmHg</td><td>30.6 &#177; 11.6</td><td>25.9 &#177; 13.1</td><td>0.273</td></tr><tr><td>Pulmonary hypertension</td><td>23 (71.9 %)</td><td>7 (53.9 %)</td><td>0.304</td></tr></table>
0ca2f642ef9745b8c46aa56da04648adf3bcf0666cea5ad9a53058203ba4073b.png
complex
<table><tr><td>Segments</td><td>Primers</td><td>Position</td><td>Length, bp</td></tr><tr><td colspan="4">Internal standard</td></tr><tr><td> P1</td><td>5&#8242;-aacatacccatggccaacct-3&#8242;</td><td>3304&#8211;3836</td><td>533</td></tr><tr><td> P2</td><td>5&#8242;-ggcaggagtaatcagaggtg-3&#8242;</td><td></td><td></td></tr><tr><td colspan="4">First cycle</td></tr><tr><td> P3</td><td>5&#8242;-tgaacctacgagtacaccga-3&#8242;</td><td>7901&#8211;14220</td><td>1342</td></tr><tr><td> P4</td><td>5&#8242;-ttagtagtagttactggttg-3&#8242;</td><td></td><td></td></tr><tr><td colspan="4">Second cycle</td></tr><tr><td> P5</td><td>5&#8242;-ttcatgcccatcgtcctaga-3&#8242;</td><td>8201&#8211;13851</td><td>673</td></tr><tr><td> P6</td><td>5&#8242;-gttgaggtctagggctgtta-3&#8242;</td><td></td><td></td></tr><tr><td colspan="4">Third cycle</td></tr><tr><td> P7</td><td>5&#8242;-cccctctagagcccactgtaaagc-3&#8242;</td><td>8282&#8211;13650</td><td>391</td></tr><tr><td> P8</td><td>5&#8242;-ggggaagcgaggttgacctg-3&#8242;</td><td></td><td></td></tr></table>
e86c6f491ec80ffc684132556b3b43a932c09504659d91d981aee445d2757dfc.png
complex
<table><tr><td>Canonical Pathways</td><td colspan="5">Number of differentially expressed molecules (<i>P</i>-value)</td></tr><tr><td></td><td>SPF</td><td>C</td><td>EF</td><td>CIF</td><td>EF&#183;CIF</td></tr><tr><td colspan="6"><i>Ranked according to ratio (differentially expressed genes/total number of genes)</i></td></tr><tr><td>Antigen Presentation Pathway</td><td>5/39 (&lt; 0.0001)</td><td>5/39 (&lt; 0.0001)</td><td>10/39 (&lt; 0.0001)</td><td>10/39 (&lt; 0.0001)</td><td>10/39 (&lt; 0.0001)</td></tr><tr><td>Interferon Signaling</td><td>1/29 (0.1)</td><td>1/29 (0.1)</td><td>9/29 (&lt; 0.0001)</td><td>6/29 (&lt; 0.005)</td><td>6/29 (&lt; 0.01)</td></tr><tr><td>IL-10 Signaling</td><td>1/70 (0.2)</td><td>2/70 (&lt; 0.05)</td><td>12/70 (&lt; 0.0001)</td><td>12/70 (&lt; 0.001)</td><td>13/70 (&lt; 0.0005)</td></tr><tr><td>p38 MAPK Signaling</td><td>1/95 (0.3)</td><td>2/95 (0.1)</td><td>13/95 (&lt; 0.001)</td><td>15/95 (&lt; 0.0005)</td><td>17/95 (&lt; 0.0001)</td></tr><tr><td>Cell Cycle: G2/M DNA Damage Checkpoint Regulation</td><td>N/A</td><td>N/A</td><td>7/42 (&lt; 0.01)</td><td>5/42 (0.06)</td><td>7/42 (&lt; 0.01)</td></tr><tr><td>Inositol Metabolism</td><td>N/A</td><td>N/A</td><td>4/24 (&lt; 0.005)</td><td>3/24 (0.13)</td><td>4/24 (&lt; 0.05)</td></tr><tr><td>Keratan Sulfate Biosynthesis</td><td>N/A</td><td>N/A</td><td>5/31 (&lt; 0.05)</td><td>3/31 (026)</td><td>5/31 (&lt; 0.05)</td></tr><tr><td>IL-6 Signaling</td><td>N/A</td><td>1/93 (0.41)</td><td>13/93 (&lt; 0.0005)</td><td>13/93 (&lt; 0.005)</td><td>15/93 (&lt; 0.0005)</td></tr><tr><td>Fatty Acid Metabolism</td><td>1/187 (0.5)</td><td>4/187 (&lt; 0.05)</td><td>28/187 (&lt; 0.0001)</td><td>26/187 (&lt; 0.0001)</td><td>28/187 (&lt; 0.0001)</td></tr><tr><td colspan="6"><i>Ranked according to P-value (as determined by IPA)</i></td></tr><tr><td>Total number of significant pathways</td><td>2</td><td>6</td><td>15</td><td>44</td><td>40</td></tr><tr><td>Fatty Acid Metabolism</td><td>1/187 (0.3)</td><td>2/187 (0.1)</td><td>28/187 (&lt; 0.0001)</td><td>25/187 (&lt; 0.0001)</td><td>28/187 (&lt; 0.0001)</td></tr><tr><td>LPS/IL-1 Mediated Inhibition of RXR Function</td><td>1/170 (0.4)</td><td>2/170 (0.2)</td><td>33/170 (&lt; 0.0001)</td><td>26/170 (&lt; 0.0001)</td><td>31/170 (&lt; 0.0001)</td></tr><tr><td>Tryptophan Metabolism</td><td>2/237 (0.05)</td><td>1/237 (0.4)</td><td>26/237 (&lt; 0.0001)</td><td>22/237 (&lt; 0.0001)</td><td>24/237 (&lt; 0.0001)</td></tr><tr><td>&#946;-alanine Metabolism</td><td>N/A</td><td>N/A</td><td>10/99 (&lt; 0.0001)</td><td>15/99 (&lt; 0.0001)</td><td>14/99 (&lt; 0.0001)</td></tr><tr><td>Valine, Leucine and Isoleucine Degradation</td><td>N/A</td><td>N/A</td><td>12/107 (&lt; 0.0001)</td><td>14/107 (&lt; 0.0005)</td><td>16/107 (&lt; 0.0001)</td></tr></table>
91adf07311651337f48daa940ad502dcebfe460c5296f64ceeddca4620f9ad6e.png
simple
<table><tr><td>Variables</td><td><sup>a</sup>Adjusted HR</td><td>95% CI</td><td><i>P</i> value</td></tr><tr><td>Age (years)</td><td>1.033</td><td>1.027&#8211;1.039</td><td>&lt; 0.001</td></tr><tr><td>Female sex</td><td>0.700</td><td>0.593&#8211;0.827</td><td>&lt; 0.001</td></tr><tr><td>Hypertension</td><td>1.025</td><td>0.897&#8211;1.172</td><td>0.713</td></tr><tr><td>Diabetes mellitus</td><td>1.427</td><td>1.216&#8211;1.675</td><td>&lt; 0.001</td></tr><tr><td>Preoperative severe anemia(Hb &lt; 8.0 g/dL)</td><td>1.282</td><td>1.036&#8211;1.586</td><td>0.022</td></tr><tr><td>Preoperative creatinine (mg/dL)</td><td>2.022</td><td>1.711&#8211;2.389</td><td>&lt; 0.001</td></tr><tr><td>Postoperative creatinine (mg/dL)</td><td>1.010</td><td>1.004&#8211;1.017</td><td>0.003</td></tr><tr><td>Intraoperative use of normal saline</td><td>1.030</td><td>0.905&#8211;1.172</td><td>0.656</td></tr><tr><td>Postoperative hyponatremia</td><td>1.331</td><td>1.148&#8211;1.542</td><td>&lt; 0.001</td></tr></table>
e6516c1045a18ee7692e3212c34ecbb7b6ae4b6a2b226e984ebd6e364a4a7729.png
simple
<table><tr><td> </td><td>Equation</td><td>Correlation coefficient</td><td>LOD (ng g<sup>&#8722;1</sup>)</td><td>LOQ (ng g<sup>&#8722;1</sup>)</td></tr><tr><td><i>&#945;</i>-HCH</td><td><i>y</i> = 0.168&#8722;0.7642</td><td>0.9906</td><td>1.00 &#177; 0.33</td><td>3.35 &#177; 0.33</td></tr><tr><td>HCB</td><td><i>y</i> = 0.0866 + 0.3576</td><td>0.9985</td><td>1.44 &#177; 0.48</td><td>4.80 &#177; 0.48</td></tr><tr><td><i>&#946;</i>-HCH</td><td><i>y</i> = 0.0111&#8722;0.0155</td><td>0.9933</td><td>1.50 &#177; 0.50</td><td>4.99 &#177; 0.50</td></tr><tr><td>Aldrin</td><td><i>y</i> = 0.1025&#8722;0.1005</td><td>0.9971</td><td>0.49 &#177; 0.16</td><td>1.62 &#177; 0.16</td></tr><tr><td>Heptachlor epoxide</td><td><i>y</i> = 0.06&#8722;0.1873</td><td>0.9970</td><td>0.73 &#177; 0.24</td><td>2.43 &#177; 0.24</td></tr><tr><td>o,p-DDE</td><td><i>y</i> = 0.0147&#8722;0.0314</td><td>0.9978</td><td>0.76 &#177; 0.25</td><td>2.53 &#177; 0.25</td></tr><tr><td><i>&#945;</i>-Endosulfan</td><td><i>y</i> = 0.0289&#8722;0.053</td><td>0.9967</td><td>0.99 &#177; 0.32</td><td>3.30 &#177; 0.32</td></tr><tr><td>p,p-DDE</td><td><i>y</i> = 0.0197&#8722;0.0206</td><td>0.9978</td><td>1.34 &#177; 0.45</td><td>4.46 &#177; 0.45</td></tr><tr><td>Dieldrin</td><td><i>y</i> = 0.0234&#8722;0.0452</td><td>0.9963</td><td>1.20 &#177; 0.40</td><td>4.01 &#177; 0.40</td></tr><tr><td>Endrin</td><td><i>y</i> = 0.0364&#8722;0.1672</td><td>0.9900</td><td>0.60 &#177; 0.20</td><td>2.00 &#177; 0.20</td></tr><tr><td><i>&#946;</i>-Endosulfan</td><td><i>y</i> = 0.0087 + 0.011</td><td>0.9983</td><td>1.32 &#177; 0.44</td><td>4.41 &#177; 0.44</td></tr><tr><td>p,p-DDD</td><td><i>y</i> = 0.0105&#8722;0.0202</td><td>0.9971</td><td>0.78 &#177; 0.25</td><td>2.59 &#177; 0.25</td></tr><tr><td>o,p-DDT</td><td><i>y</i> = 0.0298&#8722;0.1573</td><td>0.9919</td><td>0.48 &#177; 0.16</td><td>1.61 &#177; 0.16</td></tr><tr><td>p,p-DDT</td><td><i>y</i> = 0.0101&#8722;0.0232</td><td>0.9975</td><td>1.19 &#177; 0.40</td><td>3.98 &#177; 0.40</td></tr></table>
24d61b749a1e094a98470f26222e1dee4015d863325a974771025a9d7fcd92b7.png
complex
<table><tr><td rowspan="2">Mixture</td><td colspan="5">Compressive Strength (MPa) *</td></tr><tr><td>3 Days</td><td>7 Days</td><td>14 Days</td><td>28 Days</td><td>90 Days</td></tr><tr><td>C-0.50-N</td><td>18.27 <i>0.73</i></td><td>25.18 <i>0.25</i></td><td>30.47 <i>1.33</i></td><td>38.47 <i>0.14</i></td><td>51.02 <i>1.07</i></td></tr><tr><td>C-0.50-H</td><td>20.41 <i>0.58</i></td><td>28.23 <i>0.92</i></td><td>35.73 <i>0.29</i></td><td>42.87 <i>1.41</i></td><td>54.63 <i>1.12</i></td></tr><tr><td>C-0.50-SCM</td><td>23.92 <i>0.29</i></td><td>34.21 <i>0.72</i></td><td>41.90 <i>1.41</i></td><td>50.19 <i>0.09</i></td><td>58.24 <i>1.05</i></td></tr><tr><td>10FA-0.50-N</td><td>16.87 <i>0.61</i></td><td>23.62 <i>0.39</i></td><td>28.47 <i>1.33</i></td><td>36.71 <i>0.77</i></td><td>46.76 <i>1.07</i></td></tr><tr><td>10FA-0.50-H</td><td>18.29 <i>0.68</i></td><td>26.73 <i>0.54</i></td><td>31.86 <i>0.93</i></td><td>41.25 <i>1.03</i></td><td>51.30 <i>1.57</i></td></tr><tr><td>10FA-0.50-SCM</td><td>21.14 <i>0.09</i></td><td>29.84 <i>0.16</i></td><td>35.24 <i>0.19</i></td><td>45.78 <i>0.15</i></td><td>55.83 <i>1.14</i></td></tr><tr><td>20FA-0.50-N</td><td>15.23 <i>0.67</i></td><td>23.02 <i>0.13</i></td><td>27.96 <i>0.75</i></td><td>35.14 <i>1.12</i></td><td>45.39 <i>1.09</i></td></tr><tr><td>20FA-0.50-H</td><td>18.02 <i>0.32</i></td><td>25.72 <i>0.65</i></td><td>31.43 <i>0.42</i></td><td>39.21 <i>0.67</i></td><td>49.59 <i>0.35</i></td></tr><tr><td>20FA-0.50-SCM</td><td>20.81 <i>0.89</i></td><td>28.42 <i>0.43</i></td><td>34.89 <i>1.98</i></td><td>43.27 <i>0.86</i></td><td>53.87 <i>0.64</i></td></tr><tr><td>40FA-0.50-N</td><td>14.97 <i>0.22</i></td><td>22.86 <i>0.56</i></td><td>26.74 <i>0.21</i></td><td>34.95 <i>0.45</i></td><td>44.23 <i>1.69</i></td></tr><tr><td>40FA-0.50-H</td><td>17.57 <i>0.98</i></td><td>25.39 <i>1.78</i></td><td>30.33 <i>0.67</i></td><td>38.57 <i>1.02</i></td><td>47.96 <i>0.93</i></td></tr><tr><td>40FA-0.50-SCM</td><td>20.17 <i>0.34</i></td><td>27.92 <i>1.67</i></td><td>33.91 <i>0.39</i></td><td>42.18 <i>0.82</i></td><td>51.68 <i>0.74</i></td></tr><tr><td>60FA-0.50-N</td><td>14.12 <i>0.92</i></td><td>20.72 <i>0.41</i></td><td>26.07 <i>1.21</i></td><td>33.87 <i>1.08</i></td><td>43.14 <i>0.71</i></td></tr><tr><td>60FA-0.50-H</td><td>17.03 <i>0.86</i></td><td>23.11 <i>0.79</i></td><td>29.44 <i>0.29</i></td><td>37.05 <i>0.69</i></td><td>46.55 <i>1.49</i></td></tr><tr><td>60FA-0.50-SCM</td><td>19.94 <i>0.26</i></td><td>25.49 <i>0.64</i></td><td>32.81 <i>0.94</i></td><td>40.23 <i>1.09</i></td><td>49.95 <i>0.78</i></td></tr></table>
f146a805f82bfb62607656eec39178b64fdd02fc58a1720223e65665c4080f51.png
complex
<table><tr><td>Variables</td><td>Explanation</td></tr><tr><td>Measures of needs</td><td></td></tr><tr><td>Age-adjusted mortality</td><td></td></tr><tr><td>Physician density</td><td>The number of physicians who work for any medical facilities per 1,000 population</td></tr><tr><td>Hospital physician density</td><td>The number of physicians who work for hospitals per 1,000 population</td></tr><tr><td>Clinic physician density</td><td>The number of physicians who work for clinics per 1,000 population</td></tr><tr><td>Measures of residential quality</td><td></td></tr><tr><td>Urban/rural status</td><td>The metropolitan area code defined by the Ministry of Internal Affairs and Communications</td></tr><tr><td>1) urban centres, 2) suburban areas,</td><td rowspan="2"></td></tr><tr><td>3) rural areas</td></tr><tr><td><i>Per capita</i> income</td><td></td></tr><tr><td>Percent of the population</td><td>As a proxy for educational level in the community</td></tr><tr><td>with a university-level education</td><td></td></tr><tr><td>Unemployment rate</td><td>The number of unemployed individuals per the number of all individuals currently in the labour force (workforce)</td></tr><tr><td>Percent of white-collar workers</td><td>The number of professionals, technical workers, managers, and administrators per number of workforce</td></tr><tr><td>Primary school students per number</td><td>As a proxy for children&#8217;s educational opportunities</td></tr><tr><td>of primary schools</td><td></td></tr><tr><td>Crime rate</td><td>The number of crimes per total population as a proxy for neighbourhood safety</td></tr><tr><td>Temperature</td><td>As a proxy for climate discomfort. The discomfort index was calculated by using temperature and humidity and used in the model.</td></tr><tr><td>Humidity</td><td></td></tr><tr><td>Other factors</td><td></td></tr><tr><td>Total population</td><td></td></tr><tr><td>Hospital beds per 1,000 population</td><td></td></tr><tr><td>The presence or absence of</td><td>As a proxy for continuing education</td></tr><tr><td>medical schools</td><td></td></tr></table>
0ae89ca4d9568e03ef8f86a8b9639e39a708641d29dca9cad4d716880f547046.png
complex
<table><tr><td> </td><td colspan="6">Number of episodes</td><td> </td><td> </td></tr><tr><td> </td><td colspan="2">None</td><td colspan="2">Single</td><td colspan="2">Multiple</td><td> </td><td> </td></tr><tr><td>Variable</td><td>No.</td><td>%</td><td>No</td><td>%</td><td>No</td><td>%</td><td>&#967;<sup>2</sup></td><td>p</td></tr><tr><td>Age group</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td><i>&lt;1 year</i></td><td>24</td><td>57.1%</td><td>9</td><td>21.4%</td><td>9</td><td>21.4%</td><td>180.20</td><td>&lt;0.001</td></tr><tr><td><i>1 to 4 years</i></td><td>182</td><td>62.5%</td><td>86</td><td>29.6%</td><td>23</td><td>7.9%</td><td> </td><td> </td></tr><tr><td><i>5 to 14 years</i></td><td>517</td><td>82.9%</td><td>90</td><td>14.4%</td><td>17</td><td>2.7%</td><td> </td><td> </td></tr><tr><td><i>15 to 64 years</i></td><td>3,357</td><td>84.5%</td><td>518</td><td>13.0%</td><td>99</td><td>2.5%</td><td> </td><td> </td></tr><tr><td><i>65+ years</i></td><td>1,666</td><td>87.5%</td><td>198</td><td>10.4%</td><td>41</td><td>2.2%</td><td> </td><td> </td></tr><tr><td>Sex</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td><i>Male</i></td><td>2,307</td><td>86.2%</td><td>300</td><td>11.2%</td><td>69</td><td>2.6%</td><td>15.92</td><td>&lt;0.001</td></tr><tr><td><i>Female</i></td><td>3,439</td><td>82.7%</td><td>601</td><td>14.4%</td><td>120</td><td>2.9%</td><td> </td><td> </td></tr><tr><td>NS-SEC<sup>1</sup></td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td><i>Managerial and professional occupations</i></td><td>2,938</td><td>82.6%</td><td>514</td><td>14.5%</td><td>105</td><td>3.0%</td><td>30.32</td><td>0.001</td></tr><tr><td><i>Intermediate occupations</i></td><td>256</td><td>83.1%</td><td>47</td><td>15.3%</td><td>5</td><td>1.6%</td><td> </td><td> </td></tr><tr><td><i>Small employers and own account workers</i></td><td>574</td><td>82.7%</td><td>96</td><td>13.8%</td><td>24</td><td>3.5%</td><td> </td><td> </td></tr><tr><td><i>Lower supervisory and technical occupations</i></td><td>620</td><td>89.5%</td><td>63</td><td>9.1%</td><td>10</td><td>1.4%</td><td> </td><td> </td></tr><tr><td><i>Semi-routine and routine occupations</i></td><td>408</td><td>86.4%</td><td>53</td><td>11.2%</td><td>11</td><td>2.3%</td><td> </td><td> </td></tr><tr><td><i>Not classifiable</i></td><td>950</td><td>85.4%</td><td>128</td><td>11.5%</td><td>34</td><td>3.1%</td><td> </td><td> </td></tr><tr><td>Quintile of deprivation<sup>2</sup></td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td><i>1 (most deprived)</i></td><td>420</td><td>87.1%</td><td>49</td><td>10.2%</td><td>13</td><td>2.7%</td><td>12.48</td><td>0.131</td></tr><tr><td><i>2</i></td><td>644</td><td>86.2%</td><td>80</td><td>10.7%</td><td>23</td><td>3.1%</td><td> </td><td> </td></tr><tr><td><i>3</i></td><td>1,515</td><td>83.3%</td><td>247</td><td>13.6%</td><td>56</td><td>3.1%</td><td> </td><td> </td></tr><tr><td><i>4</i></td><td>1,798</td><td>83.9%</td><td>286</td><td>13.4%</td><td>58</td><td>2.7%</td><td> </td><td> </td></tr><tr><td><i>5 (least deprived)</i></td><td>1,366</td><td>83.1%</td><td>239</td><td>14.5%</td><td>39</td><td>2.4%</td><td> </td><td> </td></tr><tr><td>Urban/rural indicator<sup>2</sup></td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td><i>Urban</i></td><td>3,445</td><td>84.5%</td><td>514</td><td>12.6%</td><td>116</td><td>2.8%</td><td>15.06</td><td>0.005</td></tr><tr><td><i>Town</i></td><td>766</td><td>86.3%</td><td>96</td><td>10.8%</td><td>26</td><td>2.9%</td><td> </td><td> </td></tr><tr><td><i>Rural</i></td><td>1,532</td><td>81.9%</td><td>291</td><td>15.6%</td><td>47</td><td>2.5%</td><td> </td><td> </td></tr></table>
f8fb995174f5e4aac291efbb449ca1a373c16a1f638e1c547426eeee32525ac1.png
complex
<table><tr><td rowspan="2">Var</td><td rowspan="2">Cyt</td><td colspan="2">Frequency (%) of callus induction</td><td colspan="2">Frequency (%) of bud induction</td><td colspan="2">Average number of buds per explant</td></tr><tr><td>Photoperiod</td><td>Dark</td><td>Photoperiod</td><td>Dark</td><td>Photoperiod</td><td>Dark</td></tr><tr><td rowspan="2">SK</td><td>BAP</td><td>91.00 &#177; 3.71 a</td><td>90.00 &#177; 3.33 a</td><td>69.00 &#177; 6.74 a</td><td>56.00 &#177; 7.18 a</td><td>13.48 &#177; 0.43 abcd</td><td>07.97 &#177; 1.20 cdef</td></tr><tr><td>TDZ</td><td>0.00 &#177; 0.00 b</td><td>0.00 &#177; .00 b</td><td>12.00 &#177; 3.26 de</td><td>16.00 &#177; 5.81 cde</td><td>02.40 &#177; 0.70 e</td><td>0.90 &#177; 0.3 1 f</td></tr><tr><td rowspan="2">NM</td><td>BAP</td><td>81.00 &#177; 6.04 a</td><td>92.00 &#177; 4.42 a</td><td>53.00 &#177; 5.17 ab</td><td>66.00 &#177; 4.26 a</td><td>08.30 &#177; 0.72 ce</td><td>06.90 &#177; 0.30 def</td></tr><tr><td>TDZ</td><td>0.00 &#177; 0.00 b</td><td>0.00 &#177; 0.00 b</td><td>0.00 &#177; .00 e</td><td>06.40 &#177; 2.97 e</td><td>0.00 &#177; .00 f</td><td>0.80 &#177; 0.29 ef</td></tr><tr><td rowspan="2">EW</td><td>BAP</td><td>81.77 &#177; 6.30 a</td><td>86.00 &#177; 3.05 a</td><td>71.55 &#177; 9.59 a</td><td>54.30 &#177; 7.38 ab</td><td>11.30 &#177; 0.74 bcde</td><td>06.48 &#177; 0.86 def</td></tr><tr><td>TDZ</td><td>0.00 &#177; 0.00 b</td><td>0.00 &#177; 0.00 b</td><td>20.00 &#177; 0.00 cde</td><td>28.00 &#177; 7.42 cd</td><td>5.00 &#177; 0.00 ef</td><td>0.90 &#177; 0.23 ef</td></tr><tr><td rowspan="2">RL</td><td>BAP</td><td>100.00 &#177; 0.00</td><td>100.00 &#177; 0.00</td><td>56.00 &#177; 6.53 a</td><td>54.00 &#177; 5.81 ab</td><td>18.82 &#177; 1.52 ab</td><td>06.30 &#177; 0.65 def</td></tr><tr><td>TDZ</td><td>0.00 &#177; 0.00 b</td><td>06.00 &#177; 3.05 b</td><td>10.00 &#177; 3.33 de</td><td>34.00 &#177; 7.91 bc</td><td>0.50 &#177; 0.16 f</td><td>02.45 &#177; 0.72 ef</td></tr><tr><td rowspan="2">ER</td><td>BAP</td><td>100.00 &#177; 0.00</td><td>100.00 &#177; 0.00</td><td>62.00 &#177; 5.53 a</td><td>62.70 &#177; 5.20 a</td><td>19.67 &#177; 2.70 a</td><td>15.26 &#177; 2.22 abc</td></tr><tr><td>TDZ</td><td>0.00 &#177; 0.00 b</td><td>0.00 &#177; 0.00 b</td><td>0.00 &#177; .00 e</td><td>06.40 &#177; 2.97 e</td><td>0.00 &#177; .00 f</td><td>0.80 &#177; 0.29 ef</td></tr></table>
91bd87d1880c296425e3ddca3be14db6ff71f6a5a383529519953dc8d9e631de.png
complex
<table><tr><td></td><td></td><td colspan="4">M3</td><td colspan="4">M6</td></tr><tr><td></td><td></td><td><i>N</i></td><td>CD3+</td><td>CD4+</td><td>CD8+</td><td><i>N</i></td><td>CD3+</td><td>CD4+</td><td>CD8+</td></tr><tr><td rowspan="3">All patients</td><td>Haplo</td><td>33</td><td>264 (0&#8211;2666)</td><td>68 (0&#8211;1767)</td><td>80 (0&#8211;1666)</td><td>30</td><td>610 (140&#8211;2992)</td><td>242 (88&#8211;760)</td><td>270 (14&#8211;2596)</td></tr><tr><td>UCBT</td><td>23</td><td>540 (180&#8211;4661)</td><td>190 (72&#8211;885)</td><td>280 (18&#8211;4092)</td><td>21</td><td>852 (352&#8211;6440)</td><td>336 (105&#8211;1288)</td><td>456 (80&#8211;5152)</td></tr><tr><td><i>p</i></td><td></td><td>0.003</td><td>0.005</td><td>0.010</td><td></td><td>0.058</td><td>0.022</td><td>0.151</td></tr><tr><td rowspan="3">Malignant Haplo-HSCT</td><td>Relapse</td><td>8</td><td>279 (4&#8211;572)</td><td>29 (0&#8211;264)</td><td>84 (0&#8211;308)</td><td>7</td><td>867 (154&#8211;2460)</td><td>234 (98&#8211;369)</td><td>480 (14&#8211;2132)</td></tr><tr><td>CR</td><td>19</td><td>252 (0&#8211;2666)</td><td>138 (0&#8211;1767)</td><td>63 (0&#8211;1666)</td><td>17</td><td>560 (140&#8211;2992)</td><td>273 (88&#8211;546)</td><td>248 (14&#8211;2596)</td></tr><tr><td><i>p</i></td><td></td><td>0.894</td><td>0.300</td><td>0.831</td><td></td><td>0.193</td><td>0.975</td><td>0.075</td></tr><tr><td rowspan="3">Malignant UCBT</td><td>Relapse</td><td>3</td><td>1040 (266&#8211;4661)</td><td>234 (91&#8211;885)</td><td>819 (154&#8211;3540)</td><td>3</td><td>1250 (852&#8211;1288)</td><td>324 (250&#8211;529)</td><td>759 (516&#8211;1000)</td></tr><tr><td>CR</td><td>15</td><td>715 (180&#8211;4465)</td><td>153 (72&#8211;616)</td><td>476 (18&#8211;4092)</td><td>14</td><td>811 (352&#8211;6440)</td><td>322 (105&#8211;1288)</td><td>442 (80&#8211;5152)</td></tr><tr><td><i>p</i></td><td></td><td>0.441</td><td>0.594</td><td>0.441</td><td></td><td>0.314</td><td>0.801</td><td>0.313</td></tr></table>
604ea8ec047603d4149686908f7f4b92b5a0b257f83c01c1641d2f970f934156.png
simple
<table><tr><td></td><td>Cut off point</td><td>Sensitivity</td><td>Specificity</td><td>PPV</td><td>NPV</td></tr><tr><td>Morphology(%)</td><td>5.5</td><td>66%</td><td>94%</td><td>96%</td><td>31%</td></tr><tr><td>Motility(%)</td><td>72.5</td><td>29%</td><td>94%</td><td>94%</td><td>26%</td></tr><tr><td>Concentration(million/ml)</td><td>35.5</td><td>46%</td><td>94%</td><td>96%</td><td>32%</td></tr></table>
21f27c139f42e999b214ba7dfc6404bd26435eab1cfa454b158f0b3b1e2d1473.png
complex
<table><tr><td></td><td colspan="2">Penciclovir cream (P)</td><td colspan="2">Acyclovir cream (A)</td><td>Ratio (P/A)</td><td>Statistics</td></tr><tr><td>&#956;g/cm<sup>2</sup></td><td>Mean</td><td>s.e.m</td><td>Mean</td><td>s.e.m</td><td></td><td>P value</td></tr><tr><td>Strip 1</td><td>0.55</td><td>0.16</td><td>0.88</td><td>0.3</td><td>0.6</td><td>0.42</td></tr><tr><td>Strip 2</td><td>0.29</td><td>0.06</td><td>0.06</td><td>0.03</td><td>4.9</td><td>0.002</td></tr><tr><td>Pooled Strips</td><td>0.32</td><td>0.12</td><td>0.07</td><td>0.04</td><td>4.5</td><td>0.07</td></tr><tr><td>Epidermis</td><td>1.15</td><td>0.35</td><td>1.01</td><td>0.04</td><td>1.1</td><td>0.32</td></tr><tr><td>Dermis (residual stripped skin)</td><td>0.10</td><td>0.04</td><td>0.07</td><td>0.04</td><td>1.4</td><td>0.63</td></tr><tr><td>Permeation through the skin (receptor phase)</td><td>0.41</td><td>0.19</td><td>0.12</td><td>0.10</td><td>3.4</td><td>0.18</td></tr><tr><td></td><td colspan="2">Penciclovir cream (P)</td><td colspan="2">Acyclovir cream (A)</td><td>Ratio(P/A)</td><td>Statistics</td></tr><tr><td>% applied dose</td><td>Mean</td><td>s.e.m</td><td>Mean</td><td>s.e.m</td><td></td><td>P value</td></tr><tr><td>Strip 1</td><td>1.15</td><td>0.41</td><td>0.30</td><td>0.11</td><td>3.8</td><td>0.06</td></tr><tr><td>Strip 2</td><td>0.61</td><td>0.16</td><td>0.02</td><td>0.01</td><td>29.1</td><td>0.002</td></tr><tr><td>Pooled Strips</td><td>0.67</td><td>0.31</td><td>0.02</td><td>0.01</td><td>32.3</td><td>0.04</td></tr><tr><td>Epidermis</td><td>2.4</td><td>0.9</td><td>0.3</td><td>0.1</td><td>7.0</td><td>0.3</td></tr><tr><td>Dermis (residual stripped skin)</td><td>0.17</td><td>0.07</td><td>0.02</td><td>0.01</td><td>9.1</td><td>0.06</td></tr><tr><td>Permeation through the skin (receptor phase)</td><td>0.68</td><td>0.33</td><td>0.04</td><td>0.03</td><td>16.7</td><td>0.06</td></tr></table>
0275904182a0363d65bf0de4ec94aeb3f80c5bee76f9b4f4545ab7b08da7169a.png
complex
<table><tr><td>Hospital</td><td colspan="2">Percentage (fraction)</td><td>Adjusted Odds Ratio</td><td>99% confidence interval</td></tr><tr><td></td><td>2000</td><td>2003</td><td></td><td></td></tr><tr><td colspan="5">Getting admission without help of any external agent</td></tr><tr><td>Medical College</td><td>73% (75/103)</td><td>88% (87/99)</td><td>2.49</td><td>0.91 &#8211; 6.85</td></tr><tr><td>Sylhet DH</td><td>60% (29/48)</td><td>95% (36/38)</td><td>12.14</td><td>2.09 &#8211; 70.63</td></tr><tr><td>Sonamganj DH</td><td>84% (45/53)</td><td>94% (48/51)</td><td>2.84*</td><td>0.48 &#8211; 16.73*</td></tr><tr><td>Moulvibazaar DH</td><td>87% (45/52)</td><td>100% (56/56)</td><td>-</td><td>-</td></tr><tr><td>Hobiganj DH</td><td>40% (18/45)</td><td>92% (45/49)</td><td>33.86</td><td>6.59 &#8211; 173.98</td></tr><tr><td colspan="5">Attended by a doctor within one hour of admission</td></tr><tr><td>Medical College</td><td>55% (56/101)</td><td>72% (69/96)</td><td>2.05*</td><td>0.94 &#8211; 4.46*</td></tr><tr><td>Sylhet DH</td><td>52% (25/48)</td><td>63% (24/38)</td><td>1.58*</td><td>0.50 &#8211; 4.96*</td></tr><tr><td>Sonamganj DH</td><td>43% (23/53)</td><td>67% (34/51)</td><td>2.61*</td><td>0.92 &#8211; 7.39*</td></tr><tr><td>Moulvibazaar DH</td><td>36% (18/50)</td><td>55% (31/56)</td><td>2.20*</td><td>0.79 &#8211; 6.15*</td></tr><tr><td>Hobiganj DH</td><td>45% (23/51)</td><td>29% (14/48)</td><td>0.50*</td><td>0.17 &#8211; 1.49*</td></tr><tr><td colspan="5">No more than one attendant with the patient</td></tr><tr><td>Medical College</td><td>54% (56/104)</td><td>52% (51/99)</td><td>0.91*</td><td>0.44 &#8211; 1.88*</td></tr><tr><td>Sylhet DH</td><td>64% (30/47)</td><td>82% (31/38)</td><td>2.51*</td><td>0.67 &#8211; 9.39*</td></tr><tr><td>Sonamganj DH</td><td>43% (23/53)</td><td>47% (24/51)</td><td>1.16*</td><td>0.42 &#8211; 3.22*</td></tr><tr><td>Moulvibazaar DH</td><td>46% (24/52)</td><td>49% (27/55)</td><td>1.13*</td><td>0.41 &#8211; 3.07*</td></tr><tr><td>Hobiganj DH</td><td>48% (25/52)</td><td>60% (30/50)</td><td>1.62*</td><td>0.58 &#8211; 4.56*</td></tr><tr><td colspan="5">Satisfaction with doctor</td></tr><tr><td>Medical College</td><td>63% (64/102)</td><td>83% (82/99)</td><td>3.29</td><td>1.33 &#8211; 8.14</td></tr><tr><td>Sylhet DH</td><td>92% (43/47)</td><td>90% (34/38)</td><td>0.79*</td><td>0.12 &#8211; 5.41*</td></tr><tr><td>Sonamganj DH</td><td>56% (27/48)</td><td>77% (39/51)</td><td>2.53*</td><td>0.82 &#8211; 7.79*</td></tr><tr><td>Moulvibazaar DH</td><td>56% (29/52)</td><td>68% (38/56)</td><td>1.67*</td><td>0.60 &#8211; 4.70*</td></tr><tr><td>Hobiganj DH</td><td>65% (34/52)</td><td>76% (38/50)</td><td>1.68*</td><td>0.54 &#8211; 5.23*</td></tr><tr><td colspan="5">Satisfaction with nurse</td></tr><tr><td>Medical College</td><td>64% (66/104)</td><td>74% (73/99)</td><td>1.62*</td><td>0.74 &#8211; 3.55*</td></tr><tr><td>Sylhet DH</td><td>87% (41/47)</td><td>97% (37/38)</td><td>5.41*</td><td>0.41 &#8211; 72.19*</td></tr><tr><td>Sonamganj DH</td><td>76% (40/53)</td><td>80% (41/51)</td><td>1.33*</td><td>0.39 &#8211; 4.56*</td></tr><tr><td>Moulvibazaar DH</td><td>62% (32/52)</td><td>70% (39/56)</td><td>1.43*</td><td>0.50 &#8211; 4.10*</td></tr><tr><td>Hobiganj DH</td><td>77% (40/52)</td><td>92% (46/50)</td><td>3.45*</td><td>0.75 &#8211; 15.96*</td></tr><tr><td colspan="5">Satisfaction with cleanliness</td></tr><tr><td>Medical College</td><td>38% (39/104)</td><td>59% (58/99)</td><td>2.46</td><td>1.17 &#8211; 2.15</td></tr><tr><td>Sylhet DH</td><td>92% (43/47)</td><td>100% (38/38)</td><td>-</td><td>-</td></tr><tr><td>Sonamganj DH</td><td>43% (23/53)</td><td>61% (31/51)</td><td>2.02*</td><td>0.72 &#8211; 5.65*</td></tr><tr><td>Moulvibazaar DH</td><td>25% (13/52)</td><td>45% (25/56)</td><td>2.42*</td><td>0.83 &#8211; 7.06*</td></tr><tr><td>Hobiganj DH</td><td>77% (39/51)</td><td>56% (28/50)</td><td>0.39*</td><td>0.13 &#8211; 1.19*</td></tr><tr><td colspan="5">Satisfaction with privacy</td></tr><tr><td>Medical College</td><td>39% (40/103)</td><td>47% (46/98)</td><td>1.39*</td><td>0.67 &#8211; 2.91*</td></tr><tr><td>Sylhet DH</td><td>69% (31/45)</td><td>58% (22/38)</td><td>0.62*</td><td>0.19 &#8211; 2.04*</td></tr><tr><td>Sonamganj DH</td><td>36% (19/53)</td><td>39% (20/51)</td><td>1.15*</td><td>0.40 &#8211; 3.30*</td></tr><tr><td>Moulvibazaar DH</td><td>44% (23/52)</td><td>23% (13/56)</td><td>0.38*</td><td>0.13 &#8211; 1.12*</td></tr><tr><td>Hobiganj DH</td><td>42% (22/52)</td><td>58% (29/50)</td><td>1.88*</td><td>0.67 &#8211; 5.30*</td></tr><tr><td colspan="5">Satisfaction with overall service</td></tr><tr><td>Medical College</td><td>40% (41/103)</td><td>63% (62/98)</td><td>2.54</td><td>1.20 &#8211; 5.36</td></tr><tr><td>Sylhet DH</td><td>81% (35/43)</td><td>89% (34/38)</td><td>1.94*</td><td>0.36 &#8211; 10.48*</td></tr><tr><td>Sonamganj DH</td><td>42% (22/52)</td><td>51% (26/51)</td><td>1.42*</td><td>0.51 &#8211; 3.95*</td></tr><tr><td>Moulvibazaar DH</td><td>26% (12/47)</td><td>36% (20/56)</td><td>1.62*</td><td>0.53 &#8211; 4.98*</td></tr><tr><td>Hobiganj DH</td><td>49% (25/51)</td><td>62% (31/50)</td><td>1.70*</td><td>0.60 &#8211; 4.82*</td></tr></table>
133b820e18f5f60ccfa70f887cd800321cf2eadee3f6786f1c0f1270daaf361a.png
complex
<table><tr><td></td><td></td><td><underline>Percentage (%)</underline> (n = 100)</td><td><underline>95% CI</underline></td></tr><tr><td colspan="2">Most frequent diagnostic categories *</td><td></td><td></td></tr><tr><td></td><td>Neoplasm and chemotherapy</td><td>15</td><td>9 &#8211; 24</td></tr><tr><td></td><td>Respiratory infections</td><td>9</td><td>4 &#8211; 16</td></tr><tr><td></td><td>Asthma</td><td>5</td><td>2 &#8211; 11</td></tr><tr><td></td><td>Gastroenteritis</td><td>5</td><td>2 &#8211; 11</td></tr><tr><td></td><td>Appendicitis</td><td>4</td><td>1 &#8211; 10</td></tr><tr><td></td><td>Epilepsy or seizure</td><td>3</td><td>0.6 &#8211; 9</td></tr><tr><td></td><td>Malfunctioning device or graft</td><td>3</td><td>0.6 &#8211; 9</td></tr><tr><td colspan="2">Length of stay</td><td></td><td></td></tr><tr><td></td><td>1 day</td><td>10</td><td>5 &#8211; 18</td></tr><tr><td></td><td>2 days</td><td>25</td><td>17 &#8211; 35</td></tr><tr><td></td><td>3 days</td><td>24</td><td>16 &#8211; 34</td></tr><tr><td></td><td>4&#8211;7 days</td><td>27</td><td>17 &#8211; 37</td></tr><tr><td></td><td>8 to 103 days</td><td>14</td><td>8 &#8211; 22</td></tr><tr><td>Devices *</td><td></td><td></td><td></td></tr><tr><td></td><td>Gastrostomy or jejuenostomy tubes</td><td>10</td><td>5 &#8211; 18</td></tr><tr><td></td><td>Central venous line</td><td>7</td><td>3 &#8211; 14</td></tr><tr><td></td><td>Medication nebulizer</td><td>7</td><td>3 &#8211; 14</td></tr><tr><td></td><td>Ventriculoperitoneal shunt</td><td>2</td><td>0.2 &#8211; 7</td></tr><tr><td></td><td>Tracheotomy</td><td>1</td><td>0.03 &#8211; 5</td></tr><tr><td colspan="2">Number of medications &#167;</td><td></td><td></td></tr><tr><td></td><td>0</td><td>18</td><td>11 &#8211; 27</td></tr><tr><td></td><td>1</td><td>20</td><td>13 &#8211; 29</td></tr><tr><td></td><td>2</td><td>26</td><td>18 &#8211; 36</td></tr><tr><td></td><td>3</td><td>16</td><td>10 &#8211; 26</td></tr><tr><td></td><td>4</td><td>7</td><td>3 &#8211; 14</td></tr><tr><td></td><td>5 or more</td><td>12</td><td>6 &#8211; 20</td></tr><tr><td colspan="2">Number of daily medication administrations noted &#8225;</td><td></td><td></td></tr><tr><td></td><td>0 or PRN</td><td>33</td><td>24 &#8211; 44</td></tr><tr><td></td><td>1&#8211;4</td><td>30</td><td>21 &#8211; 40</td></tr><tr><td></td><td>5&#8211;9</td><td>24</td><td>16 &#8211; 34</td></tr><tr><td></td><td>10&#8211;22</td><td>12</td><td>6 &#8211; 20</td></tr><tr><td colspan="2">Home nursing care</td><td>8</td><td>4 &#8211; 15</td></tr><tr><td colspan="2">Other forms of home care</td><td>7</td><td>3 &#8211; 14</td></tr><tr><td colspan="2">Disposition</td><td></td><td></td></tr><tr><td></td><td>Home</td><td>91</td><td>84 &#8211; 96</td></tr><tr><td></td><td>Transfer</td><td>3</td><td>0.6 &#8211; 9</td></tr><tr><td></td><td>Death</td><td>1</td><td>0.03 &#8211; 6</td></tr><tr><td></td><td>Unknown</td><td>5</td><td>2 &#8211; 11</td></tr></table>
d5fcacfc977a4414cdf2b1b33d3bf47fc8461713da4f4fe6a1c962bf1ee149fb.png
complex
<table><tr><td rowspan="2">Income group</td><td colspan="3">Mean reduction in daily calorie intake (kcal/person/day)</td></tr><tr><td>Female</td><td>Male</td><td>Overall</td></tr><tr><td>Income group 1 (lowest)</td><td>2.2</td><td>1.6</td><td>1.9</td></tr><tr><td>Income group 2</td><td>1.9</td><td>1.9</td><td>1.9</td></tr><tr><td>Income group 3 (highest)</td><td>1.9</td><td>2.6</td><td>2.3</td></tr></table>
87b22831b7318c6e1ae211a07bb086754f7774d6040acfca31a47f7c24e50a5e.png
complex
<table><tr><td rowspan="3">Morning surge</td><td>Pulse wave velocity</td><td>Urinary albumin excretion</td><td>White matter lesions</td></tr><tr><td>m/s / mmHg</td><td>Ln (mg/mmol) / mmHg</td><td>OR/mmHg</td></tr><tr><td>Mean &#177; SE</td><td>Mean &#177; SE</td><td>Mean &#177; SE</td></tr><tr><td>All</td><td></td><td></td><td></td></tr><tr><td> MS1</td><td></td><td></td><td></td></tr><tr><td>Unadjusted</td><td>0.016 &#177; 0.010; <i>p</i> = 0.10</td><td>0.018 &#177; 0.007; <i>p</i> = 0.011</td><td>0.007 &#177; 0.014; <i>p</i> = 0.62</td></tr><tr><td>Adjusted</td><td>&#8722;0.002 &#177; 0.010; <i>p</i> = 0.81</td><td>0.014 &#177; 0.007; <i>p</i> = 0.053</td><td>&#8722;0.002 &#177; 0.015; <i>p</i> = 0.90</td></tr><tr><td> MS2</td><td></td><td></td><td></td></tr><tr><td>Unadjusted</td><td>0.006 &#177; 0.016; <i>p</i> = 0.70</td><td>0.006 &#177; 0.009; <i>p</i> = 0.51</td><td>0.005 &#177; 0.013; <i>p</i> = 0.69</td></tr><tr><td>Adjusted</td><td>&#8722;0.006 &#177; 0.011: <i>p</i> = 0.63</td><td>0.005 &#177; 0.008; <i>p</i> = 0.56</td><td>&#8722;0.001 &#177; 0.016; <i>p</i> = 0.93</td></tr><tr><td>Patients</td><td></td><td></td><td></td></tr><tr><td> MS1</td><td></td><td></td><td></td></tr><tr><td>Unadjusted</td><td>&#8722;0.017 &#177; 0.025; <i>p</i> = 0.51</td><td>0.019 &#177; 0.012; <i>p</i> = 0.11</td><td>&#8722;0.013 &#177; 0.022; <i>p</i> = 0.56</td></tr><tr><td>Adjusted</td><td>&#8722;0.027 &#177; 0.020; <i>p</i> = 0.18</td><td>0.021 &#177; 0.012; <i>p</i> = 0.08</td><td>&#8722;0.033 &#177; 0.024; <i>p</i> = 0.18</td></tr><tr><td> MS2</td><td></td><td></td><td></td></tr><tr><td>Unadjusted</td><td>&#8722;0.011 &#177; 0.027; <i>p</i> = 0.68</td><td>&#8722;0.002 &#177; 0.013; <i>p</i> = 0.86</td><td>0.003 &#177; 0.023; <i>p</i> = 0.91</td></tr><tr><td>Adjusted</td><td>&#8722;0.020 &#177; 0.022; <i>p</i> = 0.38</td><td>0.002 &#177; 0.014; <i>p</i> = 0.89</td><td>&#8722;0.013 &#177; 0.027; <i>p</i> = 0.64</td></tr><tr><td>Controls</td><td></td><td></td><td></td></tr><tr><td> MS1</td><td></td><td></td><td></td></tr><tr><td>Unadjusted</td><td>0.028 &#177; 0.016; <i>p</i> = 0.08</td><td>0.012 &#177; 0.007; <i>p</i> = 0.08</td><td>0.022 &#177; 0.019; <i>p</i> = 0.26</td></tr><tr><td>Adjusted</td><td>0.018 &#177; 0.014; <i>p</i> = 0.20</td><td>0.009 &#177; 0.007; <i>p</i> = 0.17</td><td>0.018 &#177; 0.020; <i>p</i> = 0.36</td></tr><tr><td> MS2</td><td></td><td></td><td></td></tr><tr><td>Unadjusted</td><td>0.007 &#177; 0.019; <i>p</i> = 0.71</td><td>0.007 &#177; 0.008; <i>p</i> = 0.41</td><td>0.008 &#177; 0.021; <i>p</i> = 0.72</td></tr><tr><td>Adjusted</td><td>0.006 &#177; 0.016; <i>p</i> = 0.72</td><td>0.008 &#177; 0.008; <i>p</i> = 0.32</td><td>0.004 &#177; 0.022; <i>p</i> = 0.86</td></tr></table>
6bcb6a93aaee405cdcf3748ff9ba48afffea67ffca430b1e040c3a52afb673f6.png
complex
<table><tr><td>Variable</td><td>Category</td><td>Total (<i>N</i> = 265)</td><td>BCP (<i>N</i> = 49)</td><td>MCP(<i>N</i> = 216)</td><td><i>p</i> value<sup>a</sup></td></tr><tr><td colspan="6">Demographics</td></tr><tr><td colspan="6"> Age</td></tr><tr><td></td><td> &lt;50</td><td>145 (54.7)</td><td>34 (69.4)</td><td>111 (51.4)</td><td>0.0057</td></tr><tr><td></td><td> &#8805;50</td><td>120 (45.3)</td><td>15 (30.6)</td><td>105 (48.6)</td><td></td></tr><tr><td colspan="6"> Ethnicity</td></tr><tr><td></td><td>Chinese</td><td>188 (70.9)</td><td>23 (46.9)</td><td>165 (76.4)</td><td>0.0003</td></tr><tr><td></td><td>Malay</td><td>24 (9.1)</td><td>6 (12.2)</td><td>18 (8.3)</td><td></td></tr><tr><td></td><td>Indian</td><td>13 (4.9)</td><td>3 (6.1)</td><td>10 (4.6)</td><td></td></tr><tr><td></td><td>Others</td><td>40 (15.1)</td><td>17 (34.7)</td><td>23 (10.6)</td><td></td></tr><tr><td colspan="6"> Parous</td></tr><tr><td></td><td>Yes</td><td>189 (71.3)</td><td>37 (75.5)</td><td>152 (70.4)</td><td>0.4726</td></tr><tr><td></td><td>No</td><td>76 (28.7)</td><td>12 (24.5)</td><td>64 (29.6)</td><td></td></tr><tr><td colspan="6">Personal history of cancer</td></tr><tr><td colspan="6"> Breast cancer</td></tr><tr><td></td><td>Yes</td><td>193 (72.8)</td><td>47 (95.9)</td><td>146 (67.6)</td><td>0.0009</td></tr><tr><td></td><td>No</td><td>72 (27.2)</td><td>2 (4.1)</td><td>70 (32.4)</td><td></td></tr><tr><td colspan="6"> Ovarian cancer</td></tr><tr><td></td><td>Yes</td><td>92 (34.7)</td><td>4 (8.2)</td><td>88 (40.7)</td><td>0.0002</td></tr><tr><td></td><td>No</td><td>173 (65.3)</td><td>45 (91.8)</td><td>128 (59.3)</td><td></td></tr><tr><td colspan="6">Family history of cancer in relatives<sup>b</sup></td></tr><tr><td colspan="6"> Any cancer type</td></tr><tr><td></td><td>Present</td><td>203 (76.6)</td><td>36 (73.5)</td><td>167 (77.3)</td><td>0.8350</td></tr><tr><td></td><td>Absent</td><td>62 (23.4)</td><td>13 (26.5)</td><td>49 (22.7)</td><td></td></tr><tr><td colspan="6"> Breast cancer only</td></tr><tr><td></td><td>Present</td><td>33 (12.5)</td><td>6 (12.2)</td><td>27 (12.5)</td><td>0.9508</td></tr><tr><td></td><td>Absent</td><td>232 (87.5)</td><td>43 (87.8)</td><td>189 (87.5)</td><td></td></tr><tr><td colspan="6"> Ovarian cancer only</td></tr><tr><td></td><td>Present</td><td>7 (2.6)</td><td>1 (2.0)</td><td>6 (2.8)</td><td>0.9985</td></tr><tr><td></td><td>Absent</td><td>258 (97.4)</td><td>48 (98.0)</td><td>210 (97.2)</td><td></td></tr><tr><td colspan="6">Breast and/or ovarian cancer only</td></tr><tr><td></td><td>Present</td><td>46 (17.4)</td><td>8 (16.3)</td><td>38 (17.6)</td><td>0.9013</td></tr><tr><td></td><td>Absent</td><td>219 (82.6)</td><td>41 (83.7)</td><td>178 (82.4)</td><td></td></tr><tr><td colspan="6"> Colorectal and/or endometrial cancer</td></tr><tr><td></td><td>Present</td><td>54 (20.4)</td><td>8 (16.3)</td><td>46 (21.3)</td><td>0.8903</td></tr><tr><td></td><td>Absent</td><td>211 (79.6)</td><td>41 (83.7)</td><td>170 (78.7)</td><td></td></tr></table>
9202d9dabffd896db4898a818d5a3f95ad30ce6d4fd4bd081a77c9b2c3cd1df3.png
complex
<table><tr><td rowspan="2">Trial</td><td rowspan="2">Number</td><td rowspan="2">Setting</td><td rowspan="2">Trial duration</td><td rowspan="2">ICU</td><td colspan="2">Population</td><td rowspan="2">Intervention</td><td rowspan="2">Comparator</td><td rowspan="2">Outcomes</td></tr><tr><td>Inclusion criteria</td><td>Exclusion criteria</td></tr><tr><td rowspan="2">Youness et al. [20]</td><td rowspan="2">33</td><td rowspan="2">Single-centre US</td><td rowspan="2">24 months</td><td rowspan="2">Mixed</td><td rowspan="2">Intubated mechanically ventilated patients with new-onset (&lt;48 h) atelectasis</td><td rowspan="2">CF, uncontrolled asthma, COPD, pneumothorax, pleura effusion, tumor-associated atelectasis, severe hypoxemia, hemodynamic instability, allergy to dornase alfa, use of nebulized acetylcysteine and pregnancy</td><td rowspan="2">Nebulized dornase alfa 2.5 mg twice daily in 7 days or until resolution of atelectasis</td><td>(1) Placebo (isotonic saline) same volume, dosage, and duration of treatment</td><td rowspan="2">Mortality</td></tr><tr><td>(2) Hypertonic saline (same volume, dosage, and duration of treatment)</td></tr><tr><td>Zitter et al. [19]</td><td>30</td><td>Single-centre US</td><td>12 months</td><td>Mixed</td><td>Mechanically ventilated patients aged &gt;18 years with new-onset (&lt;24 h) atelectasis</td><td>Quadriplegia, chronic ventilator dependence, pneumothorax, frank hemoptysis, elevated intracranial pressure, pregnancy or active nursing, concurrent use of other investigational drugs, and allergy to dornase alfa, Chinese hamster ovary-derived biologics or other components of the active component</td><td>Nebulized dornase alfa 2.5 mg twice daily until extubation, death or transfer (maximum 30 days)</td><td>Placebo (isotonic saline) same volume, dosage, and duration of treatment</td><td>Mortality</td></tr></table>
8d4a9ee87f7384c676dfa06dbeaf843d978f9e12e49521d8b765b352b5c7e434.png
simple
<table><tr><td><i>Cell Type</i></td><td><i>Number of Genes</i></td><td><i>% of Genes</i></td></tr><tr><td>adipocyte</td><td>188</td><td>21.23</td></tr><tr><td>alveolar macrophage</td><td>127</td><td>14.11</td></tr><tr><td>B-lymphoblast</td><td>106</td><td>12.58</td></tr><tr><td>B-lymphocyte</td><td>628</td><td>70.79</td></tr><tr><td>brown adipose</td><td>1</td><td>0.11</td></tr><tr><td>cardiac muscle cell</td><td>33</td><td>3.72</td></tr><tr><td>chondrocyte</td><td>33</td><td>3.72</td></tr><tr><td>dendritic cell</td><td>56</td><td>6.35</td></tr><tr><td>endothelium</td><td>194</td><td>21.88</td></tr><tr><td>eosinophil</td><td>1</td><td>0.11</td></tr><tr><td>epithelium</td><td>604</td><td>68.49</td></tr><tr><td>fibroblast</td><td>485</td><td>54.92</td></tr><tr><td>foam cell</td><td>25</td><td>2.74</td></tr><tr><td>germ cell</td><td>435</td><td>49.02</td></tr><tr><td>glial cell</td><td>432</td><td>48.69</td></tr><tr><td>glioblast</td><td>42</td><td>4.7</td></tr><tr><td>granulosa cell</td><td>63</td><td>7.22</td></tr><tr><td>hepatocyte</td><td>3</td><td>0.33</td></tr><tr><td>keratinocyte</td><td>287</td><td>32.17</td></tr><tr><td>leukocyte</td><td>295</td><td>33.26</td></tr><tr><td>lymphocyte</td><td>86</td><td>9.63</td></tr><tr><td>macrophage</td><td>194</td><td>21.88</td></tr><tr><td>mast cell</td><td>2</td><td>0.22</td></tr><tr><td>melanocyte</td><td>283</td><td>31.84</td></tr><tr><td>monocyte</td><td>13</td><td>1.42</td></tr><tr><td>muscle cell</td><td>233</td><td>26.37</td></tr><tr><td>myeloid cell</td><td>149</td><td>17.4</td></tr><tr><td>natural killer cell</td><td>339</td><td>38.84</td></tr><tr><td>neuroblast</td><td>396</td><td>44.86</td></tr><tr><td>neuroepithelium</td><td>143</td><td>16.19</td></tr><tr><td>neuron</td><td>124</td><td>14</td></tr><tr><td>pericyte</td><td>128</td><td>14.66</td></tr><tr><td>platelet</td><td>1</td><td>0.11</td></tr><tr><td>proerythroblast</td><td>65</td><td>7.77</td></tr><tr><td>promyeloblast</td><td>14</td><td>1.86</td></tr><tr><td>promyelocyte</td><td>44</td><td>5.03</td></tr><tr><td>retinal pigment epithelium</td><td>514</td><td>57.55</td></tr><tr><td>skeletal muscle cell</td><td>499</td><td>56.56</td></tr><tr><td>smooth muscle cell</td><td>128</td><td>14.77</td></tr><tr><td>squamous cell</td><td>376</td><td>42.67</td></tr><tr><td>stem cell</td><td>626</td><td>70.79</td></tr><tr><td>T-lymphocyte</td><td>359</td><td>40.92</td></tr><tr><td>transitional</td><td>194</td><td>22.21</td></tr><tr><td>white adipose</td><td>41</td><td>4.81</td></tr></table>
e5062ae828796bb53ed03f01d0c5b5e0bad428c3b76627825ebc06d4860d6907.png
simple
<table><tr><td>Demographic data</td><td>Control group <i>N</i> = 30</td><td>Endometriosis group <i>N</i> = 30</td><td>Ectopic group <i>N</i> = 22</td><td><i>P</i> value (control v endometriosis)</td></tr><tr><td>Age, median (range)</td><td>40 (25&#8211;47)</td><td>36 (18&#8211;45)</td><td>40 (24&#8211;51)</td><td><i>P</i> = 0.056</td></tr><tr><td>BMI, median (range)</td><td>27 (20&#8211;42)</td><td>26 (20&#8211;38)</td><td>27.1 (18&#8211;32)</td><td><i>P</i> = 0.37</td></tr><tr><td>Parity, median (range)</td><td>2 (1&#8211;4)</td><td>1 (0&#8211;3)</td><td>1 (0&#8211;2)</td><td>P &lt; 0.0001</td></tr><tr><td>Smoker</td><td>9/30 (30%)</td><td>5/30 (17%)</td><td>1/22 (5%)</td><td><i>P</i> = 0.36</td></tr><tr><td>Endometriosis stage, median (range)</td><td>&#8211;</td><td>2 (1&#8211;4)</td><td>4 (1&#8211;4)</td><td>N/A</td></tr></table>
9afe2327812c1b5ba945545ed8523f7d969c47540a4c4d16d862ef3e97bf3f10.png
complex
<table><tr><td>Pt#</td><td colspan="2">R Lung</td><td colspan="2">L Lung</td><td colspan="2">Spinal Cord</td><td colspan="2">Heart</td><td colspan="2">Spine Bone</td></tr><tr><td></td><td>synCT</td><td>CT</td><td>synCT</td><td>CT</td><td>synCT</td><td>CT</td><td>synCT</td><td>CT</td><td>synCT</td><td>CT</td></tr><tr><td>Pt1</td><td>&#8722;747</td><td>&#8722;637</td><td>&#8722;740</td><td>&#8722;616</td><td>72</td><td>33</td><td>68</td><td>120</td><td>268</td><td>244</td></tr><tr><td>Pt2</td><td>&#8722;752</td><td>&#8722;701</td><td>&#8722;737</td><td>&#8722;693</td><td>72</td><td>69</td><td>70</td><td>38</td><td>252</td><td>349</td></tr><tr><td>Pt3</td><td>&#8722;747</td><td>&#8722;774</td><td>&#8722;738</td><td>&#8722;766</td><td>72</td><td>55</td><td>68</td><td>130</td><td>260</td><td>422</td></tr><tr><td>Pt4</td><td>&#8722;730</td><td>&#8722;745</td><td>&#8722;701</td><td>&#8722;702</td><td>62</td><td>64</td><td>70</td><td>45</td><td>260</td><td>299</td></tr><tr><td>Pt5</td><td>&#8722;692</td><td>&#8722;714</td><td>&#8722;698</td><td>&#8722;721</td><td>67</td><td>49</td><td>70</td><td>49</td><td>260</td><td>365</td></tr><tr><td>Pt6</td><td>&#8722;714</td><td>&#8722;739</td><td>&#8722;690</td><td>&#8722;726</td><td>74</td><td>78</td><td>69</td><td>44</td><td>266</td><td>505</td></tr><tr><td>Pt7</td><td>&#8722;730</td><td>&#8722;650</td><td>&#8722;685</td><td>&#8722;674</td><td>109</td><td>52</td><td>66</td><td>41</td><td>269</td><td>300</td></tr><tr><td>Pt8</td><td>&#8722;740</td><td>&#8722;741</td><td>&#8722;727</td><td>&#8722;706</td><td>72</td><td>70</td><td>70</td><td>42</td><td>260</td><td>405</td></tr><tr><td>Pt9</td><td>&#8722;734</td><td>&#8722;812</td><td>&#8722;734</td><td>&#8722;793</td><td>65</td><td>42</td><td>68</td><td>31</td><td>256</td><td>249</td></tr><tr><td>Pt10</td><td>&#8722;759</td><td>&#8722;775</td><td>&#8722;758</td><td>&#8722;775</td><td>74</td><td>46</td><td>65</td><td>40</td><td>266</td><td>292</td></tr><tr><td>Pt11</td><td>&#8722;760</td><td>&#8722;838</td><td>&#8722;760</td><td>&#8722;822</td><td>86</td><td>57</td><td>63</td><td>146</td><td>268</td><td>268</td></tr><tr><td>Mean &#177; SE</td><td>&#8722;737 &#177; 6</td><td>&#8722;739 &#177; 19</td><td>&#8722;724 &#177; 8</td><td>&#8722;727 &#177; 18</td><td>75 &#177; 4</td><td>56 &#177; 4</td><td>68 &#177; 1</td><td>66 &#177; 13</td><td>262 &#177; 2</td><td>336 &#177; 25</td></tr><tr><td><i>P</i>-value</td><td colspan="2">0.90</td><td colspan="2">0.88</td><td colspan="2">0.007</td><td colspan="2">0.90</td><td colspan="2">0.014</td></tr></table>
aa98784af42d67ad678297ceee18fba21c7dec93eef973b91d7feacc6050ee92.png
complex
<table><tr><td>Challenge</td><td>CE</td><td>Matched compound</td><td>MF</td><td>RMF</td><td>Prob</td></tr><tr><td rowspan="3">1</td><td>10 eV</td><td>Kanamycin A</td><td>645</td><td>879</td><td>98.88</td></tr><tr><td>20 eV</td><td>Kanamycin A</td><td>501</td><td>833</td><td>98.81</td></tr><tr><td>30 eV</td><td>Kanamycin A</td><td>531</td><td>776</td><td>98.66</td></tr></table>
7f21a1e6b93d29c893041f2d7361a6161cd45029d5aed63fdad48765218198d6.png
simple
<table><tr><td>Motif</td><td>Count</td><td>Average length (bp)</td><td>Count/Mbp</td></tr><tr><td>Mononucleotide</td><td>19</td><td>15.89</td><td>9.35</td></tr><tr><td>Dinucleotide</td><td>30</td><td>29.60</td><td>14.76</td></tr><tr><td>Trinucleotide</td><td>92</td><td>19.99</td><td>45.26</td></tr><tr><td>Tetranucleotide</td><td>39</td><td>15.87</td><td>19.19</td></tr><tr><td>Pentanucleotide</td><td>27</td><td>16.96</td><td>13.28</td></tr><tr><td>Hexanucleotide</td><td>9</td><td>20.22</td><td>4.43</td></tr><tr><td>Total</td><td>216</td><td>19.85</td><td>106.27</td></tr></table>
46a045056a78d61b3475525c181a742aaf2cff68be6bbe932dab97cd3b9f26fd.png
complex
<table><tr><td colspan="2">Characteristic</td><td></td></tr><tr><td colspan="2"></td><td> n = 1,729</td></tr><tr><td>Age (y)</td><td>Median (IQR)</td><td>69 (62-74)</td></tr><tr><td></td><td>Range</td><td>22-93</td></tr><tr><td colspan="2">Male sex, n (%)</td><td>1,156 (66.9)</td></tr><tr><td colspan="2">Absence of previous iodinated contrast media injections, n (%)</td><td>973 (56.3)</td></tr><tr><td colspan="2">History of adverse reaction to iodinated contrast media, n (%)</td><td>45 (2.6)</td></tr><tr><td colspan="2">History of allergy, n (%)</td><td>164 (9.5)</td></tr><tr><td colspan="2">History of asthma, n (%)</td><td>23 (1.3)</td></tr><tr><td colspan="2">Use of corticosteroid at entry, n (%)</td><td>28 (1.6)</td></tr><tr><td colspan="2">Child&#8211;Pugh classification, n (%)</td><td></td></tr><tr><td colspan="2"> A</td><td>1427 (82.5)</td></tr><tr><td colspan="2"> B or C</td><td>302 (17.5)</td></tr><tr><td colspan="2">Renal function at entry</td><td></td></tr><tr><td colspan="2">eGFR (ml/min), Median (IQR)</td><td> 73.6 (61.7-87.3)</td></tr><tr><td colspan="2">Presence of renal impairment, n (%)</td><td>383 (22.2)</td></tr></table>
6bbb9bcb3c801b7e4fc1bc3ef99ec046c3fb3e46cc5c4215ba5d82dcb42413e2.png
complex
<table><tr><td rowspan="2">Compounds</td><td>Content (Mean &#177; SD, n = 3)</td></tr><tr><td>mg/g</td></tr><tr><td>Paeoniflorin</td><td>59.55 &#177; 0.39</td></tr><tr><td>Glycyrrhizin</td><td>12.13 &#177; 0.01</td></tr></table>
4fc0780ae9fadb8e2915b611fb32cedb0abcf14ec11f33229ac3350f1de2bf7f.png
complex
<table><tr><td colspan="4">Guarantee the follow-up and referral to medical services of individuals with a positive diagnosis</td></tr><tr><td>PROCESS MEASURE</td><td>Indicator description</td><td>Method of Data collection</td><td>Data Collection Frequency</td></tr><tr><td>Monitoring of the number of individuals infected with HIV that have received medical care</td><td>Number of individuals infected with HIV that have received medical care/Number of individuals infected with HIV attended and that have received health care by the NGO in the evaluation year</td><td>NGO</td><td>12 months</td></tr><tr><td>Monitoring of the number of individuals infected with HIV that are referred to other health services</td><td>Number of individuals infected with HIV that are referred to other health services/Number of individuals infected with HIV attended and that have received health care by the NGO in the evaluation year</td><td>NGO</td><td>12 months</td></tr><tr><td>Monitoring of the number of individuals referred to each service</td><td>Numbers of individuals referred to each service</td><td>NGO</td><td>12 months</td></tr><tr><td>Monitoring of the number of people working in a service</td><td>Number of people working in a service</td><td>NGO</td><td>12 months</td></tr><tr><td>Monitoring of the hours dedicated to each activity</td><td>Hours dedicated to each activity</td><td>NGO</td><td>12 months</td></tr><tr><td>OUTCOME MEASURE</td><td>Indicator description</td><td>Method of Data collection</td><td>Data Collection Frequency</td></tr><tr><td>Level of satisfaction with the service</td><td>Number of individuals infected with HIV that have received care, have responded to the satisfaction questionnaire, and have a high level of satisfaction/Number of infected individuals that have received care and have responded to the questionnaire</td><td>NGOAnswers to the satisfaction questionnaire</td><td>12 months</td></tr><tr><td>Monitoring of the questionnaire of quality of life answers of individuals attended by the NGO</td><td>Descriptive analysis and monitoring of the global score and score by dimensions of the questionnaire of quality of life answers of individuals infected with HIV and attended by the NGO</td><td>NGOAnswers to the QQV</td><td>12 months</td></tr></table>
c26250c13b1f08071bcf121169c404d46241bda2e483a1c389b0a913f56fd6b8.png
simple
<table><tr><td></td><td>Heparin</td><td>Citrate</td></tr><tr><td>Renal days</td><td>357</td><td>199</td></tr><tr><td>Median renal days per patient episode</td><td>3</td><td>3</td></tr><tr><td>Number of filters used</td><td>408</td><td>128</td></tr><tr><td>Total filter cost (&#8226;)</td><td>32807.28</td><td>10292.48</td></tr><tr><td>Renal days per filter</td><td>0.86</td><td>1.55</td></tr><tr><td>Filter cost per renal day (&#8226;)</td><td>91.89</td><td>51.72</td></tr><tr><td>Blood transfusions per day</td><td>0.33</td><td>0.25</td></tr></table>
b68f1eb586e6b0346992a29f488343b03c1fd2d4df472f74a9e248d90fd2b223.png
simple
<table><tr><td> </td><td> </td><td><i>Control</i></td><td><i>Dextrose 24 scFOS 11</i></td><td><i>Maltitol 35</i></td><td><i>Maltitol 30 scFOS 5</i></td><td><i>Maltitol 24 scFOS 11</i></td><td><i>Maltitol 17.5 scFOS 17.5</i></td><td><i>Dessert effect (</i>P<i>-value)</i></td></tr><tr><td>0&#8211;24 h</td><td>Total score</td><td>3.15&#177;4.26a</td><td>6.46&#177;5.85b</td><td>8.86&#177;6.49b,c</td><td>8.53&#177;7.10b,c</td><td>9.41&#177;6.99b,c</td><td>10.80&#177;7.98b,c</td><td>&lt;0.0001</td></tr><tr><td> </td><td>Flatulence</td><td>1.21&#177;1.49</td><td>2.11&#177;2.26</td><td>3.37&#177;2.56*</td><td>2.74&#177;2.50*</td><td>3.68&#177;2.46*</td><td>4.11&#177;2.34*</td><td>&lt;0.0001</td></tr><tr><td> </td><td>Borborygmi</td><td>0.70&#177;1.31</td><td>1.49&#177;2.01</td><td>2.11&#177;2.40*</td><td>2.41&#177;2.43*</td><td>1.85&#177;2.30*</td><td>2.43&#177;2.40*</td><td>&lt;0.0001</td></tr><tr><td> </td><td>Bloating</td><td>0.70&#177;1.69</td><td>1.40&#177;2.20</td><td>1.60&#177;2.24</td><td>1.74&#177;2.15</td><td>1.82&#177;2.41</td><td>2.17&#177;2.72*</td><td>0.0312</td></tr><tr><td> </td><td>Discomfort</td><td>0.55&#177;1.68</td><td>1.46&#177;2.41</td><td>1.77&#177;2.44*</td><td>1.65&#177;2.98</td><td>2.06&#177;2.95*</td><td>2.09&#177;2.70*</td><td>0.0135</td></tr><tr><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>24&#8211;48 h</td><td>Total score</td><td>0.88&#177;1.71a</td><td>2.34&#177;3.55a,b</td><td>3.60&#177;5.39b</td><td>2.62&#177;3.57b</td><td>2.24&#177;3.37a,b</td><td>2.71&#177;4.26b</td><td>0.0063</td></tr><tr><td> </td><td>Flatulence</td><td>0.27&#177;0.80</td><td>0.83&#177;1.50</td><td>1.37&#177;1.99*</td><td>1.12&#177;1.61*</td><td>1.06&#177;1.54*</td><td>1.20&#177;1.78*</td><td>0.0037</td></tr><tr><td> </td><td>Borborygmi</td><td>0.30&#177;0.81</td><td>0.31&#177;0.93</td><td>0.74&#177;1.60</td><td>0.79&#177;1.49</td><td>0.44&#177;1.13</td><td>0.57&#177;1.29</td><td>0.0823</td></tr><tr><td> </td><td>Bloating</td><td>0.12&#177;0.55</td><td>0.49&#177;1.17</td><td>0.69&#177;1.64</td><td>0.35&#177;0.92</td><td>0.47&#177;1.02</td><td>0.57&#177;1.36</td><td>0.2084</td></tr><tr><td> </td><td>Discomfort</td><td>0.18&#177;0.58</td><td>0.71&#177;1.54</td><td>0.80&#177;1.64*</td><td>0.35&#177;1.01</td><td>0.26&#177;0.79</td><td>0.37&#177;1.19</td><td>0.0448</td></tr></table>
44a3596b65243a8c948040ddc1f4d9467f2050796d480a713323dfbbed2a8e63.png
complex
<table><tr><td rowspan="2">Run</td><td colspan="4">Controllable parameter</td></tr><tr><td>Table separation distance</td><td>Squeegee speed</td><td>Squeegee pressure</td><td>Table speed of solder printer</td></tr><tr><td>1</td><td>1</td><td>1</td><td>1</td><td>1</td></tr><tr><td>2</td><td>1</td><td>2</td><td>2</td><td>2</td></tr><tr><td>3</td><td>1</td><td>3</td><td>3</td><td>3</td></tr><tr><td>4</td><td>2</td><td>1</td><td>2</td><td>3</td></tr><tr><td>5</td><td>2</td><td>2</td><td>3</td><td>1</td></tr><tr><td>6</td><td>2</td><td>3</td><td>1</td><td>2</td></tr><tr><td>7</td><td>3</td><td>1</td><td>3</td><td>2</td></tr><tr><td>8</td><td>3</td><td>2</td><td>1</td><td>3</td></tr><tr><td>9</td><td>3</td><td>3</td><td>2</td><td>1</td></tr></table>
c26f39103e915451e336921be32ac79de5fd3c6d770701a688e5d6b5daa6ab81.png
complex
<table><tr><td></td><td colspan="2">Men</td><td colspan="2">Women</td><td colspan="2">All</td></tr><tr><td>Study Population</td><td>46 388</td><td>46%</td><td>55 417</td><td>54%</td><td>101 805</td><td>100%</td></tr><tr><td>Random sample</td><td>2 300</td><td>46%</td><td>2 730</td><td>54%</td><td>5 030</td><td>100%</td></tr><tr><td>Study respondents</td><td>1 132</td><td>36%</td><td>2 021</td><td>64%</td><td>3 153</td><td>100%</td></tr><tr><td>Students who responded to the question concerning use of the web-based health advice service</td><td>1 113</td><td>36%</td><td>2 001</td><td>64%</td><td>3 114</td><td>100%</td></tr><tr><td>Users of the web-based health advice service</td><td>92</td><td>25%</td><td>278</td><td>75%</td><td>370</td><td>100%</td></tr></table>
afb8efc3f5d4920d3033f9e4103bb5c3746140d6a461436a5f10504de5f0fe29.png
simple
<table><tr><td>Cells</td><td>Assays</td><td>BCR-ABL-GFP*</td><td>BCR-ABL-GFP + N17 H-Ras*</td><td>GFP vector*</td></tr><tr><td>NIH 3T3</td><td># of foci</td><td>117 +/- 16&#8224;</td><td>11 +/- 2</td><td>-</td></tr><tr><td>Bone marrow</td><td># of colonies</td><td>16 +/- 0.6</td><td>0.33 +/- 0.33</td><td>-</td></tr></table>
edaab27ef7d5f97152db71f160a7586b4c639422fb43bbd602aa79d641f095f1.png
complex
<table><tr><td></td><td><i>&#946;</i></td><td><i>p</i>-value</td></tr><tr><td>Total effect</td><td>0.31</td><td>&lt;0.001</td></tr><tr><td>Direct effect</td><td>0.25</td><td>&lt;0.001</td></tr><tr><td>Total indirect</td><td>0.06</td><td>&lt;0.001</td></tr><tr><td colspan="3">Indirect effects</td></tr><tr><td> via cravings, urges to buy, unplanned purchases</td><td>0.01</td><td>0.001</td></tr><tr><td> via cravings, unplanned purchases</td><td>0.04</td><td>&lt;0.001</td></tr><tr><td> via urges to buy, unplanned purchases</td><td>0.01</td><td>0.03</td></tr></table>
90a97142b167647ebdd1db8d2b1f6c3924cd4030a101ec2d239eb0124e99b9eb.png
complex
<table><tr><td rowspan="2"></td><td colspan="3">Univariate Cox Model</td><td colspan="3">Mutivariate Cox Model</td></tr><tr><td>Hazard ratio</td><td>95%CI</td><td><i>p</i> value</td><td>Hazard ratio</td><td>95%CI</td><td><i>p</i> value</td></tr><tr><td>Age &#8804; 45 vs. &gt; 45</td><td>0.703</td><td>0.523&#8211;0.946</td><td>0.02</td><td>0.89</td><td>0.509&#8211;1.03</td><td>0.474</td></tr><tr><td>Male vs. Female</td><td>0.906</td><td>0.686&#8211;1.197</td><td>0.488</td><td></td><td></td><td></td></tr><tr><td>Astrocytic vs. oligodendroglial</td><td>1.123</td><td>0.849&#8211;1.486</td><td>0.417</td><td></td><td></td><td></td></tr><tr><td>IDH1-R132H positive vs. negative</td><td>0.437</td><td>0.326&#8211;0.586</td><td>3.15E&#8211;08</td><td>0.517</td><td>0.369&#8211;0.723</td><td>1.19E&#8211;04</td></tr><tr><td>ATRX loss vs. expression</td><td>0.645</td><td>0.486&#8211;0.856</td><td>0.002</td><td>0.913</td><td>0.659&#8211;1.264</td><td>0.584</td></tr><tr><td>WHO grade II/III vs. IV</td><td>0.529</td><td>0.388&#8211;0.772</td><td>5.79E&#8211;05</td><td>0.724</td><td>0.509&#8211;1.030</td><td>0.072</td></tr></table>
347e03c535c4149e966d903e0f6fc7a4a8832b6215cec295088bef1be6fd67a4.png
complex
<table><tr><td rowspan="2">Bacterial strains</td><td colspan="5"><i>G. tenax</i> extracts dose (mg)</td><td rowspan="2">MIC (mg/mL)</td></tr><tr><td>0.3</td><td>0.6</td><td>1.2</td><td>2.5</td><td>5.0</td></tr><tr><td><i>Staphyloccocus aureus</i></td><td>24.3</td><td>25.1</td><td>26.4</td><td>27.7</td><td>28.9</td><td>3.9</td></tr><tr><td><i>Enterococcus faecalis</i></td><td>11.2</td><td>15.6</td><td>20.3</td><td>24.5</td><td>29.3</td><td>7.8</td></tr><tr><td><i>Pseudomonas aeruginosa</i></td><td>10.2</td><td>15.5</td><td>23.1</td><td>24.2</td><td>26.6</td><td>15.6</td></tr><tr><td><i>Escherichia coli</i></td><td>15.4</td><td>18.9</td><td>20.3</td><td>21.6</td><td>23.2</td><td>3.9</td></tr></table>
758add62516e86b319e6bf0781f45dc12901aa8d85d5fa77092cbd868080a020.png
simple
<table><tr><td>Form of regression model</td><td>AICc</td><td>&#8710;AICc</td><td><i>w</i><sub>i</sub></td></tr><tr><td>Time + Vegetation density + Time: vegetation density</td><td>404.97</td><td>0.00</td><td>0.99</td></tr><tr><td>Time + Ruggedness + Time: ruggedness</td><td>415.40</td><td>10.43</td><td>0.01</td></tr><tr><td>Time + Kill probability + Time: kill probability</td><td>425.81</td><td>20.84</td><td>0.00</td></tr><tr><td>Time + Encounter risk + Time: encounter risk</td><td>429.08</td><td>24.11</td><td>0.00</td></tr><tr><td>Time</td><td>436.25</td><td>31.28</td><td>0.00</td></tr><tr><td>Vegetation density + Ruggedness + Vegetation: ruggedness</td><td>901.25</td><td>496.28</td><td>0.00</td></tr><tr><td>Vegetation</td><td>904.90</td><td>499.93</td><td>0.00</td></tr><tr><td>Vegetation density + Encounter risk + Vegetation: encounter risk</td><td>907.93</td><td>502.97</td><td>0.00</td></tr><tr><td>Vegetation density + Kill probability + Vegetation: kill probability</td><td>908.53</td><td>503.56</td><td>0.00</td></tr><tr><td>Ruggedness</td><td>914.86</td><td>509.89</td><td>0.00</td></tr><tr><td>Ruggedness + Kill probability + Ruggedness: kill probability</td><td>917.95</td><td>510.93</td><td>0.00</td></tr><tr><td>Ruggedness + Encounter risk + Ruggedness: encounter risk</td><td>915.90</td><td>512.98</td><td>0.00</td></tr><tr><td>Kill probability</td><td>932.48</td><td>527.51</td><td>0.00</td></tr><tr><td>Encounter risk</td><td>933.88</td><td>528.91</td><td>0.00</td></tr></table>
93fe961203916eb3261d9da7461699d3f6069dec08660f59759956f17976b18d.png
complex
<table><tr><td rowspan="2"> </td><td rowspan="2"><i>n</i></td><td colspan="3">Baseline</td><td colspan="3">15 min ischemia</td><td colspan="3">2 hr reperfusion</td></tr><tr><td>HR</td><td>MAP</td><td>RPP</td><td>HR</td><td>MAP</td><td>RPP</td><td>HR</td><td>MAP</td><td>RPP</td></tr><tr><td>Vehicle</td><td>7</td><td>375 &#177; 20</td><td>121 &#177; 5</td><td>51 &#177; 2</td><td>367 &#177; 20</td><td>106 &#177; 9</td><td>41 &#177; 2</td><td>366 &#177; 18</td><td>78 &#177; 8</td><td>36 &#177; 2</td></tr><tr><td>MOR</td><td>7</td><td>382 &#177; 23</td><td>121 &#177; 6</td><td>47 &#177; 3</td><td>378 &#177; 23</td><td>111 &#177; 7</td><td>42 &#177; 5</td><td>338 &#177; 35</td><td>65 &#177; 4</td><td>27 &#177; 2<sup><i>&#8727;</i></sup></td></tr><tr><td>RAD + MOR</td><td>7</td><td>343 &#177; 9</td><td>111 &#177; 5</td><td>45 &#177; 2</td><td>304 &#177; 13</td><td>74 &#177; 5</td><td>27 &#177; 2</td><td>311 &#177; 11</td><td>66 &#177; 4</td><td>28 &#177; 2</td></tr><tr><td>DSG + MOR</td><td>7</td><td>346 &#177; 9</td><td>127 &#177; 3</td><td>50 &#177; 3</td><td>347 &#177; 7</td><td>117 &#177; 6</td><td>45 &#177; 2</td><td>296 &#177; 9</td><td>82 &#177; 7</td><td>30 &#177; 2</td></tr><tr><td>SB21</td><td>7</td><td>401 &#177; 8</td><td>108 &#177; 7</td><td>46 &#177; 4</td><td>395 &#177; 11</td><td>106 &#177; 10</td><td>44 &#177; 5</td><td>360 &#177; 12</td><td>81 &#177; 4</td><td>32 &#177; 2</td></tr><tr><td>RAD + SB</td><td>7</td><td>376 &#177; 11</td><td>107 &#177; 7</td><td>45 &#177; 3</td><td>363 &#177; 12</td><td>69 &#177; 5<sup><i>&#8727;</i></sup></td><td>28 &#177; 2</td><td>371 &#177; 13</td><td>72 &#177; 4</td><td>33 &#177; 2</td></tr><tr><td>DSG + SB</td><td>5</td><td>384 &#177; 8</td><td>124 &#177; 4</td><td>56 &#177; 2</td><td>384 &#177; 6</td><td>107 &#177; 7</td><td>45 &#177; 3</td><td>380 &#177; 8</td><td>79 &#177; 3</td><td>37 &#177; 1</td></tr><tr><td>RAD</td><td>7</td><td>361 &#177; 12</td><td>125 &#177; 5</td><td>52 &#177; 2</td><td>355 &#177; 10</td><td>129 &#177; 5</td><td>50 &#177; 2</td><td>333 &#177; 10</td><td>77 &#177; 4</td><td>33 &#177; 2</td></tr><tr><td>DSG</td><td>6</td><td>392 &#177; 7</td><td>110 &#177; 4</td><td>50 &#177; 1</td><td>388 &#177; 5</td><td>94 &#177; 10</td><td>42 &#177; 3</td><td>375 &#177; 7</td><td>78 &#177; 6</td><td>36 &#177; 3</td></tr></table>
a48d503c11ce7f0f170957291e1c672abcf05b89e73c3e826d1a8bf7584f74ed.png
simple
<table><tr><td>Age (years of growth)</td><td>Number of specimen</td><td>TRR</td><td>TRM</td></tr><tr><td>1</td><td>5</td><td>0</td><td>1</td></tr><tr><td>2</td><td>8</td><td>1</td><td>2</td></tr><tr><td>3</td><td>8</td><td>2</td><td>3</td></tr><tr><td>4</td><td>8</td><td>3</td><td>4</td></tr><tr><td>5</td><td>5</td><td>4</td><td>5</td></tr><tr><td>8</td><td>3</td><td><sup>a</sup></td><td>8</td></tr><tr><td>10</td><td>1</td><td><sup>a</sup></td><td>10</td></tr></table>
f2e33bdb03a47b2dc32664508679f2b2a7b313f5e2d096cbeb2be89614d7ceb6.png
simple
<table><tr><td></td><td>Total</td><td>Fixed-dose group</td><td>Adjusted-dose group</td></tr><tr><td>January**</td><td>22.7 &#177; 2.3</td><td>24.4 &#177; 0.5</td><td>21.5 &#177; 2.3</td></tr><tr><td>February</td><td>22.9 &#177; 3.0</td><td>24.4 &#177; 0.5</td><td>22.0 &#177; 3.5</td></tr><tr><td>March</td><td>22.4 &#177; 2.8</td><td>22.2 &#177; 2.9</td><td>22.6 &#177; 2.9</td></tr><tr><td>April</td><td>22.4 &#177; 2.9</td><td>21.5 &#177; 2.6</td><td>22.9 &#177; 3.1</td></tr><tr><td>May</td><td>21.8 &#177; 2.9</td><td>23.1 &#177; 1.2</td><td>20.9 &#177; 3.4</td></tr><tr><td>June</td><td>23.0 &#177; 1.9</td><td>23.4 &#177; 1.6</td><td>22.9 &#177; 2.1</td></tr><tr><td>July</td><td>23.3 &#177; 2.5</td><td>23.2 &#177; 2.5</td><td>23.3 &#177; 2.5</td></tr><tr><td>August</td><td>23.6 &#177; 2.6</td><td>24.2 &#177; 1.0</td><td>23.2 &#177; 3.2</td></tr><tr><td>September*</td><td>23.3 &#177; 1.8</td><td>24.2 &#177; 1.0</td><td>22.7 &#177; 2.0</td></tr><tr><td>October*</td><td>23.1 &#177; 2.8</td><td>24.3 &#177; 0.8</td><td>22.2 &#177; 3.4</td></tr><tr><td>November*</td><td>23.6 &#177; 1.4</td><td>24.3 &#177; 0.8</td><td>23.1 &#177; 1.5</td></tr><tr><td>December**</td><td>22.9 &#177; 2.8</td><td>24.4 &#177; 1.0</td><td>21.9 &#177; 3.2</td></tr></table>
6dd113e8158e48c9eb223896aca2951bc48c7a8835a4c4426cd7d95117661746.png
complex
<table><tr><td colspan="2"><i>Tumor margin</i></td><td><i>HD group (n=23)</i></td><td><i>LD group (n=24)</i></td><td><i>&#967;<sup>2</sup></i></td><td><i>P</i></td></tr><tr><td rowspan="2">Lobulated</td><td>Yes</td><td>7 (30.4)</td><td>17 (70.8)</td><td rowspan="2">7.671</td><td rowspan="2">&lt;0.05</td></tr><tr><td>No</td><td>16 (69.6)</td><td>7 (29.2)</td></tr><tr><td rowspan="2">Spiculated</td><td>Yes</td><td>22 (95.7)</td><td>21 (87.5)</td><td rowspan="2">1.002</td><td rowspan="2">&gt;0.05</td></tr><tr><td>No</td><td>1 (4.3)</td><td>3 (12.5)</td></tr></table>
e0910646b4c84b8b9776c833b760e3dad1dc645f385d9539bc9f8533c2dbe6ee.png
simple
<table><tr><td> CTAS visits</td><td>Trial 1 patients</td><td>Trial 2 patients</td><td>Trial 1% in level</td><td>Trial 2% In Level</td></tr><tr><td>CTAS 1</td><td>4</td><td>7</td><td>0.14%</td><td>0.23%</td></tr><tr><td>CTAS 2</td><td>149</td><td>136</td><td>5.25%</td><td>4.40%</td></tr><tr><td>CTAS 3</td><td>1010</td><td>1216</td><td>35.59%</td><td>39.34%</td></tr><tr><td>CTAS 4</td><td>1412</td><td>1514</td><td>49.75%</td><td>48.98%</td></tr><tr><td>CTAS 5</td><td>219</td><td>170</td><td>7.72%</td><td>5.50%</td></tr><tr><td>Unknown</td><td>44</td><td>48</td><td>1.55%</td><td>1.55%</td></tr><tr><td>Total patients</td><td>2838</td><td>3091</td><td></td><td></td></tr></table>
d74e9141e95b9f6ed80e8b4d692f337ab4ac83d326c87b18c84795881238a389.png
simple
<table><tr><td>Predictor</td><td>Estimate</td><td>Standard error</td><td>Degrees of freedom</td><td>t-value</td><td>p-value</td></tr><tr><td>Intercept</td><td>0.107</td><td>0.028</td><td>12.5</td><td>3.862</td><td>.002</td></tr><tr><td>Task</td><td>0.020</td><td>0.026</td><td>12.2</td><td>0.784</td><td>.448</td></tr><tr><td>Gold-MSI Musical Training</td><td>-0.003</td><td>0.001</td><td>11.1</td><td>-0.327</td><td>.750</td></tr><tr><td>Task * Gold-MSI Musical Training</td><td>-0.001</td><td>0.001</td><td>8.8</td><td>-0.816</td><td>.436</td></tr></table>
a3c4eb89e74704127ee551e844cbd40cb436ead5f29c8319a23294b2248eae17.png
simple
<table><tr><td>Device</td><td>Frequency (GHz)</td><td>Gain (dB)</td><td>Output Power (W)</td><td>PAE (%)</td></tr><tr><td>HPA 1</td><td>4.5&#8211;18</td><td>19</td><td>2 (CW and pulsed)</td><td>25&#8211;30%</td></tr><tr><td>HPA 2</td><td>5&#8211;12</td><td>20</td><td>4 (pulsed)</td><td>25&#8211;30%</td></tr></table>
0059507bfbc9bec91ec0bf7a388936c352023b3ef134e412e36cec2fe2eee4b8.png
simple
<table><tr><td>Assembly</td><td></td></tr><tr><td>Total number of reads</td><td>1,104,651</td></tr><tr><td>Number of reads after pre-processing</td><td>990,945</td></tr><tr><td>Average read length after pre-processing</td><td>362 bp</td></tr><tr><td>Total number of contigs</td><td>54,748</td></tr><tr><td>Average contig length</td><td>965 bp</td></tr><tr><td>Sequencing length</td><td>52,832,938 bp</td></tr><tr><td>Contigs with ORF &#8805;200 bp (average length)</td><td>30,552 (540 bp)</td></tr><tr><td>Average read coverage per contig</td><td>4.34x</td></tr><tr><td>Average GC % content of contigs</td><td>37.77%</td></tr><tr><td>Annotation</td><td></td></tr><tr><td>% contigs with at least 1 GO term</td><td>30.01%</td></tr><tr><td>% contigs with an EC number</td><td>6.10%</td></tr><tr><td>% contigs with at least 1 IPR</td><td>33.27%</td></tr><tr><td>Contigs with at least 1 blast hit against nr</td><td></td></tr><tr><td>Total number</td><td>20,333</td></tr><tr><td>Average length</td><td>1,394 bp</td></tr><tr><td>% of those contigs with at least 1 IPR</td><td>42.61%</td></tr><tr><td>% of those contigs with at least 1 GO term</td><td>78.43%</td></tr><tr><td>Contigs with ORF &#8805;200 bp (average length)</td><td>18,080 (704 bp)</td></tr><tr><td>Contigs with no blast hits</td><td></td></tr><tr><td>Total number</td><td>34,416</td></tr><tr><td>Average length</td><td>712 bp</td></tr><tr><td>% of those contigs with at least 1 GO term</td><td>1.41%</td></tr><tr><td>% of those contigs with at least 1 IPR</td><td>28.01%</td></tr><tr><td>Contigs with ORF &#8805;200 bp (average length)</td><td>12,472 (301 bp)</td></tr></table>
050d573e6db44eeefc06126606b3e0770ddfbd80c75554f842f7027353e3a370.png
complex
<table><tr><td rowspan="2">Database</td><td colspan="4">Without Transfer Learning</td><td colspan="4">With Transfer Learning</td></tr><tr><td>SVM Kernel (No. PC)</td><td>APCER</td><td>BPCER</td><td>ACER</td><td>SVM Kernel (No. PC)</td><td>APCER</td><td>BPCER</td><td>ACER</td></tr><tr><td>ISPR-DB</td><td>RBF Kernel (No. PC = 200)</td><td>2.8438</td><td>2.8550</td><td>2.8494</td><td>Linear Kernel (No. PC = 70)</td><td>0.0313</td><td>0.0310</td><td>0.0311</td></tr><tr><td>Idiap (Full-DB)</td><td>RBF Kernel (No. PC = 70)</td><td>0.0000</td><td>0.0000</td><td>0.0000</td><td>Linear Kernel (No. PC = 60)</td><td>0.0000</td><td>0.0000</td><td>0.0000</td></tr><tr><td>Idiap (Cropped-DB)</td><td>RBF Kernel (No. PC = 105)</td><td>1.0000</td><td>1.0000</td><td>1.0000</td><td>RBF Kernel (No. PC = 95)</td><td>0.0000</td><td>0.0000</td><td>0.0000</td></tr></table>
18717ba4e7cec35fad54ca9f73eaa4a352f9bf7fa1c125ab22fa587d0249d17f.png
simple
<table><tr><td><i>Description of vision</i></td><td><i>Visual acuity</i></td></tr><tr><td>Good reading vision</td><td>20/20 &#8211; 20/25</td></tr><tr><td>Legal driving vision</td><td>20/30 &#8211; 20/40</td></tr><tr><td>Moderate visual loss</td><td>20/50 &#8211; 20/100</td></tr><tr><td>Legal blindness</td><td>&#8804; 20/200</td></tr></table>
20643d3794ee03b4ab33a6f777a2bec62ba74dace14e5b7a01a46d523e0a742b.png
complex
<table><tr><td rowspan="2"></td><td colspan="2">Learning memory</td><td colspan="2">Delayed recall memory</td><td colspan="2">Recognition memory</td><td colspan="2">Semantic verbal fluency test</td><td colspan="2">Phonemic verbal fluency test</td><td colspan="2">Trail test</td></tr><tr><td>&#946;</td><td>p-value</td><td>&#914;</td><td>p-value</td><td>&#914;</td><td>p-value</td><td>&#914;</td><td>p-value</td><td>&#946;</td><td>p-value</td><td>&#914;</td><td>p-value</td></tr><tr><td>Age</td><td>&#8722; 0.105</td><td>0.001</td><td>&#8722; 0.142</td><td>&lt; 0.001</td><td>0.004</td><td>0.896</td><td>&#8722; 0.081</td><td>0.013</td><td>&#8722; 0.041</td><td>0.208</td><td>0.259</td><td>&lt; 0.001</td></tr><tr><td>Body mass index</td><td>&#8722; 0.105</td><td>0.001</td><td>&#8722; 0.089</td><td>0.006</td><td>&#8722; 0.038</td><td>0.253</td><td>&#8722; 0.062</td><td>0.057</td><td>&#8722; 0.046</td><td>0.162</td><td>0.092</td><td>0.005</td></tr><tr><td>Systolic BP</td><td>&#8722; 0.124</td><td>&lt; 0.001</td><td>&#8722; 0.154</td><td>&lt; 0.001</td><td>&#8722; 0.082</td><td>0.012</td><td>&#8722; 0.111</td><td>0.001</td><td>&#8722; 0.119</td><td>&lt; 0.001</td><td>0.117</td><td>&lt; 0.001</td></tr><tr><td>Diastolic BP</td><td>&#8722; 0.082</td><td>0.013</td><td>&#8722; 0.119</td><td>&lt; 0.001</td><td>&#8722; 0.073</td><td>0.026</td><td>&#8722; 0.109</td><td>0.001</td><td>&#8722; 0.125</td><td>&lt; 0.001</td><td>0.101</td><td>0.002</td></tr><tr><td>Plasma glucose</td><td>&#8722; 0.108</td><td> &lt;0.001</td><td>&#8722; 0.127</td><td>&lt; 0.001</td><td>&#8722; 0.035</td><td>0.287</td><td>&#8722; 0.016</td><td>0.634</td><td>&#8722; 0.058</td><td>0.079</td><td>0.095</td><td>0.004</td></tr><tr><td>Triglycerides</td><td>&#8722; 0.138</td><td>&lt; 0.001</td><td>&#8722; 0.173</td><td>&lt; 0.001</td><td>&#8722; 0.068</td><td>0.040</td><td>&#8722; 0.065</td><td>0.050</td><td>&#8722; 0.044</td><td>0.183</td><td>0.075</td><td>0.024</td></tr><tr><td>HDL-cholesterol</td><td>0.135</td><td>&lt; 0.001</td><td>0.187</td><td>&lt; 0.001</td><td>0.070</td><td>0.034</td><td>0.092</td><td>0.005</td><td>0.093</td><td>0.005</td><td>&#8722; 0.093</td><td>0.005</td></tr><tr><td>LDL-cholesterol</td><td>0.037</td><td>0.261</td><td>0.030</td><td>0.359</td><td>&#8722; 0.002</td><td>0.947</td><td>0.025</td><td>0.450</td><td>0.023</td><td>0.484</td><td>&#8722; 0.039</td><td>0.242</td></tr><tr><td>HOMA-IR<sup>a</sup></td><td>&#8722; 0.087</td><td>0.008</td><td>&#8722; 0.089</td><td>0.007</td><td>&#8722; 0.012</td><td>0.722</td><td>&#8722; 0.015</td><td>0.653</td><td>&#8722; 0.043</td><td>0.192</td><td>0.004</td><td>0.911</td></tr><tr><td>CRP<sup>a</sup></td><td>&#8722; 0.032</td><td>0.329</td><td>&#8722; 0.056</td><td>0.085</td><td>&#8722; 0.019</td><td>0.554</td><td>&#8722; 0.105</td><td>0.001</td><td>&#8722; 0.046</td><td>0.161</td><td>0.084</td><td>0.011</td></tr></table>
63056ecdc1a6207e3048a196a9601ccaa945d764eba44c4bb69f87b20d6cd0e9.png
complex
<table><tr><td rowspan="2">Patient</td><td rowspan="2">Age (y)</td><td>Menopause status</td><td rowspan="2">Histologic type</td><td>Histological grading</td><td>B classification</td><td>MIB-1 (%)</td><td colspan="3">Receptor status</td><td>Molecular subtype</td></tr><tr><td></td><td></td><td></td><td></td><td>ER</td><td>PR</td><td>HER2</td><td></td></tr><tr><td>1</td><td>75</td><td>Post</td><td>IDC</td><td>2</td><td>5b</td><td>10</td><td>+</td><td>+</td><td>&#8722;</td><td>Luminal A</td></tr><tr><td>2</td><td>65</td><td>Post</td><td>IDC</td><td>2</td><td>5b</td><td>10</td><td>+</td><td>+</td><td>&#8722;</td><td>Luminal A</td></tr><tr><td>3</td><td>54</td><td>n.s.</td><td>IDC</td><td>3</td><td>5b</td><td>n.s.</td><td>n.s.</td><td>n.s.</td><td>n.s.</td><td>n.s.</td></tr><tr><td>4</td><td>39</td><td>Pre</td><td>IDC</td><td>2</td><td>5b</td><td>40</td><td>+</td><td>+</td><td>+</td><td>Luminal B</td></tr><tr><td>5</td><td>66</td><td>Post</td><td>IDC</td><td>2</td><td>5b</td><td>60</td><td>+</td><td>+</td><td>&#8722;</td><td>Luminal A</td></tr><tr><td>6</td><td>50</td><td>Pre</td><td>IDC</td><td>3</td><td>5b</td><td>50</td><td>+</td><td>+</td><td>+</td><td>Luminal B</td></tr><tr><td>7</td><td>73</td><td>Post</td><td>IDC</td><td>3</td><td>5b</td><td>20</td><td>+</td><td>+</td><td>&#8722;</td><td>Luminal A</td></tr><tr><td>8</td><td>76</td><td>Post</td><td>IDC</td><td>2</td><td>5b</td><td>20</td><td>+</td><td>+</td><td>&#8722;</td><td>Luminal A</td></tr><tr><td>9</td><td>63</td><td>Post</td><td>IDC</td><td>3</td><td>5</td><td>30</td><td>+</td><td>+</td><td>&#8722;</td><td>Luminal A</td></tr><tr><td>10</td><td>48</td><td>Post</td><td>IDC</td><td>3</td><td>5b</td><td>20</td><td>+</td><td>+</td><td>+</td><td>Luminal B</td></tr><tr><td>11</td><td>58</td><td>Post</td><td>IDC</td><td>n.s.</td><td>5c</td><td>20</td><td>+</td><td>+</td><td>+</td><td>Luminal B</td></tr><tr><td>12</td><td>61</td><td>Post</td><td>IDC</td><td>3</td><td>5b</td><td>70</td><td>&#8722;</td><td>&#8722;</td><td>&#8722;</td><td>Triple negative</td></tr><tr><td>13</td><td>52</td><td>Pre</td><td>ILC</td><td>n.s.</td><td>5b</td><td>50</td><td>+</td><td>+</td><td>&#8722;</td><td>Luminal A</td></tr><tr><td>14</td><td>42</td><td>Pre</td><td>IDC</td><td>3</td><td>5b</td><td>80</td><td>+</td><td>&#8722;</td><td>&#8722;</td><td>Luminal A</td></tr><tr><td>15</td><td>67</td><td>Post</td><td>IDC</td><td>3</td><td>5b</td><td>40</td><td>+</td><td>+</td><td>&#8722;</td><td>Luminal A</td></tr><tr><td>16</td><td>61</td><td>Post</td><td>ILC</td><td>2</td><td>5b</td><td>30</td><td>+</td><td>+</td><td>&#8722;</td><td>Luminal A</td></tr><tr><td>17</td><td>41</td><td>Pre</td><td>Mucinous</td><td>2</td><td>5b</td><td>50</td><td>+</td><td>+</td><td>+</td><td>Luminal B</td></tr></table>
1f6ef1a96c9c3692ff15561f544a54102978ed37db788765235161c271c187ef.png
simple
<table><tr><td></td><td></td><td>Location</td><td></td><td>unadjusted</td></tr><tr><td>SNP ID</td><td>CHR</td><td>bp</td><td>Gene</td><td>p value</td></tr><tr><td>rs29013431</td><td>2</td><td>15,312,400</td><td></td><td>5.99E-03</td></tr><tr><td>rs29012194</td><td>2</td><td>26,095,592</td><td></td><td>6.28E-03</td></tr><tr><td>rs29016537</td><td>2</td><td>29,654,789</td><td></td><td>1.30E-03</td></tr><tr><td>rs29020907</td><td>4</td><td>59,252,723</td><td>IMP2</td><td>4.97E-04</td></tr><tr><td>rs29024570</td><td>10</td><td>4,359,586</td><td></td><td>4.30E-04</td></tr><tr><td>AAFC02107025</td><td>10</td><td>21,153,203</td><td>DHRS1</td><td>4.73E-03</td></tr><tr><td>rs29024728</td><td>13</td><td>28,618,368</td><td></td><td>3.34E-03</td></tr><tr><td>PRNP08</td><td>13</td><td>47,214,453</td><td>PRNP</td><td>4.38E-03</td></tr><tr><td>rs29021171</td><td>14</td><td>10,106,755</td><td></td><td>3.84E-03</td></tr><tr><td>SCAFFOLD51887</td><td>14</td><td>43,984,153</td><td></td><td>7.25E-05*</td></tr><tr><td>rs29014819</td><td>15</td><td>35,713,980</td><td></td><td>7.17E-04</td></tr><tr><td>rs29014820</td><td>15</td><td>35,714,095</td><td></td><td>6.05E-04</td></tr><tr><td>rs29014821</td><td>15</td><td>35,714,113</td><td></td><td>4.66E-04</td></tr><tr><td>AAFC02014662</td><td>16</td><td>65,943,749</td><td></td><td>7.95E-03</td></tr><tr><td>AAFC02012500_1</td><td>21</td><td>11,820,092</td><td>MCTP2</td><td>1.82E-03</td></tr><tr><td>AAFC02012500_2</td><td>21</td><td>11,820,201</td><td>MCTP2</td><td>3.93E-03</td></tr><tr><td>rs29026011</td><td>21</td><td>13,254,954</td><td>LOC618464</td><td>3.00E-03</td></tr><tr><td>rs29019629</td><td>21</td><td>33,209,686</td><td>CSPG4</td><td>2.01E-03</td></tr><tr><td>rs29011202</td><td>24</td><td>18,493,192</td><td></td><td>9.08E-03</td></tr><tr><td>AJ496776</td><td>28</td><td>31,495,721</td><td></td><td>5.74E-03</td></tr></table>
aea3f707c9877b83bfdc632ba9f4f81c50d930cae476e467f765cc2d9afd3078.png
simple
<table><tr><td> </td><td>Frequency</td><td>Percent</td></tr><tr><td>Had been asked about desire to be pregnant</td><td>95</td><td>76.8 (95%CI 68&#8211;83)</td></tr><tr><td>Not at risk for pregnancy</td><td>59</td><td>47.2</td></tr><tr><td>At risk for pregnancy (either planned or unplanned)</td><td>36</td><td>28.8</td></tr><tr><td>Using effective contraception</td><td>13</td><td>10.4</td></tr><tr><td>Using ineffective contraception**</td><td>11</td><td>8.8</td></tr><tr><td>Have knowledge*</td><td>10</td><td>8.0</td></tr><tr><td>Do not have knowledge</td><td>1</td><td>0.8</td></tr><tr><td>Non-contraceptive use</td><td>12</td><td>9.6</td></tr><tr><td>Have knowledge*</td><td>8</td><td>6.4</td></tr><tr><td>Do not have knowledge</td><td>4</td><td>3.2</td></tr><tr><td>Had never been asked about desire to get pregnant</td><td>30</td><td>24.0</td></tr><tr><td>Not at risk for pregnancy</td><td>23</td><td>18.4</td></tr><tr><td>At risk for pregnancy</td><td>7</td><td>1.56</td></tr><tr><td>Using effective contraception</td><td>3</td><td>2.4</td></tr><tr><td>Using ineffective contraception</td><td>0</td><td>0</td></tr><tr><td>No contraception</td><td>4</td><td>3.2</td></tr><tr><td>Have knowledge</td><td>2</td><td>1.6</td></tr><tr><td>Do not have knowledge</td><td>2</td><td>1.6</td></tr></table>
78b630327da61cb09a56e52db3dce3ad1b56f748217a1552fe03c34aafe1a6a9.png
simple
<table><tr><td></td><td>Disabling pain, no. (%)</td><td>No disabling pain, no. (%)</td><td>Unadjusted OR (95% CI)</td><td>Adjusted OR (95% CI)b</td></tr><tr><td>Sex</td><td></td><td></td><td></td><td></td></tr><tr><td>Men</td><td>171 (43.0)</td><td>54 (50.9)</td><td>1.0</td><td>1.0</td></tr><tr><td>Women</td><td>227 (57.0)</td><td>52 (49.1)</td><td>1.38 (0.90&#8211;2.12)</td><td>1.14 (0.89&#8211;1.47)</td></tr><tr><td>Age, years</td><td></td><td></td><td></td><td></td></tr><tr><td>50&#8211;64</td><td>197 (49.5)</td><td>74 (69.8)</td><td>1.0</td><td>1.0</td></tr><tr><td>65&#8211;74</td><td>111 (27.9)</td><td>28 (26.4)</td><td>1.49 (0.91&#8211;2.44)</td><td>1.08 (0.81&#8211;1.44)</td></tr><tr><td>&#8805;75</td><td>90 (22.6)</td><td>4 (3.8)</td><td>8.45 (2.30&#8211;23.83)</td><td>1.41 (1.01&#8211;1.96)</td></tr><tr><td>Body mass index, kg/m<sup>2</sup></td><td></td><td></td><td></td><td></td></tr><tr><td>&lt;25.0</td><td>81 (21.1)</td><td>26 (25.2)</td><td>1.0</td><td>1.0</td></tr><tr><td>25.0&#8211;29.9</td><td>129 (33.7)</td><td>47 (45.6)</td><td>0.88 (0.51&#8211;1.53)</td><td>1.44 (1.02&#8211;2.02)</td></tr><tr><td>30.0&#8211;34.9</td><td>89 (23.2)</td><td>19 (18.4)</td><td>1.50 (0.77&#8211;2.92)</td><td>2.50 (1.73&#8211;3.59)</td></tr><tr><td>&#8805;35.0</td><td>84 (21.9)</td><td>11 (10.7)</td><td>2.45 (1.14&#8211;5.28)</td><td>4.69 (3.12&#8211;7.08)</td></tr><tr><td>Neighborhood deprivation (quartiles)</td><td></td><td></td><td></td><td></td></tr><tr><td>Least deprived</td><td>65 (16.3)</td><td>29 (27.4)</td><td>1.0</td><td>1.0</td></tr><tr><td>Upper mid&#8208;deprived</td><td>101 (25.4)</td><td>25 (23.6)</td><td>1.80 (0.97&#8211;3.35)</td><td>1.22 (0.82&#8211;1.80)</td></tr><tr><td>Lower mid&#8208;deprived</td><td>106 (26.6)</td><td>31 (29.2)</td><td>1.53 (0.84&#8211;2.76)</td><td>1.11 (0.75&#8211;1.65)</td></tr><tr><td>Most deprived</td><td>126 (31.7)</td><td>21 (19.8)</td><td>2.68 (1.42&#8211;5.06)</td><td>1.14 (0.78&#8211;1.67)</td></tr><tr><td>Individual occupational class</td><td></td><td></td><td></td><td></td></tr><tr><td>Higher managerial/administrative/professional</td><td>45 (12.7)</td><td>19 (18.4)</td><td>1.0</td><td>1.0</td></tr><tr><td>Intermediate</td><td>72 (20.4)</td><td>9 (8.7)</td><td>3.38 (1.41&#8211;8.11)</td><td>1.86 (1.21&#8211;2.85)</td></tr><tr><td>Routine and manual</td><td>236 (66.9)</td><td>75 (72.8)</td><td>1.33 (0.73&#8211;2.41)</td><td>1.97 (1.35&#8211;2.88)</td></tr><tr><td>Physical activity level</td><td></td><td></td><td></td><td></td></tr><tr><td>Low</td><td>158 (46.2)</td><td>961 (24.1)</td><td>1.0</td><td>1.0</td></tr><tr><td>Medium</td><td>126 (36.8)</td><td>1,694 (42.5)</td><td>0.45 (0.35&#8211;0.58)</td><td>0.53 (0.40&#8211;0.69)</td></tr><tr><td>High</td><td>58 (17.0)</td><td>1,335 (33.5)</td><td>0.26 (0.19&#8211;0.36)</td><td>0.33 (0.23&#8211;0.46)</td></tr><tr><td>Diabetes mellitus</td><td></td><td></td><td></td><td></td></tr><tr><td>Absent</td><td>310 (77.9)</td><td>268 (96.8)</td><td>1.0</td><td>1.0</td></tr><tr><td>Present</td><td>88 (22.1)</td><td>9 (3.2)</td><td>3.06 (1.49&#8211;6.30)</td><td>1.5643 (1.04&#8211;1.95)</td></tr></table>
de04845bf70673343778acdceb63e7dba5537e510dc8abfd5d75c0be4be70bd0.png
complex
<table><tr><td rowspan="2" colspan="2">Explanatory variable</td><td rowspan="2">Transmission % for group</td><td colspan="2">Univariate logistic regression</td><td colspan="2">Multivariate logistic regression</td></tr><tr><td>OR (95% CI)</td><td><i>p</i></td><td>OR (95% CI)</td><td><i>P</i></td></tr><tr><td rowspan="5">Virus Group (cf none detected)</td><td>None</td><td>20 of 95 (21.1%)</td><td>1.00 (def)</td><td>-</td><td>1.00 (def)</td><td>-</td></tr><tr><td>Picornavirus</td><td>10 of 40 (25.0%)</td><td>1.25 (0.524, 2.98)</td><td>0.615</td><td>0.996 (0.398, 2.49)</td><td>0.994</td></tr><tr><td>Influenza</td><td>5 of 17 (29.4%)</td><td>1.56 (0.493, 4.95)</td><td>0.448</td><td>1.87 (0.552, 6.36)</td><td>0.314</td></tr><tr><td>Coronavirus</td><td>3 of 6 (50.0%)</td><td>3.75 (0.703, 20.0)</td><td>0.122</td><td>2.43 (0.409, 14.4)</td><td>0.330</td></tr><tr><td>Other</td><td>0 of 8 (0.00%)</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td rowspan="2">Sex (cf male)</td><td>Male</td><td>9 of 69 (13.0%)</td><td>1.00 (def)</td><td>-</td><td>1.00 (def)</td><td>-</td></tr><tr><td>Female</td><td>30 of 108 (27.8%)</td><td>2.56 (1.13, 5.81)</td><td>0.024</td><td>2.45 (1.01, 5.93)</td><td>0.047</td></tr><tr><td rowspan="2">Smoking (cf not current smoker)</td><td>Not current smoker</td><td>36 of 161 (22.4%)</td><td>1.00 (def)</td><td>-</td><td>1.00 (def)</td><td>-</td></tr><tr><td>Current smoker</td><td>3 of 12 (25.0%)</td><td>1.16 (0.298, 4.50)</td><td>0.833</td><td>1.40 (0.319, 6.12)</td><td>0.658</td></tr><tr><td rowspan="5">Age (cf 18&#8211;24 years)</td><td>18-24 years</td><td>9 of 47 (19.2%)</td><td>1.00 (def)</td><td>-</td><td>Not included</td><td>-</td></tr><tr><td>25-34 years</td><td>5 of 28 (17.9%)</td><td>0.918 (0.274, 3.08)</td><td>0.890</td><td>Not included</td><td>-</td></tr><tr><td>35-44 years</td><td>15 of 37 (40.5%)</td><td>2.88 (1.08, 7.66)</td><td>0.034</td><td>Not included</td><td>-</td></tr><tr><td>45-54 years</td><td>6 of 36 (16.7%)</td><td>0.844 (0.270, 2.64)</td><td>0.771</td><td>Not included</td><td>-</td></tr><tr><td>55-64 years</td><td>4 of 29 (13.8%)</td><td>0.676 (0.188, 2.43)</td><td>0.549</td><td>Not included</td><td>-</td></tr><tr><td rowspan="6">Household size (cf size 2)</td><td>2</td><td>14 of 64 (21.9%)</td><td>1.00 (def)</td><td>-</td><td>Not included</td><td>-</td></tr><tr><td>3</td><td>4 of 44 (9.09%)</td><td>0.357 (0.109, 1.17)</td><td>0.089</td><td>Not included</td><td>-</td></tr><tr><td>4</td><td>11 of 46 (23.9%)</td><td>1.22 (0.456, 2.76)</td><td>0.801</td><td>Not included</td><td>-</td></tr><tr><td>5</td><td>8 of 17 (47.1%)</td><td>3.17 (1.03, 9.75)</td><td>0.044</td><td>Not included</td><td>-</td></tr><tr><td>6</td><td>2 of 3 (66.7%)</td><td>7.14 (0.602, 84.7)</td><td>0.119</td><td>Not included</td><td>-</td></tr><tr><td>7</td><td>0 of 3 (0.00%)</td><td>-</td><td>-</td><td>Not included</td><td>-</td></tr><tr><td rowspan="2">Presence of child (cf no children in house)</td><td>No child in house</td><td>22 of 123 (17.9%)</td><td>1.00 (def)</td><td>-</td><td>1.00 (def)</td><td>-</td></tr><tr><td>At least one child in house</td><td>17 of 54 (31.5%)</td><td>2.11 (1.01, 4.41)</td><td>0.047</td><td>2.63 (1.18, 5.88)</td><td>0.018</td></tr></table>
3e9921baf9181cc1d28f75e49c0c50bb34adb540d45ec6d0aa4691223fc262f9.png
complex
<table><tr><td>Response</td><td>Predictor</td><td>OR (95% CI)</td><td>P-value</td></tr><tr><td rowspan="9">Knowledge on malaria in pregnancy</td><td>Age category (years)</td><td></td><td></td></tr><tr><td>20-24</td><td>2.3 (0.8, 6.6)</td><td>0.124</td></tr><tr><td>25-29</td><td>3.3 (1.2, 8.9)</td><td>0.02*</td></tr><tr><td>30+</td><td>4.3 (1.6, 11.7)</td><td>0.004*</td></tr><tr><td>Education</td><td></td><td></td></tr><tr><td>Educated (&gt;Primary School)</td><td>1.7 (1.1, 2.8)</td><td>0.046*</td></tr><tr><td>Status in the household</td><td></td><td></td></tr><tr><td>Spouse</td><td>2 (1.0, 4.2)</td><td>0.06</td></tr><tr><td>Daughter</td><td>1.8 (0.6, 5)</td><td>0.263</td></tr><tr><td rowspan="7">Receiving two doses of SP</td><td>Age category (years)</td><td></td><td></td></tr><tr><td>20-24</td><td>2.0 (0.5, 7.5)</td><td>0.302</td></tr><tr><td>25-29</td><td>3.0 (0.9, 10.5)</td><td>0.077</td></tr><tr><td>30+</td><td>3.3 (1.0, 10.8)</td><td>0.05*</td></tr><tr><td>Time spent at ANC clinic</td><td></td><td></td></tr><tr><td>1-2 hr</td><td>0.7 (0.4, 1.4)</td><td>0.349</td></tr><tr><td>3-4 hours</td><td>0.7 (0.3, 1.5)</td><td>0.38</td></tr><tr><td></td><td>5-6 hours</td><td>0.2 (0.1, 0.8)</td><td>0.016*</td></tr></table>
d678fc4f5ebef1f94c4f2f84f8e75b0c9131a9303884385f2ceed996fae88a79.png
simple
<table><tr><td></td><td>Methodological quality featuresassessed in the included studies</td><td>Score</td></tr><tr><td> A</td><td> Description of study objectives</td><td> 1</td></tr><tr><td> B</td><td> Study design (retrospective = 0 point;prospective = 1 point; randomized prospective = 2 points)</td><td> 2</td></tr><tr><td> C</td><td> Description of sample inclusion/exclusioncriteria</td><td> 1</td></tr><tr><td> D</td><td> Intervention clearly described (reason forchoosing the extracted tooth/performing the wear)</td><td> 1</td></tr><tr><td> E</td><td> Measures for evaluating the resultsdescribed</td><td> 1</td></tr><tr><td> F</td><td> Determining the sample size (sample sizecalculation)</td><td> 1</td></tr><tr><td> G</td><td> Description of statistical analysismethods</td><td> 1</td></tr><tr><td> H</td><td> Sample description (demographic - age, sex andethnicity)</td><td> 1</td></tr><tr><td> I</td><td> Sample description (overjet, overbite,perimeter discrepancy, Bolton, tooth form, oral health, profile) (0.5point/item. More than 6 items = 3 points)</td><td> 3</td></tr><tr><td> J</td><td> Description of treatment duration and follow-up(1 point each)</td><td> 2</td></tr><tr><td> K</td><td> Description of limitations, biases andinaccuracies of the study</td><td> 1</td></tr><tr><td> L</td><td> Operator calibration</td><td> 1</td></tr></table>
907b090d24e7848bf107ad7228a3eecd4b00054495b9e5bad2e45dcf7503f3c5.png
simple
<table><tr><td>Strain/Population</td><td>Wing length in mm (standard error)</td><td>Fecundity* (standard error)</td><td>Blood-meal size (&#956;l) (standard error)</td></tr><tr><td>Mbita</td><td>2.86 (0.03)</td><td>35.97 (2.56)</td><td>3.15 (0.14)</td></tr><tr><td>Ifakara</td><td>2.89 (0.03)</td><td>49.27 (2.67)</td><td>2.54 (0.08)</td></tr><tr><td>F<sub>1 </sub>from Mbita female &#215; Ifakara male</td><td>3.13 (0.03)</td><td>74.87 (2.63)</td><td>4.04 (0.16)</td></tr><tr><td>F<sub>1 </sub>from Ifakara female &#215; Mbita male</td><td>3.03 (0.02)</td><td>83.20 (5.36)</td><td>4.51 (0.21)</td></tr><tr><td>F<sub>5 </sub>from Mbita female &#215; Ifakara male</td><td>2.94 (0.02)</td><td>68.93 (2.61)</td><td>4.02 (0.16)</td></tr><tr><td>F<sub>5 </sub>from Ifakara female &#215; Mbita male</td><td>3.14 (0.02)</td><td>68.77 2.69)</td><td>3.38 (0.18)</td></tr></table>
c948b75a5c08c6b0181b2a75f14f4d3059f877040a66a0492b4923139955bbf8.png
complex
<table><tr><td rowspan="2">Sponge isolate</td><td colspan="3">Inhibition zone diameter (mm)</td></tr><tr><td><i>S. aureus</i> 8325</td><td><i>E. faecalis</i> JH212</td><td><i>C. albicans</i> S314</td></tr><tr><td><i>Actinokineospora</i> sp. EG49*</td><td>0</td><td>0</td><td>12</td></tr><tr><td><i>Dietzia</i> sp. EG67</td><td>13</td><td>0</td><td>0</td></tr><tr><td><i>Microbacterium</i> sp. EG69*</td><td>10</td><td>9</td><td>0</td></tr><tr><td><i>Micromonospora</i> sp. RV115</td><td>12</td><td>10</td><td>0</td></tr><tr><td><i>Rhodococcus</i> sp. EG33*</td><td>12</td><td>8</td><td>0</td></tr><tr><td><i>Rubrobacter</i> sp. RV113**</td><td>9</td><td>0</td><td>0</td></tr><tr><td><i>Streptomyces</i> sp. RV15*</td><td>17</td><td>11</td><td>13</td></tr></table>
f83d47b3447058a7c32a2f64a56dafe0de9d79fde43a587ff36dbc31e3d1491c.png
simple
<table><tr><td>Meaning units</td><td>Condensed text</td><td>Themes</td></tr><tr><td>Has gained greater insight from the patients&#8217; perspective to better understand and involve the patients Has developed and increased an awareness of nurturing the whole patient</td><td>An increased understanding of the patients&#8217; perspective makes it easier to involve patients. The awareness of caring for the whole patient has increased</td><td>Focus on the patient perspective and paying more attention to others</td></tr><tr><td>Working in study groups motivates one to engage more in studies and provides greater learning</td><td>It is motivational and educational to work in study groups</td><td>Learning from discussions and reflections on one&#8217;s own learning</td></tr></table>
c1ed65d06390bca1bc928a38630d0f31f0026ea2abc82ef07d6d96cdd5849dfc.png
complex
<table><tr><td></td><td colspan="2">Nulliparae</td><td colspan="2">Multiparae</td></tr><tr><td></td><td>1998-2002</td><td>2003-2007</td><td>1998-2002</td><td>2003-2007</td></tr><tr><td>Characteristics</td><td colspan="2">OR* multivariable</td><td colspan="2">OR* multivariable</td></tr><tr><td></td><td colspan="2">(95% CI<sup>#</sup>)</td><td colspan="2">(95% CI<sup>#</sup>)</td></tr><tr><td>referral</td><td></td><td></td><td></td><td></td></tr><tr><td> - before the onset of labour (reference)</td><td>1.00</td><td>1.00</td><td>1.00</td><td>1.00</td></tr><tr><td> - during labour</td><td>1.23 (1.18-1.28)</td><td>1.02 (0.99-1.05)</td><td>1.54 (1.48-1.60)</td><td>1.12 (1.08-1.16)</td></tr><tr><td>process of birth</td><td></td><td></td><td></td><td></td></tr><tr><td> - spontaneous, no induction, no augmentation (reference)</td><td>1.00</td><td>1.00</td><td>1.00</td><td>1.00</td></tr><tr><td> - induction</td><td>0.74 (0.70-0.77)</td><td>0.78 (0.75-0.81)</td><td>0.78 (0.75-0.81)</td><td>0.83 (0.80-0.86)</td></tr><tr><td> - augmentation</td><td>0.81 (0.77-0.84)</td><td>0.80 (0.77-0.82)</td><td>0.79 (0.76-0.83)</td><td>0.79 (0.76-0.82)</td></tr><tr><td> - vacuum/forceps/CS</td><td>0.01 (0.01-0.02)</td><td>0.03 (0.03-0.03)</td><td>0.01 (0.01-0.01)</td><td>0.01 (0.01-0.01)</td></tr><tr><td>time of birth</td><td></td><td></td><td></td><td></td></tr><tr><td> - weekday 8.00-20.00 (reference)</td><td>1.00</td><td>1.00</td><td>1.00</td><td>1.00</td></tr><tr><td> - evening, night of weekend</td><td>0.83 (0.80-0.86)</td><td>0.71 (0.70-0.73)</td><td>0.82 (0.80-0.85)</td><td>0.75 (0.73-0.77)</td></tr><tr><td>Maternal age</td><td></td><td></td><td></td><td></td></tr><tr><td> - &lt; 25</td><td>1.03 (0.98-1.07)</td><td>1.05 (1.02-1.08)</td><td>0.97 (0.91-1.03)</td><td>1.02 (0.97-1.08)</td></tr><tr><td> - 25-&lt; 35 (reference)</td><td>1.00</td><td>1.00</td><td>1.00</td><td>1.00</td></tr><tr><td> - &#8805; 35</td><td>0.96 (0.91-1.03)</td><td>0.93 (0.89-0.97)</td><td>0.99 (0.95-1.02)</td><td>0.95 (0.92-0.98)</td></tr><tr><td>Ethnicity</td><td></td><td></td><td></td><td></td></tr><tr><td> - western (reference)</td><td>1.00</td><td>1.00</td><td>1.00</td><td>1.00</td></tr><tr><td> - non-Western</td><td>1.16 (1.10-1.22)</td><td>1.07 (1.03-1.11)</td><td>1.23 (1.19-1.28)</td><td>1.04 (1.01-1.08)</td></tr><tr><td>Gestational age</td><td></td><td></td><td></td><td></td></tr><tr><td> - &lt; 32 weeks</td><td>0.24 (0.21-0.28)</td><td>0.20 (0.18-0.22)</td><td>0.24 (0.21-0.28)</td><td>0.24 (0.21-0.27)</td></tr><tr><td> - 32-&lt; 37 weeks</td><td>0.59 (0.55-0.62)</td><td>0.63 (0.61-0.66)</td><td>0.57 (0.54-0.61)</td><td>0.61 (0.58-0.64)</td></tr><tr><td> - 37-&lt; 42 weeks (reference)</td><td>1.00</td><td>1.00</td><td>1.00</td><td>1.00</td></tr><tr><td> - &#8805; 42 weeks</td><td>1.12 (1.04-1.19)</td><td>1.19 (1.13-1.25)</td><td>1.12 (1.06-1.19)</td><td>1.21 (1.15-1.27)</td></tr><tr><td>Type of hospital</td><td></td><td></td><td></td><td></td></tr><tr><td> - academic</td><td>8.62 (8.01-9.28)</td><td>2,12 (2,02-2,21)</td><td>8,80 (8.46-9.52)</td><td>3.29 (3.16-3.43)</td></tr><tr><td> - teaching (reference)</td><td>1.00</td><td>1.00</td><td>1.00</td><td>1.00</td></tr><tr><td> - non-teaching</td><td>8.21 (8.02-9.28)</td><td>3.50 (3.41-3.60)</td><td>7.55 (7.18-7.94)</td><td>4.09 (3.97-4.21)</td></tr></table>